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Abstract
Studies within this thesis have investigated various aspects of the relationship between 
physique, coronary artery disease (CAD) and certain CAD risk factors. Data presented 
was collected on two separate occasions. Firstly, in a hospital setting on men 
undergoing investigative coronary angiography (CAD men), and secondly during a 
university health-screening programme (healthy men). Physique has been described 
using body mass and height, somatotype, skinfolds, girth measurements and various 
skinfold and girth ratios. CAD risk factors were related to ’metabolic fitness’ : fasting 
serum glucose, total cholesterol (TC), triglyceride (TG), low-density lipoprotein 
cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C) and the LDL-C ; 
HDL-C ratio. A unique aspect of certain studies is that a proportionality technique 
was used to adjust the anthropometric measurements for variation in body mass and 
stature. Also, an angiographic scoring system was used to describe the severity of 
atherosclerosis as a continuous rather than dichotomous variable. Anthropometric 
measurements were not related to the severity of atherosclerosis and there was no 
discernible pattern of subcutaneous adiposity (skinfolds) in the CAD or healthy men. 
However, in relation to age-matched healthy men, the CAD men were heavier (P < 
0.01), had a greater BMI (P < 0.01), biceps skinfold (P < 0.05) and subscapular 
skinfold (P < 0.001). The CAD men also had significantly greater waist and 
abdominal girths, abdominal sagittal diameter (ASD), waist-to-hip ratio (WHR), 
abdomen-to-hip ratio (AHR), waist-to-thigh ratio (WTR), waist-to-height ratio 
(WHtR) and ASD-to-height ratio (ASD/Ht) (all P < 0.001). When the skinfolds and 
girths were adjusted for variation in stature the differences in biceps and subscpaular 
skinfolds, and waist and abdominal girths remained. However, when adjusted for
XIII
body mass variation the differences were no longer apparent. Abdomen and waist 
girths exhibited a closer association with TC, TG, HDL-C, LDL-C and the LDL-C : 
HDL-C ratio than skinfolds. A higher waist or abdominal girth was positively 
correlated with TG (P < 0.01), and the LDL-C : HDL-C ratio (P < 0.01) but 
negatively with HDL-C (P < 0.01). Adjusting for stature had no effect on these 
relationships, but adjusting for body mass reduced them considerably. In studies 
focusing on somatotype, both the CAD and healthy men were characterised by high 
ratings for endomorphy and mesomorphy but low ratings for ectomorphy. The CAD 
men had a small but significantly greater endomorphy rating (P = 0.038) and the 
healthy men had a small but significantly greater ectomorphy rating (P = 0.006). 
Somatotype was not related to the angiographic findings but a somatotype of low 
endomorphy and high ectomorphy was associated with a better metabolic profile in 
terms of cardiovascular disease risk. In conclusion, CAD men appear to have a 
physique characterised by abdominal obesity, a higher rating of endomorphy and a 
low rating for ectomorphy. However, a distinctive skinfold pattern is not apparent. 
Normalising anthropometric measurements for stature does not affect the relationship 
between elevated serum lipids and abdominal obesity but adjusting for body mass 
does.
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CHAPTER 1 
INTRODUCTION
The association between human physique and susceptibility to a wide variety of 
morbid conditions, including atherosclerotic coronary artery disease (CAD), has 
intrigued scientists for many years. There are references to ill-health accompanying 
excess body fat (obesity) from Hippocrates and an awareness of differences in 
anatomical fat patterning that date back about 30,000 years (see Kissebah and 
Krakower, 1994 for further details). In more recent times, Kretschmer (1926) noted 
differences in the prevalence of stroke and gout according to variation in body 
habitus. With regard to health status, there is no doubt that most attention has focused 
on the important issue of obesity. However, there are other aspects of human 
physique, such as muscularity, linearity and proportionality, that have received much 
less attention. Since the discoveries of Vague were reported in 1947 (Vague, 1947), 
many investigators have concentrated their efforts on clarifying the apparent 
importance of adipose tissue distribution - particularly with regard to CAD and 
diabetes.
As outlined in Section 1.3, diseases of the cardiovascular system, of which 
atherosclerotic CAD is the most prevalent, are the major cause of premature mortality 
in the ’modernised’ world. Atherosclerosis is a condition in which fatty substances, 
especially cholesterol, are deposited within the wall of small and medium-sized 
arteries. This deposition is accompanied by damage to endothelial cells lining the 
arterial wall, the adhesion of circulating monocytes to the site of injury and 
proliferation of smooth muscle cells. The monocytes subsequently develop into lipid­
laden macrophages. As these processes continue and arterial occlusion increases, a 
significant reduction in blood flow distal to the site of injury occurs. If coronary 
vessels are affected, and blood flow is sufficiently reduced, myocardial ischaemia 
results. In some instances, the atherosclerotic plaque may rupture leading to the
release of large particles into the bloodstream. These particles can result in the almost 
total blockage of smaller coronary vessels leading to a myocardial infarction - more 
commonly referred to as a heart attack’.
1.1 DEFINITIONS AND CLASSIFICATION OF OVERWEIGHT AND 
OBESITY
The medical, scientific and popular literature is replete with references to the terms 
overweight and obesity. In the majority of studies, and for most individuals, 
overweight refers to a condition in which an excess of body fat is present and is 
thought to be associated with deterioration in health. In the ’general public’ it has been 
estimated that about 1 in 10 will be described as overweight when, in fact, their body 
fat is not elevated excessively. In athletically trained populations, this proportion will 
be much higher because of the increased muscle mass. This problem of 
misclassification is due to the application of relatively crude indices of body fatness, 
most noticeably body mass index (BMI). A detailed description of BMI is given in 
Section 1.1.1. In large-scale epidemiological surveys, therefore, when simple and 
inexpensive measures are needed these indices suffice. In smaller, heterogeneous 
populations, however, they may be inappropriate.
Based on the BMI system presented in Section 1.1.1, obesity represents a 
continuation of the overweight condition to a higher level of body fat. Again, when 
body mass-for-stature is used, no indication of actual body fat is given. Thus, there is 
a need for some clarification of these terms so that they become meaningful in the 
context of either representing some level of body fat or, they are associated with co- 
morbid conditions. The aim of the following section is to provide this clarification by 
outlining currently used methods for assessing overweight and obesity. The focus has
been restricted to simple methods for two reasons. Firstly, these are the methods that 
have been employed by epidemiologists in their study of the relationship between 
obesity and disease. Second, they are the methods that the public is encouraged to 
recognise because they are used to direct public health policy.
Any index or measurement of overweight and obesity should meet three 
important conditions. If the index is going to be used to identify individuals who are 
more likely to experience ill-health or functional limitations, it should be closely 
associated with morbidity and mortality. However, it is important to note that the 
association with the index of overweight or obesity may vary with the health risk 
examined. For example, Sakurai et al. (1995) have shown that the waist-to-hip ratio 
(WHR), an index of anatomical fat distribution, is a good predictor of diabetes, 
probably because this index also contains information about muscle mass, whereas 
hypertension was more closely related to BMI than WHR. A further important issue 
that should be delineated clearly is the interaction of the index or measurement with 
age, ethnicity and gender. That is, does the association with fatness, morbidity and 
mortality change with variation in these population parameters. If this is the case, 
adjustments should be considered and a population-specific index derived.
Finally, the measurements used to construct the index should be relatively 
simple and reproducible. This ensures that primary health professionals are able to 
record them with minimal training and equipment. The measurements or index should 
also be related to body fatness in order that underlying mechanisms can be explored.
1.1.1 Body mass index
With the above factors in mind, several methods have been investigated and 
subsequently proposed for classifying and defining overweight and obesity. Body 
mass index is calculated from measurements of body mass and stature (kg.m'^).
The rationale for the use of BMI as an index of fatness is that it provides a 
stature-independent measure of body mass. In most free-living individuals in 
modernised societies, an increase in body mass that is independent of stature will be 
due to an increase in fat mass. Therefore, on a population basis, BMI should provide a 
reasonable estimate of fatness. However, in the general population, the variation in 
body fat explained by variation in BMI is 50 to 60% (James, 1996). This suggests 
there is a wide variation in body fatness within any BMI category. Bouchard (1990), 
who suggests that the common variance between BMI and relative fat derived from 
underwater weighing is only about 40%, supports this. Furthermore, misclassification 
will occur when BMI is applied to lean individuals who have a large muscle mass. 
The use of stature squared is also questionable and is used by most researchers 
without proper consideration. Ideally, this power-function should be determined for 
each population on the basis that it provides the minimal correlation between BMI and 
stature i.e. a mass-for-stature index that is truly independent of stature
Body proportions also effect BMI. Very tall individuals with legs that are 
relatively long for stature have spuriously low BMI scores in comparison to shorter 
individuals of similar body fat. Shorter individuals, with relatively short muscular legs 
and a thick trunk will have a high BMI and may, therefore, be classified as obese even 
though they may be lean (James, 1996).
Despite these limitations, BMI remains a useful index of overweight and obesity 
for the following reasons. It is determined from body mass and stature, measurements
that are in widespread use throughout the world. Body mass and stature are simple 
measurements that can be made in the health-care facility, research centre or in the 
field. The simplicity and robustness of the nieasurements mean that normative values 
exist for many populations. Finally, it shows a statistical relationship with morbidity 
and mortality from many causes - including cardiovascular disease (CVD). This 
relationship will be examined in detail in Chapter 2.
The most recent classification scheme based on BMI values is given below 
[Table I (1.1)]. These values, proposed by the World Health Organisation (WHO, 
1998) and the National Institutes of Health and National Heart, Lung, and Blood 
Institute (NIH & NHLBI, 1998) are appropriate for use with adults. The table also 
presents the health risk associated with the respective level of BMI.
Table 1(1.1). World Health Organisation Classification o f Body Mass Index
Classification BMI (kg.m- )^ Associated health risks
Underweight <18.5 Low (but risk of other clinical
problems increased).
Normal range 18.5-24.9 Average
Overweight 25.0 or higher
Pre-obese 25.0-29.9 Increased
Obese class I 30.0-34.9 Moderately increased
Obese class II 35.0-39.9 Severely increased
Obese class III 40 or higher Very severely increased
1.1.2 Skinfolds and Relative Body Fat
Anthropometric skinfold measurements have been used to estimate body fatness for 
many years and in many different populations. Initially, it was thought that the
proportion of stored subcutaneous fat is relatively constant. Lohman (1981) suggested 
that approximately 50 to 70% of body fat is stored subcutaneously. Thus, there 
appeared to be some logic behind the use of skinfolds as a measure of body fatness. 
However, subsequent studies discussed later in this section have cast doubt on this 
assumption (Martin et al., 1985, 1992, 1994; Clarys et al., 1987). The skinfold 
method requires a double thickness of skin and underlying adipose tissue (AT) to be 
measured with callipers that exert a constant pressure over the range of skinfold 
thickness encountered.
As a close inverse relationship exists between whole-body density and relative 
body fat (Dumin and Womersley, 1974), it is possible to predict fatness from whole- 
body density. The estimation of body fat (relative and absolute) from skinfolds is, 
therefore, based upon the regression of the logarithmic transformation of skinfolds 
against whole-body density. The procedure of underwater weighing usually provides 
the criterion method for measuring body density. Thus, body fat derived from skinfold 
measurements is regarded as being ’doubly-indirect’ i.e. one indirect method is 
validated against another indirect method. As whole-body density determined from 
underwater weighing is dependent on the densities of all of the body’s component 
parts, the relationship between skinfolds and body density varies across populations. 
For the same amount of body fat, individuals who differ in the density of their fat-free 
mass (FFM) will have different whole-body densities. Thus, the literature contains 
many linear and quadratic regression equations for the estimation of body density (or 
body fat) from skinfolds. The linear equations of Dumin and Womersley (1974), and 
the quadratic equations of Jackson and Pollock (1978) and Jackson, Pollock and Ward 
(1980) are probably the most frequently used equations for predicting fatness in the 
general population. Each equation is specific to the population on which it was
validated and the application to other populations is likely to result in unacceptable 
estimation error.
Despite their widespread use, the use of skinfold regression equations to predict 
body fatness has been severely criticised recently. Much of this criticism emanates 
from the findings of the Brussels Cadaver Analysis Study (Martin et al., 1985, 1992, 
1994; Clarys et al., 1987).
When skinfolds are used to predict body fat, several assumptions have to be 
made (Martin et al., 1985; Heyward and Stolarczyk, 1996; Hawes and Martin, 2001). 
These are outlined below but are not presented in order of importance. Firstly, one has 
to assume that the skinfold is closely related to subcutaneous fat at that particular site. 
As outlined previously, a skinfold consists of a double layer of skin and the 
underlying AT. This assumption has two potential problems, both of which relate to 
factors that are unknown to the anthropometrist. The thickness of skin is an unknown 
quantity and the composition of the AT within the skinfold is also unknown. The 
second assumption is that there is a constant distribution of internal and subcutaneous 
fat for all individuals. Third, the compressibility of skin is assumed to be either 
constant or represents a negligible fraction of the skinfold thickness. The fourth 
assumption is that a limited number of skinfolds can be used to estimate total body 
fat. For this assumption to be valid, there would need to be consistency in 
subcutaneous fat pattern between all individuals.
The Brussels Cadaver Analysis Study (Martin et al., 1985, 1992, 1994; Clarys 
et al., 1987) consisted of two separate cadaver dissection studies of men (n = 12) and 
women (n = 13) ranging in age from 55- to 94-years. Cadavers were extensively 
measured and dissected into skin, AT, skeletal muscle, bone, organs and visceral 
tissues. The study aimed to extend the existing quantitative data on tissues and organs
in humans, and obtain data to validate existing in vivo body composition methods and 
develop new anthropometric models of body composition. This study has, in recent 
years, provided the most precise data so far with respect to the mechanical and 
morphological characteristics of the skinfold (although the small sample of cadavers 
from an elderly and in some cases diseased group raises a question about the external 
validity of these findings). It has also questioned the validity of the method of 
predicting relative body fat from skinfolds by refuting the assumptions outlined 
above. For example, the constancy of skinfold thickness and compressibility was 
shown to be fallacious. Skin thickness clearly comprises a greater fraction of a thin 
skinfold in comparison to a thick skinfold. Skin thickness has been shown to vary 
between individuals and from site to site (Martin et al., 1992). Furthermore, AT 
compressibility varies with factors such as age, gender, tissue hydration, anatomical 
site and cell size (Martin et al., 1992). The lipid fraction of AT may also be highly 
variable. Martin et al. (1994) suggested a range of 60-85% although an earlier 
investigation found a much greater variation of 5.2 to 94.1% (Orpin and Scott, 1964). 
The final assumptions relating to the distribution of body fat are also questionable. 
Whilst several phenotypes for classifying regional fat distribution have been 
described, the distribution of fat internally (intra-abdominal, inter-muscular, intra­
muscular, intra-pelvic and essential lipids) and externally (subcutaneous) is, in fact, 
highly variable. Fat distribution is affected by factors such as age, gender, energy 
balance and the level of total body fat, and local AT biology (Bouchard et al., 1993). 
In general, for any sum of skinfolds, total body fat is likely to be higher in older 
individuals because of greater fat internalisation with age (Lemieux et al. 1995).
Given the apparent limitations associated with predicting total body fat from 
skinfolds, some now advocate using the sum of skinfolds as an index of body fatness
(Hawes and Martin, 2001). There are further advantages of using skinfolds in this 
way. When multiple skinfolds are selected from the torso and limbs, they are also 
useful for identifying variation in AT patterning. Furthermore, skinfold measurements 
are highly reproducible in the hands of trained and experienced investigators and can 
be compared to normative values where they exist. Finally, they represent an indicator 
of energy balance over the long-term and may, therefore, be related to diseases 
associated with lifestyle and nutritional status.
Two methods can be used to determine obesity from skinfolds. A population- 
specific regression equation could be used to provide an estimation of relative body 
fat. There are an abundance of such equations available in the literature. As well as 
being limited by the assumptions outlined earlier, this method is also subject to the 
inherent error of applying a regression formula to a sample that is different from the 
original validation sample. Apparently, this error can reach 200% (Katch and Katch, 
1980). The second approach is to compare skinfolds against age, gender and ethnicity 
specific normative values. Percentile rankings can then be used to form an opinion on 
individuals body fatness.
One further important point is worthy of mention with regard to the use of 
skinfolds. High-quality skinfold callipers such as the Harpenden and Lange 
instruments, are calibrated within the range of 0 to 60 mm and have a precision of 0.2 
and 1.0 mm respectively (Heyward and Stolarczyk, 1996). They are not accurate, 
therefore, when measuring the extremely obese who have skinfolds outside of this 
range. Furthermore, even when the skinfolds are within this range, measurement error 
is likely to be greater when dealing with larger skinfolds. The identification of bony, 
anatomical landmarks is also more difficult in the obese (Bray and Gray, 1988). For 
these reasons, alternative anthropometric methods that rely on circumference
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measurements (Weltman et a l, 1987; Weltman et al., 1988) have been recommended 
for estimating body composition in the obese (Heyward and Stolarcyzk, 1996).
If relative body fat is predicted from skinfolds or estimated by some other 
method, at what level of body fatness does obesity begin? Unlike BMI, there are few 
prospective epidemiological investigations that have used a ’direct’ measure of relative 
body fat as the main predictor variable (Keys et at., 1971; Weinsier et a l, 1976). It is 
not possible, therefore, to ascribe an obesity level commensurate with increased 
morbidity or mortality. An alternative approach is to assess body fatness in relation to 
the average for the population (McArdle et a l,  2001). This value should be 
considered in relation to the variation that is observed in populations who differ with 
regard to age, gender and ethnicity. However, this technique is also subject to a major 
limitation. Whilst the body composition of many different groups has been evaluated, 
no large-scale studies of the general population exist. McArdle et at. (2001) suggested 
that the average body fat of younger men is approximately 15%. For older men they 
suggest a value of about 25%, and for younger and older women, 25% and 32% 
respectively. The standard deviation (SD) of these mean values is about 5% body fat. 
Thus, an extremely rigorous way of defining where the lower boundary of obesity 
begins is to consider the average value and its variation. Obesity then begins at the 
average body fat plus 5%, i.e. 20% for younger men, 30% for older men and younger 
women, and 37% for older women. Although no clear rationale is provided for using 
one SD, with respect to the number of people classified as obese in the USA, this 
approach apparently corresponds closely to the method of using a BMI value >25 
kg.m'^ (McArdle et a l, 2001).
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1.1.3 Anthropometric girth measurements
One of the most significant advancements to the understanding of the association 
between obesity and cardio-metabolic disease came with the publication of two papers 
(Larsson et al., 1984; Lapidus et al., 1984) that supported an earlier observation made 
by Vague (1947). It appears from these studies that an obesity phenotype 
characterised by an accumulation of fat in the abdominal region carries the greatest 
risk of CAD. The reasons for this phenomenon, that has been shown in many studies 
subsequently, are explored in greater detail in Chapter 2. Briefly, disturbances in 
carbohydrate and lipid metabolism, elevated blood pressure, increased plasma 
viscosity, and a greater susceptibility to inflammation and thrombogenesis have all 
been implicated.
Fat deposition differences between males and females begin in childhood and 
become progressively established after maturation (Malina and Bouchard, 1988). 
Males tend to accumulate more truncal fat, whereas fat deposition in females tends to 
be at the same rate on the trunk and limbs (Malina and Bouchard, 1988). The study of 
a large number of obese men and women highlighted the sexual dimorphism that 
exists with regard to AT distribution in the mature individual (Krotkiewski et al., 
1983). When matched for body fat mass, females had a greater fat cell size and 
number in the gluteal and femoral regions and males a greater fat cell size and number 
in the abdominal region. Consequently, men had a greater AT thickness in the 
abdominal region and females a greater thickness in the gluteo-femoral region. Men 
also tend to have more visceral or intra-abdominal fat (lAF) for any given total body 
fat, although it increases with age in both genders and in the non-obese as well as the 
obese (Bouchard et al., 1993; Lemieux et al., 1993). Abdominal obesity, despite being 
primarily a male characteristic, is also observed in a sub-group of obese women.
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As lAF is thought to be the principal fat depot responsible for the atherogenic 
metabolic profile in abdominal obesity (Bjomtorp 1990), its valid determination is of 
great importance. The most frequently used anthropometric indicators of abdominal 
obesity have been the WHR and the waist and abdominal girths (see Williams et al., 
1997 for a review). The underlying theory of the WHR, is that it discriminates 
between fat deposited in the upper (waist and abdomen areas) and lower trunk (hips 
and buttocks). As a predominance of fat in the upper trunk is primarily a masculine 
characteristic, and predominance in the lower trunk feminine, the terms android and 
gynoid obesity (Vague, 1947) are used to characterise these types of fat distribution. 
Previous studies have shown that the waist circumference, measured at the level of 
natural narrowing between the lower rib and superior iliac crest, is the best 
anthropometric correlate of computed tomography (CT) measured lAF mass (Pouliot 
et al., 1994). This finding has received some support from a recent cadaver dissection 
of 100 men which found that the waist circumference, measured at a level within 1 cm 
of the umbilicus, is the best predictor of lAF (Pounder et al., 1997).
Several cut-off or threshold points of abdominal obesity have been suggested 
for WHR and waist circumference measurements [Table II (1.1)]. Based on the 
incidence of CVD morbidity and mortality in the prospective study of 792 
Gothenburg men, Bjomtorp (1985) suggested a WHR cut-off point of 1.00 for men. 
The same value was also later proposed by Bray (1987). Using the absolute level of 
visceral fat as the criteria defining increased CVD risk, Lemieux et al. (1996) 
proposed a WHR cut-off point of 0.94 and waist circumferences of 100 cm and 90 cm 
for men aged 40-years or less and greater than 40 respectively. Following analysis 
based on Receiver Operating Characteristic (ROC) Curves, Lean et al. (1995) 
proposed two waist circumference “action levels” that could be used to identify
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individuals at increased CVD risk from being both overweight (BMI > 25 kg.m'^) 
and/or abdominally obese (WHR > 0.95). This approach utilises the concepts of 
sensitivity (the proportion of people with a disease who are correctly identified by a 
positive test) and specificity (the proportion of people without the disease who are 
correctly identified by a negative test) (Fletcher et al., 1996). The waist circumference 
“action 1” level for men (94 cm) identified such subjects with a sensitivity of > 96% 
and a specificity of > 97.5%. The “action 2” level (102 cm) identified men with a 
BMI > 30 kg.m'^ and/or abdominal obesity with a sensitivity of > 96% and a 
specificity of > 98%. The same researchers later applied these “action levels” to a 
group of 2183 men in order to evaluate the sensitivity and specificity of identifying 
individuals with a total cholesterol (TC) > 6.5 mmol.L'\ a high-density lipoprotein- 
cholesterol (HDL-C) < 0.9 mmol.L'\ hypertension (treated and/or systolic pressure > 
160 mmHg and/or diastolic pressure > 95 mmHg) or a combination of these risk 
factors (Han et al., 1996a). At “action level 1”, sensitivity ranged from 56.8 to 71.2% 
and specificity from 63.1 to 72.1%. The point at which sensitivity equalled specificity 
provided a waist circumference that was within 2 cm of “action level 1”. This study 
found that using waist circumference as a tool to screen for individuals at risk of CVD 
because of hypercholesterolaemia, low HDL-C and/or hypertension would misclassify 
about 35% of subjects.
14
Table II (1.1 ). Guidelines for classifying abdominal obesity in men°.
Measurement Cut-off point Reference
WAIST GIRTH > 94.0 cm" Lean et al. (1995)
WAIST GIRTH > 102 cm' Lean et al. (1995)
WAIST GIRTH > 100 cm Lemieux et al. (1996)
WHR >1.0 Bjomtorp (1985) 
Bray (1987)
WHR >0.94 Lemieux et al. (1996)
“Molarius, A. and Seidell, JC. (1998). Selection of anthropometric indicators for classification of 
abdominal fatness - a critical review. International Journal o f Obesity, 22,719.
'’Represents a threshold above which risk of cardiovascular disease is slightly increased. Further weight 
gain should be avoided.
Represents a threshold above which risk of cardiovascular disease is increased further. Weight loss 
should be an aim.
1.2 THE CURRENT EPIDEMICS OF OBESITY AND TYPE 2 DIABETES
One of the major concerns for health professionals today is the alarming increase in 
obesity and the associated increase in type 2 diabetes. This is a feature of most 
modem westemised countries and also developing countries from the third-world 
(WHO, 1998). Perhaps more worrying is the sharp increase in obesity prevalence in 
children. This is also a global phenomenon (Lehingue, 1999; Reilly et al., 1999; 
Rasmussen and Johansson, 2000; Dwyer et al., 2000; Chinn and Rona, 2001; Rudolf 
et al., 2001; Magarey et al., 2001; Styne, 2001). In the majority of developed 
countries, obesity prevalence tends to increase with age up to about 60- to 70-years, 
and is more frequent in those of relatively low socio-economic status (Seidell and 
Flegal, 1997; Evans et al., 2000). Increasing economic prosperity in certain 
population groups may limit, but not stop, the increase in obesity prevalence (Maillard 
et al., 1999).
15
Type 2 diabetes is a condition of hyperglycaemia caused by marked skeletal 
muscle and hepatic insulin resistance. Skeletal muscle is the major site of post­
prandial glucose disposal, and the liver is responsible for glucose production by the 
process of gluconeogenesis. As both of these processes are mediated by insulin, any 
defect in the normal action of this hormone on these tissues will lead to 
hyperglycaemia. In skeletal muscle the defect is reduced glucose uptake. In the liver, 
the defect is a lack of suppression of gluconeogenesis. Diabetes is diagnosed by 
reference to the plasma glucose concentration either in the fasting state (> 7.0 
mmoLL'^) or 2-hours after an oral glucose challenge (> 11.1 mmol.L'^) (The Expert 
Committee on the Diagnosis and Classification of Diabetes Mellitus, 1999).
Obesity prevalence has increased during a time when caloric intake, per capita, 
has decreased or remained stable (Abraham et al., 1995; Iwane, 1996; James, 1995; 
Kromhout et al., 1990), and the proportion of calories derived from dietary fat has 
declined (Ernst et al., 1997; Stephen and Sieber, 1994). Thus, other mechanisms have 
to be sought to explain this global occurrence. For example, Astrup (1998) reports that 
in Denmark, the prevalence of obesity has continued to increase despite a 10% 
reduction in dietary fat intake. In America, this phenomenon has been termed the 
American paradox’ and has been attributed to the increased consumption of high 
energy, low fat foods (Astrup, 1998).
As body mass is affected by energy intake as well as energy expenditure, it is 
not surprising several studies have reported an inverse relationship between habitual 
physical activity and weight gain (French et al., 1994; Schulz and Schoeller, 1994; 
Klesges et al., 1992; Rissanen et al., 1991; King et al., 2001). Further support for the 
role of physical activity as an important determinant of body weight regulation comes 
from a unique, forty-year study of UK citizens (Prentice and Jebb, 1995) and
16
investigations of traditional rural communities who have become progressively 
urbanised (Orr et a l, 1998). Thus, whilst many individuals still, undoubtedly, 
consume a diet containing a high proportion of fat, and are at risk of significant 
weight gain, the development of obesity is extremely complex and is determined by 
factors affecting both sides of the energy balance equation. The rapid increase in the 
prevalence of obesity suggests that the epidemic cannot be explained by changes in 
genotype. Instead, alterations in lifestyle, particularly reductions in habitual physical 
activity, offer the best possible explanation of the increased obesity prevalence. Foreyt 
and Goodiick (1995) have suggested that the increased annual incidence of obesity is 
"unstoppable" in the face of modernisation and mechanisation. Adopting the term "the 
ultimate triumph of obesity", they further suggest that at the current rate of increase, 
100% of US adults will be obese by the year 2230. The problem of the increasing 
incidence of obesity is not confined to modem, developed nations. In densely 
populated countries such as China and India, a 1% increase in obesity prevalence 
results in about 20 million new cases of obesity (Visscher and Seidell, 2001). The 
health consequences of this obesity ’explosion’, especially in children and adolescents, 
will lead to unprecedented cases of type 2 diabetes, CVD, hypertension, gallbladder 
disease, postmenopausal breast cancers, osteoarthritis of the knees, back pain and 
mental disabilities (Bouchard, 2000).
In recognition of this increased prevalence, several of the world’s major health 
organisations have convened expert panels to produce strategies aimed at confronting 
this problem. Reports from the WHO and the NIH & NHLBI in the USA summarise 
the findings of these panels (WHO, 1998; NIH & NHLBI, 1998).
Estimates of obesity prevalence by global region are shown below [Table I
(L2%.
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Table I (1.2). Estimated World Prevalence of Obesity.
Region Population 
aged over 
15 years 
(millions)
Prevalence 
of obesity 
(%)
Approximate estimate of 
number of obese subjects in 
millions (midpoint)
Established market 640 15-20 96-128 (112)
economies
Former socialist 330 20-25 66-83 (75)
economies
India 535 0.5-1.0 3-7 (5)
China 825 0.5-1.0 4-8 (6)
Other Asia and 430 1-3 4-12 (8)
islands
Sub-Saharan Africa 276 0.5-1.0 1-3 (2)
Latin America and 280 5-10 14-28 (21)
Caribbean
Middle Eastern 300 5-10 15-30 (22)
Crescent
World 3616 (251)
Information taken from Seidell (2000) and the population sizes and regions from Murray and Lopez, 
(1996).
Best estimates suggest that there are approximately 250 million obese adults 
worldwide - this is about 7% of the global population (Seidell, 2000). The global 
prevalence of overweight, defined as a BMI between 25 and 30 kg.m'^, is two or three 
times greater than the prevalence of obesity (Seidell, 2000).
In the UK, the prevalence of obesity (BMI > 30.0 kg.m'^) has also increased 
dramatically. From 1980 to 1996, the proportion of obese women increased from 8 to 
18%. During the same period, the proportion of men who were classified as obese 
rose from 6 to 16% (Fehily, 2000).
The WHO MONICA project has recently provided data on global obesity 
prevalence using waist girth cut-off points (Molaiius et al., 1999). This study has 
shown a marked variation in the prevalence of obesity in different regions. For 
example, using a waist girth of 102 cm as the cut-off point for the classification of 
obesity, the prevalence of obese men in Beijing, China was only about 4%. In rural
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Czech Republic this value is about 32% and Glasgow, Scotland about 22%. This waist 
girth criteria also results in a higher obesity prevalence than using BMI > 30.0 kg.m"^, 
because it also includes some men in the overweight category (Seidell, 2000). In 
women, the prevalence of abdominal obesity (waist girth > 88 cm) in the USA has 
recently been reported to be about 43%, 56% and 55% in White, Black and Hispanic 
groups respectively (Okosun et al., 1999). For men, corresponding figures using a 
waist girth cut-off point of > 102 cm were approximately 27%, 20% and 21%.
Whilst the aetiology of type 2 diabetes as it relates to obesity and fat distribution 
will be reviewed in Chapter 2, an outline of its frequency is appropriate at this point, 
because the increased prevalence of this disease closely resembles the increase in 
obesity prevalence.
Data from the Behavioural Risk Factor Surveillance System (BRFSS) have 
recently shown that the prevalence of diabetes in the USA increased from 4.9 to 6.5% 
between 1990 and 1998 (Mokdad et al., 2000). This increase in diabetes frequency 
appears to be a characteristic of all age, sex and ethnic groups (Mokdad et al., 2000; 
Burke et al., 1999).
Figure 1 (1.2), shows the global prevalence of diabetes in 1995 and projected 
estimates for the year 2025 in adults aged > 20 years (King et al., 1998). These 
projections are based on the expected expansion of the world’s population in 
developed and developing economies. Developed economies include all European and 
North American Nations, Australia, New Zealand and Japan. Developing economies 
represents all other countries. Between 1995 and 2025, it is estimated that there will 
be an increased global prevalence of diabetes of 35%. In developed countries the 
increased prevalence will be 27% and in developing countries the increase will be 
48%.
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Figure 1 (1.2). Global prevalence o f diabetes by world region in 
1995 and projected estimates in 2025.
(Adapted from King et al. 1998).
Developed Developing World
The number of people diagnosed with diabetes in 1995 and the projected 
estimate in 2025 is shown in Figure 2 (1.2). The number of adults with diabetes in the 
world is estimated to increase by 122%, from 135 million in 1995 to 300 million in 
2025. In the developed countries, there will be a 42% increase - from 51 to 72 million. 
In the developing countries, the increase will be 170%. An increase from 84 to 228 
million (King et al., 1998).
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Figure 2(1.2). Number o f people with diabetes by world region in 
1995 and projected estimates in 2025.
(Adapted from King et al, 1998).
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These trends for obesity and type 2 diabetes are of obvious personal and 
economic concern. Type 2 diabetes is the sixth leading cause of death, and accounts 
for nearly 95% of all diabetes in the USA (Kriska et al., 1993). With treatment costs 
exceeding $1 billion each year, the increasing prevalence of type 2 diabetes is one of 
the major health issues of current times. Data from the first National Health and 
Nutrition Examination Survey (NHANES I) and the NHANES I Epidemiologic 
Follow-up Survey have recently shown that, since 1970, coronary heart disease 
(CHD) mortality has fallen by 36% and 27% in non-diabetic males and females 
respectively. However, for diabetic males there has been a decline of only 13%, and 
for diabetic females, there has actually been an increase in CHD mortality of 23% (Gu 
et al., 1999).
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In the USA in 1995, obesity-related medical complications were estimated to 
have cost approximately $52 billion. Approximately $32 billion was attributable to 
diabetes (Wolf and Colditz, 1998). The estimated annual number of deaths in the USA 
attributed to obesity is about 300,000 (Allison et al., 1999; Calle et al., 1999).
1.3 RECENT AND FUTURE TRENDS IN CARDIOVASCULAR DISEASE
Despite continuing to be the leading cause of morbidity and mortality in modem 
industrialised nations, CVD death rates have declined over the past 30 years in many 
developed countries (Ounpuu et al., 2001). In developing countries, the opposite has 
been the case, where CVD mortality rates have increased (Ounpuu et al., 2001). The 
incidence of coronary artery disease (CAD), the most prevalent cardiovascular disease 
has also declined during recent decades since its peak in the 1960’s (Rosamund et al., 
1998; Goldberg et al. 1999). Globally, however, it is anticipated that between the 
years 1990 and 2020 morbidity and mortality rates from CAD will more than double 
(Ounpuu et al., 2001). About 82% of the increase in mortality and 89% of the 
anticipated increase in morbidity will be seen in developing countries (Murray and 
Lopez, 1996).
The close association between diabetes and CVD suggests that current 
predictions of a large increase in the prevalence of type 2 diabetes may well precede a 
large increase in CVD (James, 2001). Some evidence for this is already available. Hu 
et al. (2000) have recently reported that an increase in BMI among 85,941 females 
explained an 8% increase in CHD, whilst decreases in cigarette smoking, an 
improvement in diet and an increase in postmenopausal hormone use explained 
decreases in CHD of 13%, 16% and 9% respectively. Table I (1.3) below, adapted
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from Ounpuu et al. (2001) gives the estimated rates of global CAD based on 
demographic changes and the future effects of current cigarette smoking patterns. In 
the established market economies of Europe, North America, Japan and Australasia 
this increase in CAD mortality is equal to a 46% increase in men and a 32% increase 
in women from 1990 to 2020.
Table I  (1.3). Regional différences in the burden o f CAD by sex and projected 
estimates for the future.
Population estimates
Region Total Total CAD CAD
number of number of prevalence in prevalence in
men women men women
1990/2020 1990/2020 1990/2020 1990/2020
(millions) (millions) (x 100,000) (x 100, 000)
Established market 390/434 407/455 8.3/12.1 8.4/11.1
economies
Former socialist 165/170 181/191 4.7/7.1 5.6/7.0
economies
India 439/608 410/589 6.2/14.1 5.6/12.0
China 585/727 548/721 3.9/8.1 3.8Z6.8
Other Asia and 343/497 340/505 2.3/5.8 2.315.5
islands
Sub-Saharan Africa 252/555 258/565 0.9/2.2 1.2/2.6
Latin America and 222/331 223/336 1.8/4.4 1.7/4.1
Caribbean
Middle Eastern 256/496 247/487 3.2/8.7 2.911.2
Crescent
World 2654/3819 2614/3848 31.3/62.6 31.3/56.3
From Ounpuu et al. (2001)
1.4 PHYSIQUE AND CORONARY ARTERY DISEASE
1.4.1 Obesity and fat distribution
The association between physique and CAD morbidity and mortality has been studied 
extensively over several decades. Many of these studies have been reviewed recently 
(Williams et al., 1997). Methods employed in these studies to characterise physique
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include body weight and height, weight-for-height, relative weight, body composition, 
adipose tissue distribution and somatotype. Vague (1947) was the first to suggest that 
an obesity phenotype characterised by an accumulation of fat in the abdominal region 
confers the greatest risk of CAD. Several prospective and case-control studies, using 
the WHR or some other simple anthropometric indicator of AT distribution, have 
since confirmed this finding (Larsson et ah, 1984; Casassus et al., 1992; Hauner et al., 
1990; Kahn et al., 1996; Thompson et al., 1991), although there are studies reporting 
contrary results (Hodgson et al., 1994; Flynn et al., 1993; Hartz et al., 1990).
The distribution of subcutaneous AT, and torso skinfold thickness, have also 
been shown to be predictors of CAD (Ducimetiere et al., 1986; Donahue et al., 1987; 
Hargreaves et al., 1992; Stokes et al., 1985; Freedman et al., 1995). However, only 
one study has previously examined skinfold thickness in relation to angiographically- 
determined CAD (Hodgson et al., 1994).
Data from large-scale studies of British and Japanese adults suggest that the 
ratio of waist circumference-to-height is the most powerful anthropometric predictor 
of mortality (Cox et al., 1996) and CAD risk factors (Hsieh and Yoshinaga, 1995). 
Although Ashwell et al. (1996a) have supported these claims, and suggested that this 
ratio is a better predictor of lAF than waist circumference alone (Ashwell et al., 
1996b), others have disagreed (Han et al., 1996b; Han et al., 1997).
Most ratios aim to control for the confounding influence of the denominator. In 
the case of the waist-to-height ratio the aim is to control for differences in stature. 
This ratio has been used to address the question of whether it is the absolute waist 
girth, or the relative size of the waist girth to height, that is the best predictor of 
cardiovascular morbidity and mortality. As discussed recently, however, ratios present 
problems with regard to their interpretation (Molarius and Seidell, 1998) and also in
24
their use in statistical analyses (Allison et al., 1995). For example, a large waist-to- 
height ratio, may result from a large waist circumference or alternatively to short 
stature. As height is inversely related to the risk of CAD (Hebert et al., 1993) this 
makes it difficult to separate risk associated with increased waist girth from risk 
associated with shorter stature.
Proportionality refers to the relationship of body parts to one another or to the 
whole body (Ross and Marfell-Jones, 1991) and provides an alternative approach to 
the study of fat distribution in CAD that avoids the use of ratios. This approach was 
devised by Ross and Wilson (1974) and is based on the concept of a theoretical 
unisex, bilateral reference human (a Phantom) which can be used to proportionally 
adjust anthropometric measurements to a given body size. The Phantom is not a 
normative system but a calculation device based on the geometrically-adjusted means 
(adjusted to the Phantom stature, 170.18 cm) and standard deviations of large 
samples. Any anthropometric measurement can be geometrically-scaled and 
expressed as a z-value (interpreted as a SD) or proportionality score.
No study has previously used this approach to consider the proportional size of 
skinfolds and girth measurements in patients with CAD, although several 
investigators have considered this issue in relation to athletic performance (Ross and 
Ward, 1984; Soval et al., 1992; DeRose et al., 1989). Furthermore, the proportional 
size of skinfolds and abdominal girth measurements has not been examined in relation 
to the metabolic component of health-related fitness. This component, termed 
"metabolic fitness" by Bouchard and Shephard (1993) includes factors such as fasting 
and postprandial glucose and lipids.
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1.4.2 Somatotype
The somatotype is a classification of human physique based on the concept of body 
shape independent of size (Carter and Heath, 1990). In the somatotype, body-shape is 
expressed as a series of three numbers each representing a particular component. 
These are always recorded together and in the same order. The first figure represents a 
rating of endomorphy, the second mesomorphy, and the third ectomorphy (Carter and 
Heath ,1990). Dominant in the early development of somatotype methodology was the 
work of Sheldon et al. (1940), in which ratings began at zero and had a fixed upper 
point of seven. More recently, the method developed originally by Heath and Carter 
(1967) has predominated. This method uses much of Sheldon’s original vocabulary, 
although some of the fundamental ideas have been revised. A detailed description of 
this method has been provided recently (Carter and Heath, 1990). Briefly, Heath- 
Carter somatotype classifications can be obtained either by inspection of a standard 
somatotype photograph, from a series of anthropometric measurements, or preferably, 
from a combination of photographic inspection and anthropometric measurements 
(Carter and Heath, 1990). A physique attributed a high endomorphy rating is 
characterised by a large subcutaneous fat deposit, or noticeable relative fatness. High 
ratings in mesomorphy signify a large musculature and bone mass relative to stature. 
High ratings in ectomorphy describe a physique with little mass relative to stature and 
relatively elongated limb segments (Carter and Heath, 1990). Component ratings still 
begin theoretically at zero but have no fixed upper-end points. In general, component 
ratings of 0.5 to 2.5 are regarded as low, 3 to 5 as midrange, 5.5 to 7 as high and 
greater than 7 extremely high. Thus, the classification 7 - 1 - 1  represents an extreme 
endomorph, 1 - 7 - 1  represents an extreme mesomorph and 1 - 1 - 7 an extreme 
ectomorph. A 3 - 3 - 3  or 4 - 4 - 4  classification represents a central or balanced
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somatotype, 4 - 5 - 1 an endomorphic-mesomorph and 2 - 3 - 5 a mesomorphic- 
ectomorph. Extreme examples for each of these components would be an obese 
individual (endomorphy), a body-builder (mesomorphy) and the Nilote people of 
Sudan who exhibit extreme ectomorphy (Carter and Heath, 1990).
The association between somatotype and CHD received some attention several 
decades ago but has not been studied extensively (Gertler et al., 1950, 1951, 1967; 
Spain et al., 1953, 1955, 1963; Paul et al., 1963; Damon 1965; Damon et al., 1969). 
The majority of these studies have indicated that most of the cardiac cases examined 
have been dominant in mesomorphy with endomorphy the secondary characteristic. 
However, these studies as well as now being somewhat dated, were limited by a 
number of features including the subjectivity of the somatotype method (Sheldon et 
al., 1940), the failure to account for confounding variables and consideration of the 
somatotype as a Gestalt. The recent developments in somatotype methodology by 
Carter and Heath (1990) and somatotype data analysis (Carter et al., 1983; Cressie et 
al., 1986), together with a greater knowledge and understanding of CHD risk factors 
should enable these limitations to be overcome. The only researchers to have studied 
CHD in relation to Heath-Carter anthropometric somatotypes are Smit et al. (1979). 
To date, no data have been available on the somatotypes of men with 
angiographically-determined atherosclerotic CAD. Also, no mention has been given 
to the relationship between somatotype and fat distribution in men with CHD, 
although men with an android fat distribution have been found to be more 
mesomorphic and less endomorphic than men with a gynoid fat distribution (Mueller 
and Joos, 1985).
The most likely explanation of a link between somatotype and CAD will be 
provided by an examination of cardiovascular risk factors. In adults, Gertler et al.
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(1950), Tanner (1951), Gordon et al. (1987) and Malina et al. (1997) have previously 
examined the association between somatotype and blood lipids and lipoproteins. 
Fredman (1972) studied somatotype and glycaemic status in a group of Tamil 
diabetics and Malina et al. (1997) also examined glucose and blood pressure in 
healthy adults. Only the studies by Gordon et al. (1987) and Malina et al. (1997) used 
the somatotype methodology of Carter and Heath (1990). This technique 
predominates today and is generally preferred because of the objectiveness provided 
by the anthropometric measurements on which it is based. Katzmarzyk et al. (1998) 
used this method in a study of somatotype and metabolic fitness in boys and girls aged 
9-18 years from the Quebec Family Study. Results suggested that a physique 
characterised by high endomorphy and mesomorphy ratings is associated with a 
metabolic fitness profile that predisposes to increased CAD risk. The study of Malina 
et al. (1997) was exclusive to adults of French-Canadian ancestry and suggested that 
somatotype was only weakly associated with metabolic risk-factors. However, it was 
clear that a poor risk-f actor profile was more likely in individuals who had higher 
ratings of endomorphy and mesomorphy and a low ectomorphy rating. Therefore, 
additional studies are required to further elucidate the significance of somatotype in 
relation to both CAD and metabolic fitness.
1.5 INVESTIGATIVE AIMS, RESEARCH QUESTIONS AND 
ORGANISATION OF THE THESIS
Data presented in this thesis were gathered on two occasions between the months of 
May and August. On the first occasion, men undergoing coronary angiography in the 
Department of Cardiology, University Hospital of Wales were examined over a three-
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month period. Approximately one-year later, a control group of apparently healthy, 
male, university employees were examined over a period of several weeks. The data 
collected allowed the research questions outlined in Sections 1.5.1 and 1.5.2 to be 
addressed. These studies form the general theme of this thesis, which is an exploration 
of the relationship between physique, CAD and CAD risk-factors in men. They have 
been grouped into two main categories, one focusing on the significance of obesity 
and AT distribution, the other on somatotype. The numerical order in which these 
studies are presented is a logical sequence beginning with a description of the 
anthropometric characteristics of men with CAD, and culminating with an 
examination of risk-factor associations with the anthropometric measurements.
In Chapter 4 of this thesis, the results and discussions of the studies focusing on 
obesity and AT distribution are presented in the order of the research questions that 
follow. Chapter 5 performs the same function for studies focusing on somatotype. 
These chapters are preceded by a Review of Literature (Chapter 2) and Methodology 
(Chapter 3). The Review of Literature has been sub-divided into three distinct sub­
sections. The first of these sub-sections (Section 2.1) reviews the relationship between 
"body habitus" and CAD in men. The term "body habitus"’has been used to describe 
physique in terms of its size, shape and composition. Section 2.2 examines the 
validity of assessing abdominal obesity using anthropometric measurements. Section
2.3 examines the relationship between obesity, AT distribution and several established 
risk factors for CAD. As the literature in this area is very extensive, where possible 
the review has been restricted to studies of men. However, where a study has been 
performed using female subjects or animals, and it has made a significant contribution 
to our understanding of this area, it has been included.
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The methods outlined in Chapter 3 are common for all studies presented in this 
thesis. Within the statistical analysis sub-section (3.7), reference is given to the study 
where these procedures were applied.
Chapter 6 - the concluding chapter - presents a summary of the findings of all of 
the studies contained within this thesis, conclusions and recommendations for further 
investigations.
Finally, even though it results in the duplication of some references, a 
bibliography of the literature cited in each chapter is given at the end of that chapter.
1.5.1 Research Questions: Studies Focusing on Obesity and Adipose Tissue 
Distribution
Study 1. Are simple anthropometric measures of obesity and adipose tissue 
distribution related to left ventricular function and the severity of atherosclerotic CAD 
determined using coronary angiography?
Study 2. Are men with CAD characterised by a specific subcutaneous adipose tissue 
pattern that can be identified with principal component analysis?
Study 3. Are there differences in anthropometric indices of obesity and adipose tissue 
distribution between men with CAD and healthy age-matched controls and what is the 
effect of adjusting for body size differences?
Study 4. Are anthropometric indices of obesity and adipose tissue distribution related 
to fasting serum glucose and lipids? Which anthropometric measurement is the best 
discriminator of differences in glucose and lipids? Does adjusting for body size
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variation, modify the relationship between obesity, adipose tissue distribution, glucose 
and lipids?
Results of these studies are presented in Chapter 4, sections 4.1, 4.2, 4.3 and 4.4 
respectively.
1.5.2 Research Questions: Studies Focusing on Somatotype
Study 1. What is the somatotype of men with angiographically-determined CAD? Is 
somatotype related to CAD severity and left ventricular function? Is somatotype 
related to adipose tissue distribution in men with CAD?
Study 2. Is there a difference in the somatotype of men with CAD and healthy, age- 
matched controls?
Study 3. Is there an association between somatotype and fasting serum glucose and 
lipid concentrations?
Results of these studies are presented in Chapter 5, sections 5.1, 5.2 and 5.3 
respectively.
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2.1 BODY HABITUS AND CORONARY ARTERY DISEASE IN MEN
During the last several decades, a great deal of attention has been focused on the 
identification of potentially modifiable biological, physiological and biochemical risk 
factors (Leon, 1987) that place the individual at an increased risk of developing 
atheromatous lesions in the coronary blood vessels. The degree of overweight and 
obesity are two possible risk factors that have attracted a great deal of research 
attention in men. Height has also been studied as a potential marker for ischaemic 
CAD. Despite this abundance of information, contrasting findings suggest that the 
exact position of overweight or obesity in the aetiology of CAD remains unclear. One 
possible explanation for this disparity is that the measurement techniques employed 
do not satisfactorily estimate body fatness. More recent evidence suggests that these 
inconsistencies can also be partly explained by the distribution of body fat. As the 
metabolic complications associated with excess body fat may require a prolonged 
period of time before their effect on cardiovascular disease mortality is observable, 
the duration of the obese state may also be an important factor in explaining these 
inconsistencies (Bjomtorp, 1985).
The focus of this part of the Review of Literature is the association between 
human body habitus and atherosclerotic CAD. The terms cardiovascular disease 
(CVD), coronary heart disease (CHD), coronary artery disease (CAD) and ischaemic 
heart disease (IHD) are not used interchangeably, rather, no attempt has been made to 
alter the terminology adopted by the original research. Commentary is made on the 
wide variety of both simple and more complex methods that have been used to assess 
body habitus. The term body habitus has been chosen to incorporate a number of 
distinct physical bodily characteristics. These include body weight and height, weight- 
for-height, relative weight, total body fat, fat distribution, subcutaneous fat pattem and
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somatotype. Body weight and height are the simplest, most accessible measurements 
of body size and are generally reliable with small technical errors of measurement 
(Micozzi et al. 1986). Thus, they have become important and extensively used 
epidemiological research tools. However, it is clear they cannot provide information 
on body composition. To overcome this limitation, there has been continued interest 
in the development of valid and reliable body composition estimators such as relative 
weight scores or weight-for-height indices. These have been the most extensively 
used indicators of overweight. CAD mortality and morbidity rates have also been 
examined in a variety of ways, including the analysis of hospital and physicians 
records, self-reporting of coronary events, information from the next of kin, post­
mortem findings, death certificates and recently coronary angiography. These factors, 
coupled with varying lengths of subject follow-up, contrasting statistical analysis and 
socio-economic, ethnic and risk factor variation between subjects from different 
studies, make interpretation of the vast amount of available literature difficult.
2.1.1 Body weight and height
(a) prospective studies
Amongst the earliest investigations of an association between CHD, body weight and 
height are the classic studies of Harvard and Pennsylvania University students 
(Faffenbarger et al., 1966a, 1966b). They found that for later coronary decedents, 
body weight at initial examination was greater than controls. This study also found 
that compared to controls, a greater percentage of coronary decedents were less than 
68 inches tall (32 v 22 %, P < 0.001).
An increased incidence of IHD was reported for shorter London transport 
workers (height range 151 to 167 cm) compared to their taller counterparts (P < 0.1)
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(Morris et al., 1966). A study of 17530 London office workers reported an inverse 
relationship between height and IHD after 7.5- and 10-years follow-up following 
multivariate adjustment for age and grade of employment (Marmot et al., 1978; 
1984). Further research of nearly 18000 civil servants discovered the highest IHD 
incidence rate was for subjects shorter than 5 feet 5 inches (165.1 cm) (Morris et al., 
1980).
A 16-year prospective study of almost 1.8 million Norwegians (approximately
900,000 men) found CVD mortality was clearly reduced for those who were taller 
(Waaler, 1984). For males shorter than 160 cm, CVD mortality was 50 to 100% 
greater than the total. For those between 185 and 189 cm, however, CVD mortality 
was only 70 to 80% of the total mortality.
The British Regional Heart Study of 7735 middle-aged men demonstrated a 
similar finding (Walker et al., 1989). The mean height of subjects who suffered an 
IHD event (n = 443) was significantly lower than the height of the remaining subjects 
(171.7 V 173.3 cm, P < 0.001). Adjustment for age, social class, serum TC, HDL-C, 
systolic blood pressure and cigarette smoking weakened the association by over 50%. 
As height and lung function (forced expiratory volume in one second, FEVj) were 
closely correlated (r = 0.44, P < 0.002), and lung function is associated with IHD 
(Cook and Shaper, 1988), FEVj was added to the multivariate model. The addition of 
lung function alone (P = 0.25) or in combination with other confounding variables (P 
= 0.70) further weakened the relationship.
The height and IHD relationship has been reported for 2512 South Wales men 
(Caerphilly cohort) and 2348 men from the West of England (Speedwell cohort) 
(Yamell et al., 1992). After just 61- and 38-months follow-up respectively, significant 
inverse trends were found between height and the number of IHD events (both fatal
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and non-fatal) in the Caerphilly (P < 0.001) and Speedwell (P < 0.05) cohorts. In 
comparison to men in the tallest 20% of the height distribution, men in the shortest 
20% suffered more than double the IHD events. Adjustment for age, social class, 
smoking habit and FEVj in the Caerphilly cohort, weakened the relationship (P < 
0.05).
After 26-years follow-up of a select cohort of almost 4000 North American 
male airline pilots, body weight was significantly greater (76.5 ± 0.5 v 74.2 ± 0.2 kg, 
P < 0.01) and height shorter (175.8 ± 0.3 v 176.9 ±0.1 cm, P < 0.01) in subjects who 
developed CHD (Rabkin et al., 1977).
Hebert et al. (1993) found that among a population of 22,071 US male 
physicians, the relative risk of myocardial infarction was 35% lower in the tallest men 
(> 73 inches or 185.4 cm) compared to the shortest men (< 67 inches or 170.2 cm). 
Although the inverse relationship between height and myocardial infarction risk was 
not strictly linear, for every inch of added height, there was an approximate 2 to 3 % 
reduction in risk.
In a more recent but short-term study (3-year follow-up) of almost 30,000 US 
men, Rimm et al. (1995) found that, in comparison to men whose height was < 68.0 
inches (173 cm), the multivariate relative risk of CHD decreased steadily with 
increasing stature. The relative risk in the highest quintile for height (> 73.0 inches or
186.0 cm) was 0.67 (95% confidence intervals (Cl) 0.48-0.93).
In a study that adjusted for age, obesity, smoking status, HDL-C, TC, 
hypertension, diabetes and education, Parker et al. (1998) have recently reported a 
strong inverse association between height, CHD and stroke. In this study, men taller 
than 69.75 inches had an 83% lower risk of CHD compared to men shorter than 65 
inches.
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Post-mortem findings of 71 decedents from the Framingham Study revealed 
that body weight 1- and 9-years before death independently predicted left ventricular 
thickness (Feinleib et ah, 1979). Height and body weight measured 5-years before 
death had inverse and positive associations with heart weight respectively.
(b) case-control studies
Gertler and co-workers (1951) found that men hospitalised with myocardial infarction 
were approximately 5.0 cm shorter and 3 kg heavier than control subjects. Later 
analysis found height to be second only to TC as a predictor of CHD although 
cigarette smoking was not considered (Gertler et aL, 1959).
(c) angiography studies
The use of coronary angiography to group subjects into those with significant (> 50% 
stenosis in one, two or three coronary vessels) or insignificant arterial disease (a 
normal angiogram or < 50% stenosis), has recently shown a non-significant 
association (P > 0.05) between body weight and disease status (Flynn et aL, 1993). 
Height and CAD exhibited a significant inverse relationship following univariate (P < 
0.01) and multivariate analysis (P < 0.05).
Hauner et aL (1990) found that height was significantly shorter (P < 0.01) and 
weight greater (P < 0.05) in subjects with CAD and a history of myocardial infarction 
compared to men free of CAD. In a further angiography study, there was no 
difference in height and weight between normal men and men with CAD (Ley et aL, 
1994).
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(d) evaluation o f body weight and height as predictors o f CHD 
A number of possible explanations have been proposed to give the inverse 
relationship between height and CHD a biological basis. As suggested, 
multicollinearity with lung function as a confounding variable may be one 
explanation. Inadequate pre-natal, infant and childhood nutrition and the occurrence 
of illness during the growing years may partly account for some cases of shorter 
attained adult stature. It is plausible that these factors may also directly affect 
pulmonary development and, therefore, explain the association between height and 
lung function. Based on findings from a large number of studies. Barker has suggested 
that undemutrition of the foetus can lead to permanent changes in structure, 
physiology and metabolism that predispose to elevated fibrinogen and factor VII, non­
insulin dependent diabetes, hypertension, hyperlipidaemia and, therefore, to an 
increased risk of CVD (Barker, 1994). Stem (1996) has supported this hypothesis by 
suggesting that non-insulin dependent diabetes mellitus and CVD share common 
genetic and environmental antecedents, including foetal and early life nutritional 
deficiencies. Inverse relationships between height and TC, HDL-C, systolic blood 
pressure and smoking duration have also been reported (Walker et aL, 1989). 
Correlation coefficients are weak, however (r = - 0.04 to - 0.11, P < 0.002), and are 
significant due to the large sample size.
A further possible biological mechanism is that taller individuals have larger 
coronary arteries than shorter individuals and, therefore, have a lessened risk of 
occlusion (Palmer et aL, 1990). Support for this mechanism can be derived from 
studies that have found a higher rate of post coronary by-pass surgery mortality in 
shorter individuals compared to taller individuals (Loop et aL, 1983; Fisher et aL, 
1982).
55
Results from studies examining the CHD relationship with body weight are 
inconclusive. In the Manitoba study (Rabkin et aL, 1977), the mean body weight of 
the CHD subjects (76.5 ± 0.5 kg) was only moderate, and although significant, 
differed from the body weight of subjects free of CHD by only about 2.0 kg. The 
striking similarity in the body weight of subjects with significant (77.4 ± 9.6 kg) and 
insignificant (77.8 ± 11.3 kg) arterial disease (Flynn et aL, 1993) may be partly 
accounted for by the insensitivity of the disease classification criteria used. Of interest 
would be a comparison of the mean body weight of asymptomatic subjects and those 
with evidence of extreme arterial disease. Contrary to this theory, however, no 
difference was found in the height and weight of men free from CAD when compared 
to men with angina and an angiogram showing greater than 50 % luminal narrowing 
(Ley et aL, 1994).
From the limited amount of research, it appears that body weight, per se, is not 
as strong a predictor of CVD as height, although the underlying biological mechanism 
linking height and CVD remains to be firmly established.
2.1.2 Weight-for-height ratios
Complex laboratory methods for estimating body composition are inappropriate for 
large-scale surveys. The simplicity of measurement and availability of normative data 
have, therefore, contributed to the widespread use of weight-for-height ratios (W/Hp). 
The power function (p) should be calculated so that the index is highly correlated with 
body weight and fatness but be independent of height. The most widely used weight- 
for-height ratio is BMI. Other ratios that have been applied in epidemiological studies 
include W/H (Carlson et aL, 1972) and Sheldon’s (1940) pondéral index (HAV'O-33) 
(Faffenbarger «/., 1966a, 1966b; Weinsier gr a/., 1976).
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(a) prospective studies
A number of large-scale population studies examining the association between BMI 
and CHD have been performed in both North America and Europe. Jooste and co­
workers (1988) have examined this relationship in 7188 white South Africans. Data 
gathered in these studies have produced inconsistent findings.
Dyer et al. (1975) found that a U-shaped curve described the relationship 
between BMI and CHD mortality in 1233 white middle-aged North American men 
followed for 14-years. Rhoads and Kagan (1983) reported this phenomenon in 8006 
men aged 45- to 68-years who were subsequently followed for 10-years as part of the 
Honolulu Heart Program. In this latter study, excess deaths amongst those in the lower 
BMI category were due primarily to cancer and in the upper BMI groups to CHD. In 
South Africa, the incidence of CHD in relation to BMI was greater in both the lowest 
(BMI < 20 kg.m'^) (P > 0.05) and highest (BMI 30-35 and > 35 kg.m’^ ) (P < O.OI) 
BMI categories (Jooste et al., 1988).
Conversely, a number of studies with varying lengths of follow-up (5-26 
years) have shown little or no association between BMI and CHD. Keys et al. (1971) 
reported no association between CHD and a variety of physical measurements 
(including BMI) in their 23-year study of Minnesota Executives. Similar findings 
were observed after a 5-year investigation of 11400 men from Northern and Southern 
Europe and North America (Minnesota Railroad Workers) (Keys et al., 1972). 
Despite an excessive incidence of CHD in overweight subjects, after the confounding 
effects of age, blood pressure, TC and smoking were removed, the contribution of 
BMI to this trend was not significant (P > 0.05). After 15-years follow-up there was 
still no relationship (Keys et al., 1984).
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In a further multivariate model, with age, TC, triglyceride (TG), systolic blood 
pressure, cigarette smoking, presence of diabetes and a fat distribution index entered 
as covariates, BMI was not a predictor of CHD (P > 0.05) (Ducimetiere et aL, 1986). 
The Stockholm prospective study of 3168 men identified smoking and elevated levels 
of plasma TC and TG as independent risk factors for IHD but not the index W/H 
(Carlson and Bottiger, 1972). Further Scandinavian research found no association (P > 
0.05) between BMI and the 13-year incidence of IHD, stroke and death (Larsson et 
aL, 1984).
After adjustment for subscapular skinfold thickness, the independent effect of 
BMI on either non-fatal myocardial infarction or death from CHD was not significant 
(P > 0.05) after 12-years follow-up in the Honolulu Heart Program (Donahue et aL, 
1987).
Hargreaves et aL (1992) reported that, of an original random sample of 107 
Edinburgh men, 11 developed clinical CHD over the subsequent 12-year period. 
Examination of baseline data revealed the BMI of CHD men (26.7 ±0 .8  kg.m'^) was 
greater (P < 0.05) than the men who remained free of the disease (24.9 ± 0.3 kg.m'^) 
(values are means ± SEM.). Other risk factors (TC, TG, diastolic blood pressure and 
indices of glucose-insulin homeostasis) were not significantly different (P > 0.05). 
However, following adjustment for HDL-C, which was lower in CHD patients (P < 
0.05), BMI was no longer a significant risk factor (P > 0.05).
Recently, researchers from the Paris Prospective Study found increasing BMI 
was modestly associated with CVD in subjects with a mean blood pressure less than 
96 mmHg, but had no effect in men with higher blood pressure (> 96 mmHg) 
(Filipovsky et aL, 1993).
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In a few instances, large-scale prospective studies have reported a significant 
independent relationship between BMI and CHD. After adjustment for age and blood 
pressure, BMI was found to be a significant independent predictor of sudden death (P 
< 0.01), coronary insufficiency or suspected myocardial infarction (P < 0.05) and 
myocardial infarction (P < 0.05) (Rabkin et aL, 1977).
A 7-year follow-up of 3786 men in eastern Finland found men with a BMI of
28.5 kg.m’^  or more, experienced a significantly greater incidence of acute myocardial 
infarction (P < 0.05) (Tuomilehto et aL, 1987). This effect was independent of age 
and smoking but not other major coronary risk factors (TC and blood pressure).
In the Framingham cohort, standardised logistic regression analysis controlling 
the effects of age, serum TC, cigarette smoking, systolic blood pressure, blood 
glucose and ECG evidence of left ventricular hypertrophy demonstrated a significant 
(P < 0.05) positive influence of BMI on the 22-year incidence of CHD (Stokes III et 
a/., 1985).
Galanis et aL (1998) examined the 17-year incidence of CHD events in 
relation to BMI at 25-years of age after adjusting for the effects of age, smoking and 
weight change. The relative risk between the lowest and highest categories of BMI 
was 2.44 (95% Cl 1.6 - 3.69). In comparison to men who gained less than 2.5 kg, men 
who gained between 2.6 kg and 5 kg, between 5.1 kg and 10 kg, or more than 10 kg 
had relative risks of CHD of 1.41 (95% Cl 1.00-1.97), 1.60 (95% Cl 1.22-2.11) and
1.75 (95% Cl 1.32-2.33) respectively. After adjusting for Vitamin E, age, smoking, 
calories consumed, alcohol intake, family history and occupation, Rimm et aL (1995) 
reported a similar finding in men less than 65-years of age in the US Health 
Professionals Study. In older men (> 65-years) the association was much weaker. This 
study was also notable for showing that moderate levels of overweight (BMI between
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25.0 and 28.9 kg.m'^) resulted in a 72% increased risk of CHD after only 3-years of 
follow-up. In one of the longest follow-up studies of its kind (27-years), Lee et al. 
(1993) also found a significant positive trend (P = 0.0003) between the relative risk of 
CVD mortality and BMI. The lowest relative risk was for men in the BMI category <
22.5 kg.m'^. In the next quintile (BMI 22.5 - 23.5 kg.m'^) the relative risk increased to 
2.02, and in the highest quintile (BMI > 26.0 kg.m'^) to 2.54. This study suggested 
that the lowest mortality risk is observed among men weighing, on average, 20% less 
than the US average. In the UK (Shaper et al., 1997) and California (Lindsted and 
Singh, 1998) similar findings have been reported. Shaper et al. (1997) suggested that 
risk of cardiovascular death, heart attack and diabetes increases progressively from a 
BMI of < 20.0 kg.m'^, even after adjusting for age, smoking, social class, alcohol 
consumption and physical activity. Lindsted and Singh (1998) studied 5062 Seventh- 
day Adventists who had never smoked. The lowest risk of cardiovascular mortality 
was for men with a BMI in the range 14.3 to 22.5 kg.m'^.
The validity of these findings, however, has been recently questioned by a 
study of 21,856 men who also underwent a treadmill exercise test to evaluate 
cardiorespiratory fitness (Lee et al., 1998). In each BMI category, unfit men had a 
significantly higher relative risk of cardiovascular and all-cause mortality than fit 
men. This suggests that fitness offers some protection against the health 
impairment(s) of overweight, and that weight guidelines based on BMI may be 
misleading unless fitness is also considered.
(b) angiography studies
Recent results from the Honolulu Heart Program have shown BMI to be a significant 
predictor of both arteriographically-diagnosed severe coronary stenosis and incident
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myocardial infarction after 20-years follow-up of 357 men (Reed and Yano, 1991). 
However, further recent angiography studies that provided similar results, conflict 
with these later findings from the Honolulu Program. BMI was not related (P = 0.197) 
to CAD in 286 men following stepwise logistic regression analysis (Hauner et al., 
1990). Chi-square analysis also revealed no difference (P > 0.05) in the BMI of men 
with CAD (> 30% stenosis), men with CAD plus a history of myocardial infarction, 
and men without CAD.
Flynn and her colleagues (1993) found no relationship (P > 0.05) between 
CAD and BMI. Other weight-for height indices, including the risk index of body build 
[W (kg)/H (m)2-2], adipose tissue index [0.75 (W/H0^^)-21.4] and body fat index [0.72 
(W/H®'^®)-23.5] also showed no correlation with CAD (P > 0.05) (Sjostrom, 1987). 
Hodgson and co-workers (1994) applied different scoring systems to quantify an 
extent score (proportion of coronary endothelial surface area affected by atheroma) 
(Sullivan et al., 1990) and a myocardial score (degree of stenosis of any number of 
arterial branches) (Brandt et al., 1977) in 160 men and 66 women undergoing cardiac 
catheterisation. Spearman’s rank correlation coefficients between BMI, extent score 
and myocardial score were not significant (P > 0.05) for men or women.
Ley et al. (1994) reported non-significant differences (P > 0.05) for the BMI 
of middle-aged men free of CAD (24.5 ± 0.3 kg.m'2), men with angina but a normal 
angiogram (25.1 ± 0.4 kg.m'2) and men with angina and an abnormal angiogram (25.1 
± 0.3 kg.m‘2).
Thompson and co-workers (1991) found no difference in the BMI of patients 
with coronary atherosclerosis (27.0 ± 3.5 kg.m'^), hospitalised controls (27.0 ± 3.7 
kg.m'2) and neighbourhood controls (26.4 ± 3.5 kg.m'^) (P > 0.05).
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(c) evaluation o f weight-for-height ratios as predictors o f CHD 
The variation in the relationship between weight-for-height indices and CHD may be 
due partly to the inaccuracy of these indices in estimating body fat. The numerator, 
body weight, is composed of lean as well as fat tissue. Body mass indices are, 
therefore, as much estimations of musculoskeletal mass as fat mass. An individual 
with a considerable muscle, bone and organ mass relative to height may be classified 
as obese even though they may not have a large fat mass. Similarly, in individuals 
with small muscle and bone masses relative to height, body fat will be underestimated 
(Lohman, 1992). In a population sense, this may be unimportant as the main cause of 
excessive weight-for-height is an increased fat mass (Shephard, 1994). However, 
using simple weight-for-height ratios to compare different populations is particularly 
unreliable if they differ in ethnicity and socio-economic status (Shephard, 1994). For 
instance, high BMFs found amongst the Canadian Inuit were explained by short 
stature and well-developed musculature rather than excessive body fat (Shephard, 
1980). The genetically homogeneous Pima Indians, on the other hand, exhibit a high 
prevalence of obesity (Knowler et al., 1981).
The correlation between BMI and body fat derived from underwater weighing 
has been reported to be 0.55 for men (Womersley and Dumin, 1977). This leaves 70% 
of the variation in fatness unexplained. Correlations between densitometrically 
assessed body fat and other weight-for-height indices (W/H, W/H^, W'^-^ /^H, HTW'^ -^  ^
and percentage overweight based on age, sex and height) were of a similar magnitude 
(Womersley and Dumin, 1977). Smalley et al. (1990) found a slightly stronger 
relationship (r = 0.70) between BMI and relative body fat estimated from 
densitometry in 150 men. In their study of United States Air Force personnel, 
Weinsier et al. (1976) found a correlation of 0.74 between BMI and relative body fat
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estimated using tritium dilution. Another study reported a common variance of 41% 
between BMI and relative body fat in 342 males (Bouchard, 1992). Micozzi et al. 
(1986) reported a correlation of 0.77 between BMI and subscapular skinfold thickness 
in men in NHANES I. Even though these correlations indicate a stronger relationship, 
with respect to body fat estimation BMI still has little predictive power. Gam et al. 
(1986) found a significant correlation (r = 0.65) between BMI and lean body mass in 
their analysis of data froni the Tecumseh Community Health Survey. BMI was also 
related to radiogrammetrically-determined bony chest breadth in men aged 50 to 60- 
years (r = 0.67) (Gam et al., 1986). This supports the notion that BMI is as much a 
reflection of lean body mass as it is fat mass.
Weight-for-height indices are also supposed to dissociate height. Data from 
NHANES I show a non-significant association between height and BMI in men 
(Micozzi et a l, 1986). Gam et al. (1986), however, have shown a relationship 
between relative sitting height (sitting height/stature) and BMI in men aged 20 to 35 
and 36 to 50-years (r = 0.21). This suggests BMI is also influenced by body 
proportions and means that shorter-legged individuals can have higher BMI values by 
as much as 5 units (Gam et al., 1986).
The consequence of these limitations is that to describe individuals as obese 
on the basis of a W:H index is unfounded and potentially misleading. The term 
obesity refers to excess body fat and should, therefore, be applied when more precise 
measurements of body fat are used. As weight-for-height indices simply describe 
body weight in relation to height, the term overweight is preferable as their validity as 
an indicator of fatness is questionable.
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2.1.3 Relative Weight
Relative weight is obtained by expressing the individuals bodyweight as a percentage 
of some reference weight. This reference data, usually based on a large, random, 
cross-sectional sample can be obtained from a regression equation or chart 
(Lieberman and Probart, 1992) or more frequently a set of height-weight tables. 
Although relative weight implies no value judgement (Harrison, 1985), correlations 
with mortality has led to the application of the concept of "desirable" or "ideal" 
weight. These terms are used to describe individuals at lowest-risk of premature 
mortality and as the standard for weight reduction targets.
(a) prospective studies
The relationship of Framingham Relative Weight (deviation of body weight from the 
median weight of the population distribution) to the 12-year incidence of CHD 
suggested an excess risk of angina and sudden death in "obese" men (Kannel et al., 
1967). This excess risk existed in the absence of elevated blood pressure and serum 
TC. After 18-years follow-up, a positive linear association was observable in the male 
population (Kannel and Gordon, 1974). An autopsy study of 127 Framingham 
decedents found relative weight 9-years prior to death was an independent predictor 
of heart weight but not left ventricular muscle thickness, percentage luminal 
involvement or percentage luminal insufficiency (Feinleib et al., 1979). Hubert and 
her colleagues (1983) later gathered data on 2252 Framingham men. Metropolitan 
Relative Weight (ratio of actual to desirable weight) independently predicted the 26- 
year incidence of angina, coronary disease other than angina, coronary death and 
congestive heart failure. Desirable weight was derived from Metropolitan Life 
Insurance Company height-weight tables (Metropolitan Life Insurance Company,
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1959) by taking the midpoint of the weight range for a medium build at a specified 
height. Metropolitan height-weight tables were also used to calculate excess weight in 
a group of 200 "morbidly obese men" (mean excess bodyweight = 130%) aged 23- to 
70-years (Drenick et aL, 1980). After 7.6-years follow-up, the total number of deaths 
was 50. CVD was the most common cause in the study subjects (54.0%) and the U.S. 
male population (40.3%). Compared to the general population, life-table techniques 
demonstrated a 12-fold excess mortality in subjects aged 25- to 34-years and a six­
fold excess in subjects aged 35- to 44-years. This ratio continued to diminish with 
advancing age.
The final report of the Pooling Project Research Group (1978) suggested 
relative weight was associated with an increased risk of a first coronary event only in 
younger men aged 40- to 44-years (P < 0.01) and 45- to 49-years (P < 0.05).
Keys et aL (1971) found no association between CHD and relative weight in 279 men 
after 20-years follow-up. Later multivariate analysis also found no association 
between relative weight and CHD in larger male cohorts from the United States, 
southern Europe and northern Europe after 5- and 15-years follow-up (Keys et aL, 
1972,1984).
(b) evaluation o f relative weight as a predictor o f CHD
As with weight-for-height ratios, one unequivocal limitation of the relative weight 
concept is its inability to differentiate fat and lean tissues and, therefore, satisfactorily 
predict adiposity. The 1959 Metropolitan height-weight tables (Metropolitan Life 
Insurance Company, 1959) were first to consider the significance of skeletal mass by 
introducing the Trame-size’ concept. Later, anthropometric measurements were 
introduced to give this concept some objectivity. The frequently used biepicondylar
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elbow breadth, however, which is used to categorise frame-size in the 1983 
Metropolitan tables (Metropolitan Life Insurance Company, 1984) has a poor 
correlation with other measures of skeletal size, bone density and, thus, bone mass 
(Lieberman and Probart, 1992). Furthermore, considerable inter-individual variation 
in bone mineral density means that even if bone size is controlled, bone mass may still 
differ markedly. Anthropometric bone diameters are also influenced by subcutaneous 
adipose tissue and skin thickness. This means that frame size tends to be 
overestimated in fatter subjects and underestimated in lean subjects.
Further limitations of the relative weight concept are discussed in-depth by 
Harrison (1985) based on Knapp’s earlier discourse (Knapp, 1983). First, the quality 
of data used to construct height-weight tables is in some instances questionable. For 
example, about 10% of weights and heights used to construct the 1983 Metropolitan 
tables were self-reported. In addition, the clothing of those who were measured in this 
study (Build Study, 1980) was not standardised. Second, few studies, including the 
Build Study (1980) have adequately controlled variables known to have a 
confounding influence on the weight and mortality relationship, most noticeably 
cigarette smoking (Garrison et ah, 1983). Third, describing weight as a percentage of 
a reference value does not represent a constant degree of overweight. For example, 
40% overweight could describe both a person weighing 84 kg whose ’desirable’ 
weight is 60 kg, or a person weighing 140 kg whose ’desirable’ weight is 100 kg. 
Finally, even some of the largest data sets may not be representative of populations as 
a whole. This means that for some under-represented sections of the population (e.g. 
lower socio-economic groups, non-caucasians and those older than 60-years) the 
tables may not be a valid indicator of the weight-to-height relationship with mortality.
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2.1.4 The two-component model
(a) evaluation o f absolute and relative fat mass
The lack of validity of weight-for-height ratios and relative weight as body fat 
surrogates is a possible explanation for the variation in the relationship between 
obesity and CHD (Despres, 1991). A more precise measurement of body composition 
should, therefore, yield a stronger correlation between body fatness and CHD. Several 
studies have used more valid body composition measurement methods and adopted a 
two-component model that includes fat and fat-free masses. In this respect, skinfold 
thickness measurement, which has been used in both cross-sectional (Flynn et aL, 
1993) and prospective studies (Keys et aL, 1971, 1972, 1984; Larsson et aL, 1984), 
has predominated. Others have used more sophisticated methods including 
underwater weighing (Keys et aL, 1971), tritium dilution (Weinsier et aL, 1976) and 
dual energy X-ray absorptiometry (Ley et aL, 1994).
The underpinning theory for the use of skinfolds and underwater weighing was 
outlined in the Chapter 1.0. There follows a brief explanation of tritium dilution and 
dual energy X-ray absorptiometry (DEXA). Tritium dilution allows measurement of 
total body water from which fat-free mass can be estimated (assuming a fixed 
hydration of this tissue component, usually 73 %) i.e. fat-free mass = total body water 
/ 0.73. The method is based on the assumption that the radio-isotope tritium (^H), 
which is measured with liquid scintillation counting, has the same distribution volume 
as water. The subject is given an accurately measured oral or intravenous dose of 
labelled water, followed by an equilibration period of at least 2-hours before sampling 
a body fluid, either saliva, blood or urine (Westerterp, 1994). The accuracy of both 
isotope dilution and underwater weighing is in the range of 1-2 % (Westerterp, 1994).
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Dual energy x-ray absorptiometry allows the precise measurement of total and 
regional body composition with a very low radiation exposure. As the dual energy 
radiation source scans soft tissue, the relative attenuation of the photons changes in 
proportion to the fat content (Lohman, 1992). The short-term precision of DEXA for 
measuring the relative fat in soft tissue has been reported as 1-2 % (Mazess et aL, 
1990).
(b) prospective studies
Recognising that neither relative weight nor BMI provide satisfactory estimates of 
body fat. Keys et aL (1971, 1972) examined the CHD relationship with the sum of 
triceps and subscapular skinfolds and whole-body density derived from underwater 
weighing. Neither exhibited a significant relationship with CHD incidence (P > 0.05). 
The sum of triceps, subscapular and parathoracic skinfolds were found to be unrelated 
to CVD in Gothenburg men (Larsson et aL, 1984). Weinsier et aL (1976) estimated 
relative body fat using the tritium dilution technique and found no difference (P > 
0.05) between those with CHD (23%) and those without (21.1%).
(c) angiography studies
Flynn et aL (1993) estimated relative body fat from the sum of biceps, triceps, 
subscapular and suprailiac skinfolds using the regression equation of Dumin and 
Womersley (1974). They found a significant difference (P < 0.05) between men with 
insignificant disease (27.7 ± 6.0 %) and men with significant disease (29.3 ±5 .2  %). 
In a multivariate model, however, relative body fat was not an independent predictor 
of CVD.
68
More recently, no differences (P > 0.05) in absolute fat mass measured by 
DEXA were found between normal healthy men (17.1 ± 0.6 kg), men with angina and 
a normal angiogram (18.6 ± 0.9 kg) and men with angina and an abnormal angiogram 
(17.0 ± 0.6 kg) (Ley et a l, 1994).
(d) evaluation o f fa t mass as a predictor o f CHD
If total body fat is important in the pathogenesis of atherosclerotic CVD the results 
from these studies (Flynn et aL, 1993; Keys et aL, 1971, 1972, 1984; Larsson et aL, 
1984; Weinsier et aL, 1976; Ley et aL, 1994) are perhaps somewhat surprising. 
Neither long-term prospective nor case-control designs, including angiography, have 
shown a relationship between CVD and body fat.
The estimation of relative body fat from body density relies on several 
questionable assumptions (Novak, 1974). Perhaps the most notable being that the fat- 
free mass has a chemical composition resulting in a density of 1.10 g.ml k For this 
reason, the calculation of relative body fat from body density has been criticised and 
the use of density in its own right advocated (Clarys et aL, 1984). As Keys et aL 
(1971) used body density rather than relative body fat in their analysis, the inaccurate 
estimation of body fat cannot be a contributory factor in the explanation of these 
findings.
As outlined in Chapter 1.0, the validity for the prediction of relative body fat 
from skinfold thickness is based on the inverse relationship with body density and 
several assumptions about the morphology and mechanical properties of the skinfold. 
Cadaver dissections suggest that, in the elderly at least, these assumptions should be 
rejected (Clarys et aL, 1984, 1987; Martin et aL, 1985, 1992, 1994). Evidence to date 
suggests that a limited number of skinfolds, used either to estimate relative body fat or
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in their own right to avoid some of the assumptions of predicting body fat, are poor 
predictors of CVD.
2.1.5 Body fat distribution
(a) evaluation o f fa t distribution
Since the results of two large prospective studies in Scandinavia (Larsson et aL, 1984; 
Lapidus et aL, 1984) confirmed the findings originally reported by Vague et aL (1947, 
1956), the focus of research in the area of obesity and CVD has shifted. Evidence is 
accumulating in support of the hypothesis suggesting the anatomical distribution of 
body fat is a stronger predictor of susceptibility to CHD mortality and morbidity, than 
measures of overweight or obesity, per se.
A  variety of anthropometric indices have been used to describe the distribution 
of fat in relation to CVD. Major prospective studies such as the Paris Prospective 
Study (Ducimetiere et aL, 1986), Honolulu Heart Program (Donahue et aL, 1987), and 
Framingham Study (Stokes III et aL, 1985) used skinfolds on the trunk and limbs to 
assess subcutaneous fat pattern. Others, including the Scandinavian studies (Larsson 
et aL, 1984; Lapidus et aL, 1984), and recent work embracing coronary angiography 
(Flynn et aL, 1993; Hauner et aL, 1990; Hartz et al., 1990; Hodgson et al., 1994; 
Thompson et al., 1991) have relied on circumference measurements of the waist and 
hips to distinguish upper- and lower-trunk fatness. Later analysis of the Paris cohort 
also included the ratio of iliac-to-left thigh circumference, termed the circumference 
index, as an indicator of abdominal obesity (Filipovsky et aL, 1993).
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(b) CHD in relation to subcutaneous fat pattern: prospective studies 
Extending the period of follow-up to 30-years, Stokes et al. (1985) published further 
data from the Framingham Study. They claimed the results not only reconfirmed 
earlier findings (Hubert et al., 1983), but indicated that upper-trunk (subscapular) and 
arm (triceps) skinfolds were better CHD predictors than skinfolds measured at the 
waist (abdominal) or front-thigh.
In the Paris Prospective Study, 6718 men aged 42- to 53-years were followed 
for an average of 6.6-years (Ducimetiere et al., 1986). CHD was classified as angina 
pectoris, non-fatal myocardial infarction or sudden death due to CHD. Trunk 
skinfolds (subscapular, axillary and subumbilicus) were the strongest predictors of 
CHD (P < 0.05), whereas thigh skinfolds (anterior, posterior, internal and external) 
were not associated with CHD (P > 0.05). The trunk-to-thigh skinfolds ratio was a 
highly significant predictor of angina pectoris (P < 0.0001) and, to a lesser extent, 
sudden death and myocardial infarction (P < 0.01). The association between the 
skinfold ratio and total incidence of CHD was also highly significant (P < 0.00001). 
In multivariate analysis, with TC, cigarette habit, blood pressure, diabetes, age, BMI 
and TG as co-variables, the skinfold ratio remained a significant predictor (P < 0.025).
A third large-scale prospective study, examined the relationship between 
definite CHD (non-fatal myocardial infarction and death from CHD) and subscapular 
skinfold thickness in 7692 men from the Honolulu Heart Program (Donahue et al., 
1987). For a given BMI, subscapular skinfold remained a significant predictor of 
CHD after adjustment for several established risk factors (P < 0.05 for the highest 
versus lowest tertile of subscapular skinfold and P < 0.01 for the middle versus lowest 
tertiles).
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The study of Edinburgh men found baseline abdominal skinfold thickness was 
significantly greater (P < 0.05) in the 11 men who developed CHD than the 96 men 
who remained free of the disease (Hargreaves et al., 1992). There was no difference in 
triceps and subscapular skinfold thickness (P > 0.05). After adjustment for HDL-C, 
abdominal skinfold thickness remained an independent predictor of CHD (P < 0.05).
(c) evaluation o f subcutaneous fa t pattern as a predictor o f CHD 
Whilst the findings from these studies (Ducimetiere et al., 1986; Donahue et al., 1987; 
Hargreaves et al., 1992; Stokes III et al., 1985) exhibit some commonality, there are 
distinctive differences. Excluding the Edinburgh men, subscapular skinfold 
consistently appears as a stronger predictor of CHD than any other skinfold. However, 
it only accounted for approximately 10% (R^) of the total variance across the entire 
age spectrum (Stokes III et al., 1985). Examined in relation to specific age groups, 
subscapular skinfold presents as the strongest predictor in subjects less than 50- and 
50- to 59-years of age (R  ^= 15 % and 16 % respectively) but the weakest predictor in 
subjects older than 60-years (R  ^ = 5 %) (Stokes III et al., 1985). In these older 
subjects, thigh skinfold showed the strongest association with the 22-year incidence of 
CHD (R2 = 15 %). This contradicts the results of the Paris cohort for whom thigh 
skinfolds clearly exhibited the weakest relationship with CHD incidence (Ducimetiere 
et al., 1986). The claim that triceps skinfold is generally a stronger CHD predictor 
than abdominal or thigh skinfolds (Stokes III et al., 1985) appears to be exaggerated. 
The results show that for each age stratum, coefficients of multiple logistic regression 
between triceps skinfold and CHD incidence are lower than for both abdominal and 
thigh skinfolds. This may be suggestive of an alternative phenomenon. That is, it is
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truncal deposition of subcutaneous fat that is associated with increased CHD risk. 
This appears particularly apparent for younger subjects.
(d) CHD in relation to gynoid or android obesity: prospective studies 
In Sweden, 13-years follow-up in men revealed significant associations between the 
WHR and the occurrence of stroke (P = 0.002) and IHD (P = 0.04) but not death (P = 
0.053) (Larsson et aL, 1984). After the confounding effects of BMI and the sum of 
three skinfolds were removed, WHR remained a long-term predictor of stroke and 
myocardial infarction and also correlated with death (P < 0.001). Following 
adjustment for other major risk factors (smoking, systolic blood pressure and TC), 
WHR was not a predictor of any of the end-points. Extension of the follow-up period 
by 5-years revealed that only 1.7% of men in the lowest 10% of the WHR distribution 
suffered cerebral infarction compared with 18.9% in the upper 10% (Larsson, 1987). 
Whilst WHR was no longer an independent predictor of myocardial infarction, either 
in univariate or multivariate analysis, the risk of myocardial infarction was greater in 
the upper 10% compared to the lowest 10% of the WHR distribution. This difference, 
however, was markedly reduced at 72-years of age (after 18-years follow-up) 
compared to the maximal risk difference observed after 13-years.
Rimm et al. (1995) reported that after controlling for height and BMI, the 
relative risk of CHD in men in the highest WHR quintile was 1.42 (95% Cl 0.99 - 
2.04) in comparison to men in the lowest quintile. When separated according to age, 
WHR was a stronger predictor of CHD in men > 65-years than their younger 
counterparts. Further analysis of waist circumference data showed men in the upper 
quintile (> 40 inches or 102 cm), had a relative risk of 1.44 (95% Cl 0.95 - 2.17) in 
comparison to men in the lowest quintile (< 35 inches or 89 cm). When variation in
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height was controlled statistically, the relative risk of men in the upper quintile of 
waist circumference increased to 1.86 (95% Cl 1.17 - 2.95). As with WHR, the 
association between CHD and waist circumference was stronger among older men. 
However, not all studies have agreed with this finding. In the Baltimore Aging Study, 
abdominal sagittal diameter (ASD) was a predictor of CHD mortality (Seidell et aL, 
1994). This association was independent of age, height and BMI, and was more 
pronounce in younger men with lower TC, TG, glucose and diastolic blood pressure. 
BMI, WHR and skinfolds were not related to CHD mortality.
Megnien et aL (1999) has recently reported on the 10-year incidence of 
cardiovascular events in relation to WHR in 552 men. A high WHR (> 0.98) was a 
strong predictor of CAD, and the number of subjects in this group who exceeded a 
15% risk of developing a coronary event was more than twice the number in the 
lowest WHR group (< 0.88).
After 11-years follow-up in the Paris Prospective Study, iliac-to-thigh ratio 
appeared as an independent predictor of the 129 CHD deaths that occurred in this 
period (Casassus et aL, 1992). Later analysis found this ratio was a weak predictor of 
CVD mortality in men with a lower mean blood pressure (< 96 mm Hg) but a stronger 
predictor in men with a higher mean blood pressure (> 96 mm Hg) (Filipovsky et aL,
1993).
Two recent notable studies have reported that WHR is significantly related to 
cardiovascular mortality in Mediterranean populations. In an Italian population 
characterised by low TC levels and a low incidence of early CHD (Barbagallo et aL, 
2001). Although there were only a small number of cardiovascular deaths recorded 
over an 8-year follow-up period, the relative risk for those with a WHR greater than 
the median was 5.49 (95% Cl 1.12 - 18.40) in comparison to those with a WHR below
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the median. Azevedo et al. (1999) also found that WHR rather than BMI was 
associated with a higher risk of a first myocardial infarction. In comparison to men in 
the first tertile of WHR, the odds ratio of a heart attack in the second and third tertiles 
were 2.5 (95% Cl 1.3 - 4.9) and 11.1 (95% Cl 6.0 - 20.6) respectively.
The increased risk of CVD in men with a greater WHR is also apparent among 
subjects of African-American origin. The Atherosclerosis Risk in Communities Study 
has reported similar positive trends (P = 0.06) between WHR and CHD in both black 
and white men (Folsom et al., 1998).
(e) angiography studies
Hauner et al. (1990) examined the degree of coronary stenosis and several established 
risk factors in 286 men aged 30- to 74-years. Coronary stenosis (> 30%) or occlusion 
of one or more of the coronary arteries was present in 207 men. Those remaining were 
free of CHD and served as controls. There were no significant differences (P > 0.05) 
between control and CHD subjects with respect to circumference measurements at the 
waist (midway between xiphoid process and umbilicus), umbilicus, or hips (level of 
greater trochanter). WHR was also not significantly different (P > 0.05). Stepwise 
logistic regression analysis revealed that in addition to low-density lipoprotein- 
cholesterol (LDL-C) (P = 0.0001) and age (P = 0.0005), an abdominal type fat 
distribution was a significant predictor (P = 0.0129) of CHD. This association was 
independent of TC, HDL-C, TG, fasting insulin and systolic and diastolic blood 
pressures. A similar study found WHR was related (Spearman’s rank correlation) to 
both an extent (r^  = 0.18, P < 0.05) and myocardial score (r^  = 0.17, P < 0.05) 
(Hodgson et al., 1994). After adjusting for several covariables (age, BMI, smoking 
habit, TC, LDL-C, HDL-C, apolipoprotein A1 (apo Al), apolipoprotein B (apo B) and
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TG) these relationships lost their significance (r^  = 0.17 and 0.05 respectively, P > 
0.05). Hartz et aL (1990) also failed to show a relationship between WHR and CAD 
(> 50 % stenosis) in men after adjusting for age.
Ley and co-workers (1994) used DEXA and the procedures outlined by 
Mazess et al. (1990) to evaluate android and gynoid fat in 77 men aged 31- to 60- 
years who presented with chest pain typical of angina pectoris. Android fat was 
measured by selecting a region from the superior iliac crest upward to include all 
abdominal and thoracic soft tissue laterally. Gynoid fat was measured as a region of 
the same length as the android fat region, from the lower sacral border downward to 
include all soft tissue laterally. Angiography revealed 39 men had greater than 50% 
luminal stenosis in one or more epicardial coronary arteries. The remainder had no 
detectable abnormality on their angiogram (< 50% stenosis of any epicardial coronary 
artery). A further 40 men of similar age and weight and who were apparently 
asymptomatic were studied as a control group. Compared to men without angina, men 
with angina had a greater proportion of android fat (P < 0.05). Consequently, there 
was a trend towards a greater proportion of gynoid fat in asymptomatic men compared 
to men with angina but a normal angiogram (P > 0.05), and men with angina and an 
abnormal angiogram (P < 0.05).
Thompson et al. (1991) found the WHR of patients with atherosclerosis was 
significantly greater than the WHR of subjects recruited from the same 
neighbourhood and matched for age, sex and race (0.96 ± 0.05 v 0.92 ± 0.06, P <
0.025). In a similar study, Kahn et al. (1996) reported that the ratio of supine ASD-to- 
mid-thigh girth was the AT index that best discriminated patients with LHD compared 
to matched controls (P < 0.0001).
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Flynn et al. (1993) reported that both waist-to-thigh circumference ratio 
(WTR) (P < 0.005) and WHR (P < 0.05) were independently associated with CAD. 
Whilst WTR was positively associated with CAD, in contrast to other prospective 
(Larsson et al., 1984) and angiography studies (Hauner et al., 1990; Hodgson et al., 
1994; Thompson et al., 1991) WHR was inversely related to CAD.
All of the studies reviewed in this section have relied on anthropometric girth 
measurements as a marker of intra-abdominal fat. To date, only one study has 
attempted to measure intra-abdominal fat ’directly’. Nakamura et al. (1994) compared 
CT-determined intra-abdominal fat in non-obese men with CAD and a group of men 
free of CAD and matched for age, sex and BMI. The men with CAD had significantly 
greater intra-abdominal fat (P < 0.05) but not subcutaneous abdominal fat (P > 0.05). 
Thus, this study not only supported the view that intra-abdominal fat was important 
with regard to predicting CAD risk (Bjomtorp, 1990b) but also partly explains the 
sometimes weak association between CAD and BMI (Garrison et al., 1996).
(f) evaluation o f anthropometric circumference measurements as predictors o f CHD 
Individuals characterised by an android fat distribution appear to represent a sub­
group of obese individuals at increased risk of CVD. This may partly explain the 
somewhat weak associations between CVD and obesity per se (Bjomtorp, 1985). 
Consequently, it has been suggested that as android obese individuals appear to be 
those at increased risk, the gynoid obese, whose risk of CVD is elevated only slightly, 
should be considered to have a cosmetic rather than clinical problem (Bjomtorp, 
1990a). Evidence from two prospective studies suggests anthropometric indicators of 
abdominal obesity are stronger predictors of CHD than BMI (Larsson et al., 1984; 
Filipovsky et al., 1993). After adjustment for three risk factors however, WHR lost its
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predictive power (Larsson et al., 1984). Furthermore, results from case-control studies 
with angiographically-diagnosed CAD are not convincingly supportive of the ability 
of WHR to predict CHD (Flynn et al., 1993; Hauner et al., 1990; Hodgson et al.,
1994). Indeed, some evidence is entirely conflicting (Flynn et al., 1993). This 
highlights the complex nature of the fat distribution relationship with CAD and 
supports the conclusion that more than one measure of obesity and fat distribution 
should be included in future research designs (Despres et al., 1990).
2.1.6 Somatotype
(a) CHD in relation to somatotype
The relationship between somatotype and CHD attracted attention in the United States 
in the 1950’s and 1960’s (Gertler et al., 1951, 1959; Spain et al., 1953, 1955, 1963; 
Paul et al., 1963) and later in South Africa (Smit et al., 1979). Of 97 men and 3 
women who experienced a non-fatal myocardial infarction before 40-years of age, 42 
% were found to be dominant mesomorphs, 26 % dominant endomorphs, 25 % were 
in the mid-rànge (no dominant component) and only 7 % were dominant ectomorphs 
(Gertler 1951,1959).
In 1953, the first of three papers examining the somatotype-CHD relationship 
was published (Spain et al., 1953). This reported the autopsy findings on 111 
consecutive white males under 46-years of age. Of these, 38 had suffered death 
secondary to CAD and 73 had died suddenly and unexpectedly by violent means 
(suicide, homicide, accident) or some other non-cardiac condition. Of the 38 who died 
from CAD, 24 were classified as being dominant mesomorphs, 3 endomorphs, 3 
ectomorphs and 8 were in the mid-range. In the 73 apparently healthy males, the 
degree of atherosclerosis was found to be distinctly more pronounced in mesomorphic
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individuals compared to those of ectomorphic dominance. A second post-mortem 
study also revealed that the extent of coronary atherosclerosis was markedly greater in 
mesomorphic compared to ectomorphic individuals (Spain et a i, 1955). Of 64 
consecutive autopsy examinations involving sudden death from coronary occlusion, 
44 cases were classified as dominant mesomorphs. In a third study, the incidence of 
CHD amongst 5000 males aged 36- to 50-years was three times greater for 
endomorphic-mesomorphs (9.2%) compared to dominant ectomorphs (3.0%) (Spain 
et a l, 1963). This further evidence led to the conclusion that individuals characterised 
by mesomorphic dominance, were at greater risk of CHD than their ectomorphic 
counterparts (Spain et a l, 1963). This was attributed to the mesomorphs large relative 
muscle mass, which was hypothesised to have a more direct association with 
atherosclerotic CHD than adipose tissue (Spain et al., 1963).
The examination of 87 men aged 40- to 55-years, failed to support these 
earlier findings (Paul et al., 1963). It was reported that endomorphic dominance was 
important since there was an excess of coronary cases in the group characterised by 
endomorphy (P < 0.01). Further examination, however, showed that whilst the 
difference between observed to expected coronary cases (myocardial infarction, 
angina pectoris, death from CHD) was greatest in the endomorphic sub-sample (19 
observed / 13 expected), the total number of cases was greatest in the mesomorphic 
group. In these individuals, for whom mesomorphy was dominant and endomorphy 
greater than ectomorphy, 37 confirmed cases were found, one more than may have 
been expected. There was also a significant number of cases in the group for whom 
mesomorphy and endomorphy were approximately equal (15 observed / I I  expected). 
Of further interest is the lower than expected number of cases in the ectomorphic 
dominant and mesomorphic-ectomorphic individuals.
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(h) evaluation o f somatotype classification as a predictor o f CHD 
These early studies (Gertler et al., 1951, 1959; Spain et at., 1953, 1955, 1963; Paul et 
al., 1963) can be criticised on several grounds. Most notably, the subjectivity of the 
photoscopic somatotype technique (Sheldon et al., 1940), the lack of statistical 
analysis or control of covariables and failure to recognise the somatotype as a Gestalt. 
Despite these limitations, the findings were later confirmed in a study of 146 cardiac 
rehabilitation patients (mean age = 52.7-years) (Smit et al., 1979). Using Heath and 
Carter’s technique (Heath and Carter, 1967) a mean somatotype of 4 - 5.5 - 1 was 
reported, the majority of patients being endomorphic-mesomorphs.
The overwhelming number of cardiac cases amongst mesomorphic individuals 
necessitates further explanation. Predominant mesomorphs show considerable 
variation in body density, hence mesomorphy is only modestly associated with 
measures of pure muscularity (Bailey, 1985). An equally plausible interpretation is 
that many large-framed and muscular older males also have enlarged fat stores 
(Bailey, 1985).
As body fat distribution appears to be particularly important in the relationship 
between body habitus and CVD, the association between somatotype and fat 
distribution is of great interest and may help explain the abundance of CHD amongst 
mesomorphic individuals. Among 824 men, those classified as android obese (mean 
somatotype 4.67 - 4.21 - 1.89) were reported to be significantly more mesomorphic 
and less endomorphic than those with gynoid obesity (mean somatotype 5.91 - 2.16 - 
1.84) (P < 0.01) (Mueller and Joos, 1985). Mesomorphy is also a masculine 
characteristic, and as reported for non-insulin-dependent diabetes mellitus, there 
appears to be an assemblage of male differentiation factors amongst individuals at 
increased risk of CHD (Mueller and Joos, 1985).
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2.1.7 Synopsis
Whilst some studies have used quite sophisticated laboratory procedures to quantify 
body fat (Keys et al., 1971; Ley et al., 1994; Weinsier et al., 1976), most have relied 
upon anthropometric measurements to determine some component of body habitus. 
Of these, body weight and height are the simplest measurements and are, therefore, 
well suited to large-scale prospective studies. Height and weight are highly 
reproducible measurements, although in the short term, weight can have considerable 
physiological variation associated with gastric emptying and state of hydration 
(Mueller and Martorell, 1988). Less reliable measurements than height and weight are 
skinfolds and body circumferences, both of which have been used extensively in 
cross-sectional and prospective analyses. For skinfolds, both the inter and intra- 
observer variability is affected by the measurement technique, location of the skinfold 
site, the skinfold calliper used and skinfold compressibility (Lohman, 1992). As 
measurement error has been shown to be a function of skinfold thickness (Pollock et 
al., 1986), accurate and repeatable skinfold measurements are particularly difficult to 
make in the obese. In these subjects, it is not always possible to locate a specific 
anatomical bony landmark or to pull a parallel skinfold away from the underlying 
tissue. Furthermore, in the extremely obese it is sometimes possible for a skinfold to 
be thicker than the jaws of the currently available commercial callipers (Bray and 
Gray, 1988). Alternately, body circumferences are obtainable in all subjects and have 
greater reproducibility than skinfolds (Bray and Gray, 1988). They are, therefore, the 
preferred method in obese subjects (Bray and Gray, 1988). However, there is 
considerable work to be done to establish their association with body fatness.
The evidence examined in this section suggests that body weight is a poor 
predictor of CHD. Some studies have reported no difference in the body weight of
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CHD patients compared to subjects free of the disease (Flynn et al., 1993; Ley et al., 
1994; Paul et al., 1963), others found the body weight of subjects with CHD to be 
slightly greater (Gertler et al., 1951; Paffenbarger et al., 1966a, 1966b; Rabkin et al., 
1977; Feinleib et al., 1979), and one found the body weight of cardiac patients to be 
less than controls (Hauner et al., 1990). Height, however, is negatively associated 
with CHD in prospective studies with long-term (Paffenbarger et al., 1966a, 1966b; 
Morris et al., 1966; Marmot et al., 1978, 1984; Morris et al., 1980; Waaler et al., 
1984; Walker et al., 1989) and shorter-term (Yamell et al., 1992) follow-up periods 
and case-control designs (Gertler et al., 1951, 1959; Flynn et al., 1993; Hauner et al., 
1990). Foetal, infant and childhood undemutrition may link shorter adult height and 
susceptibility to CVD (Barker, 1994).
Many researchers have studied the relationship between overweight and CHD 
by using a surrogate measurement of body fatness such as relative weight or a weight- 
for-height index. In general, results produced by these studies suggest weight-for- 
height indices, particularly the often-used BMI, are not strong predictors of CHD once 
the confounding influence of other risk factors has been considered. Indeed case- 
control designs have consistently failed to show a relationship between BMI and 
CHD. Inconsistent results from prospective studies however, are difficult to interpret. 
To further confuse the situation, BMI has been examined in relation to different CHD 
end-points and adjusted for different confounding variables. Explaining the 
inconsistent results on the basis of length of follow-up is also not simple. When 
follow-up periods exceed 20-years (Rabkin et al., 1977; Stokes III et al., 1985; Lee et 
al., 1993), and sample size is large, BMI exhibits a stronger relationship with CHD. 
When sample size is small however, this closer association has not been found, even 
with a long follow-up period (Keys et al., 1971). Whilst some studies have found no
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association after 15, 13 and 12 years (Keys et al., 1984; Larsson et al., 1984; Donahue 
et ah, 1987) others have reported a relationship after 3-, 8.5-, 10-, 12-, 10- and 7-years 
(Rimm et al., 1995; Morris et al., 1980; Rhoads and Kagan, 1983; Hargreaves et al., 
1992; Jooste et al., 1988; Toumilehto et al., 1987). Some of the best evidence of a 
strong, graded association between BMI and CAD is provided by the 22-year follow- 
up data from the Framingham Study (Stokes III et al., 1985), the 15-year follow-up 
data from the British Regional Heart Study (Shaper et al., 1997) and the 27-year 
follow-up of Harvard Alumni (Lee et al., 1993). Despite adjusting for several 
established risk factors (age, TC, systolic blood pressure, cigarette smoking, blood 
glucose and ECG evidence of left ventricular hypertrophy), the ’true’ relationship 
between BMI and CAD awaits more extensive adjustment for factors associated with 
the overweight state (for example, small dense LDL, endothelial dysfunction and 
plasminogen activator inhibitor I).
As BMI has been shown to have only a moderate correlation with body fatness 
(Weinsier et al., 1976; Micozzi et al., 1986; Womersley and Dumin, 1977; Smalley et 
al., 1990; Bouchard, 1992), future research should establish whether BMI is a valid 
predictor of body fat in that particular population before the term obesity is adopted. 
Ideally, the power function of height should be calculated so that the index exhibits 
the strongest possible relationship to body fatness and is independent of height.
Relative weight, a further simple index of overweight based on height and 
weight alone, has been used less extensively than BMI. Data from the Framingham 
Study suggests relative weight can predict CHD in the short (Kannel et al., 1967; 
Kannel and Gordon, 1974) and long term (Hubert et al., 1983). However, there is 
contradictory evidence from studies with follow-up periods ranging from 5- to 20- 
years (Keys et al., 1971, 1972, 1984). The principal limiting feature underpinning
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measures of relative weight is the same as for BMI, i.e. an inability to reflect 
adiposity.
It has been suggested that the failure of weight-for-height indices and relative 
weight to reflect adiposity may partly account for the inconsistency in the relationship 
between ’obesity’ and CVD (Despres, 1991). If this is so, then the more ’direct’ 
measurement of body fat should theoretically produce a closer association between 
obesity and CVD. However, studies reviewed here suggest that this is not the case. 
Neither prospective (Keys et al., 1971, 1972, 1984; Larsson et al., 1984) nor case- 
control (Flynn et al., 1993; Ley et al., 1994; Weinsier et al., 1976) studies that 
assessed body fat by more direct methods have shown a relationship between the level 
of fatness and CVD. This is not to say that obesity is unimportant in the pathogenesis 
of CVD. Studies of obese and overweight men have shown a relationship between fat 
loss and weight reduction and improvements in blood pressure and blood lipids 
(Wood et fl/., 1988; Sopko et al., 1985; Berchtold et al., 1982; Reisin et al., 1978; 
Schotte and Stunkard, 1990; Dustan, 1985). However, recent data from the Swedish 
Obese Subjects (SOS) study suggests that longer-term weight loss may not have an 
effect on the incidence of hypertension (Sjostrom et al., 2000). Thus, despite the lack 
of an independent statistical association between obesity and CVD, the avoidance of 
obesity or the loss of excess fat with subsequent maintenance of the lower level 
should be an important aspect of CVD risk reduction (Leon, 1995).
As the combination of various skinfolds seem unrelated to CHD when 
summed (Keys et al., 1971, 1972, 1984; Larsson et al., 1984) or used to estimate 
relative body fat (Flynn et al., 1993), it is perhaps surprising that several studies have 
found that individual skinfolds treated as discrete variables independently predict 
CHD. It appears that central or truncal skinfolds are stronger predictors than limb or
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peripheral skinfolds. However, which trunk skinfold is the strongest predictor remains 
unclear. For instance, one study found subscapular skinfold to be a better predictor 
than abdominal skinfold (Stokes III et a l, 1985). The study of Edinburgh men 
however, found that baseline abdominal skinfold was significantly greater in men who 
developed CHD compared to those who did not (Hargreaves et al., 1992). There was 
no difference in subscapular skinfold thickness.
Results from two prospective studies (Larsson et al., 1984; Lapidus et al., 
1984) suggest that abdominal obesity, as measured by the WHR and ratio of iliac-to- 
left thigh circumference respectively, is important in the evaluation of CVD risk. 
However, more recent findings from case-control studies (Flynn et al., 1993; Hauner 
et al., 1990; Hodgson et al., 1994) indicate that WHR is not closely associated with 
CAD. This may well be due to the fact that WHR exhibits only a moderate 
relationship with intra-abdominal fat. It is this fat compartment, particularly the 
metabolically-unique omental and mesenteric adipose tissues that drain into the portal 
circulation (Bjomtorp, 1990b), that have been linked with the metabolic complications 
associated with CVD (Despres, 1993). When evaluating CVD risk, therefore, 
considerable emphasis should be attached to measuring this depot. Comprehensive 
examinations of the assessment of intra-abdominal fat and its metabolic complications 
are presented in Sections 2.2 and 2.3 of the literature review.
The studies that examined CHD in relation to somatotype revealed very 
consistent findings. Men with an endomorphic-mesomorphic physique appear to 
experience a far greater incidence of coronary events than other somatotypes. 
Ectomorphic dominance appears to be the somatotype least associated with CHD. 
Although somatotyping does not allow the quantitative assessment of body 
composition compartments, it could be used to complement indices such as BMl and
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waist girth, for the early identification of the individual at risk of CHD. The 
somatotype could be particularly useful when used in conjunction with other well- 
established risk factors. Advances in methodology, allows somatotype classification 
to be made objectively and relatively easily. Reliability of the classification depends 
entirely on the reliability with which several anthropometric measurements can be 
made (Carter and Heath, 1990).
It is clear from the literature examined in this review that a wide variety of 
aspects of body habitus have been studied in relation to the incidence of CHD. These 
characteristics have ranged from the most basic and easily quantified to the 
profoundly more complex. Results suggest that it is not necessarily the more complex 
that are most closely associated with CHD. The variability in findings indicate that 
future research in this area should include a wide variety of measurements in order to 
identify the strongest predictor for a given population.
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2.2 DETERMINATION OF ABDOMINAL OBESITY: THE EFFECTS OF 
GENDER, AGE AND DEGREE OF OBESITY
2.2.1 Anthropometric circumference measurements, computed tomography 
and magnetic resonance imaging
In 1956, Vague reported how simple girth measurements and skinfolds could 
delineate the importance of fat distribution in relation to various diseases, including 
diabetes and atherosclerosis (Vague, 1956). Since this original study, numerous 
investigators have outlined alternative methods for the evaluation of fat distribution 
using simple anthropometric measurements and these are reviewed below.
In recent years, the introduction and development of CT and magnetic 
resonance imaging (MRI) have also enabled researchers to determine lAF 
accumulation. This facilitates the differentiation of the ’deep’ fat depot from the more 
superficial subcutaneous abdominal adipose mass. The expense of these techniques, 
together with the significant radiation exposure with CT, inhibits their use in 
extensive epidemiological surveys, but has permitted the validation of anthropometric 
indicators of lAF.
Following the initial study by Vague (1956) and maintaining the same 
terminology, Ashwell et al. (1978) described a method of classifying women 
according to their fat distribution using a side-view somatotype photograph to 
determine waist and thigh diameters. These investigators later suggested an alternative 
approach to the assessment of female fat distribution using anthropometric 
circumference measurements (Ashwell et al., 1982). Also in the early 1980’s, 
Krotkiewski et al. (1983) and Hartz et al. (1983) became the first groups to use the 
WHR as an indicator of fat distribution. It was claimed that this ratio was equal to the
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WTR proposed by Ashwell et al. (1978) for distinguishing between android and 
gynoid obesity.
An important landmark in the search for methods that could classify fat 
distribution, and facilitate the investigation of hypotheses with respect to fat 
distribution and metabolic disease risk, came in 1982 (Borkan et al., 1982). This was 
the first publication to recognise that a single CT scan could be used to measure 
abdominal fat content and, therefore, be used to differentiate between intra-abdominal 
and subcutaneous fat. In the subsequent decade, there were many further studies of fat 
distribution using CT methodology (Tokunaga et al., 1983; Grauer et al., 1984; 
Ashwell et al., 1985; Enzi et al., 1986; Kvist et al., 1986; Seidell et al., 1987; Seidell 
et al., 1988; Kvist et al., 1988a, 1988b; Baumgartner et al., 1988; Weits et al., 1988; 
Ferland et al., 1989; Rossner et al., 1990; Despres et al., 1991; Zamboni et al., 1992; 
Koester et al, 1992), most of which were reviewed by van der Kooy and Seidell 
(1993). Since 1993, the use of CT technology has been further evaluated (Armellini et 
al., 1993; Zamboni et al., 1993; Pouliot et al., 1994; Thaete et al., 1995; Jensen et al., 
1995; Lemieux et a l, 1996a; Vehmas et al., 1996; Armellini et al., 1997; Schoen et 
al., 1998; Zamboni et al., 1998; Rankinen et al., 1999). The measurement of AT with 
CT is accurate and highly reproducible (Thaete et al., 1995). It iSj therefore, regarded 
by many as the "gold-standard" for measuring lAF. However, the fact that it exposes 
the subject to radiation inhibits its use on ethical grounds. MRI is limited by its 
financial cost but does not expose the subject to radiation and, therefore, offers an 
attractive alternative to CT. The validity of multi-scan MRI, as a method for 
determining total percent lipid and total percent AT in vivo, has been shown using 
lean and obese pigs (Fowler et al., 1992). Residual standard deviations were 1.9 and 
2.1% respectively. Unlike CT, MRI has yet to be validated using human cadavers.
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In a comparison of a multi-scan CT method and a multi-scan MRI method, 
Seidell et al. (1990) found differences of 5.4%, 10.6% and 10.1% for total, visceral 
and subcutaneous abdominal AT areas respectively. They concluded that whilst MRI 
may yield slightly different results to CT, these differences were not of sufficient 
magnitude to change the rank-order of individuals assessed with these methods, or to 
invalidate MRI as a useful tool for studying the metabolic complications of visceral 
obesity.
Whilst Dooms et al. (1986) were first to examine the effects of age, gender and 
obesity on the technical aspects of the MR imaging of fat, other investigators (Foster 
et ah, 1984; Fuller et al., 1985; McNeil et al., 1989) were first to use MRI for 
assessing human body composition. As with CT, many subsequent studies have 
evaluated MRI as a method for measuring abdominal AT distribution (Staten et al., 
1989; Gray et a l, 1991; Fowler et a l, 1991; Sobol et al., 1991; Fowler et al., 1992; 
Ross et al., 1992; van der Kooy et al., 1993a; Terry et al., 1995; Sohlstrom and 
Forsum, 1995; Ross et al., 1996).
The aim of this section is to review the CT and MRI studies of body fat 
distribution and to appraise the anthropometric measurements that have been 
validated against them. Furthermore, a discussion of how race, age, gender and degree 
of obesity or overweight affects the distribution of fat assessed by CT or MRI is also 
presented. For a technical discussion of CT and MRI, the reader is directed to the 
paper by van der Kooy and Seidell (1993).
Tokunaga et al. (1983) extended the single-slice CT method previously outlined 
by Borkan et al. (1982) with a multi-scan assessment of lean and obese individuals. 
This method was used to compute total body fat volume by dividing the body into 11 
cylindrical shapes and measuring the height of each cylinder. However, as the CT-
105
scans were performed only at the middle of each segment, the determination of the 
cylinder volumes was limited by the assumption of a constant fat thickness along the 
entire length of the segment.
In a study of 25 age-matched males and females, Dixon (1983) was the first to 
show a difference in the distribution of abdominal fat between genders. The total 
cross-sectional area of the abdomen in men was approximately 100 cm^ greater. There 
was no difference in the total abdominal fat content, but males had almost twice as 
much lAF as females (P < 0.01).
Grauer et al. (1984) also reported differences in CT-determined abdominal fat 
distribution between males and females. Scans performed at the LI, L3 and L5 
vertebral levels revealed that females had a greater total fat volume at the L5 but not 
LI, and L3 levels. Relative to total fat volume, females also tended to have greater 
abdominal subcutaneous fat, whereas males had the greater lAF accumulation. These 
findings were supported by Enzi et al. (1986) in a study of 62 male and 68 female 
subjects using thoracic (heart apex level) and abdominal (upper renal pole) CT-scans. 
At both levels, the siibcutaneous-to-visceral AT ratio was higher in non-obese women 
than in non-obese men, and the difference was more pronounced in obese subjects.
The suggestion that anthropometric circumference measurements are unable to 
differentiate visceral and subcutaneous abdominal AT was recognised by Ashwell et 
al. (1985). In a group of 28 women who exhibited a large variation in age, BMI, waist 
and hip circumferences, these investigators were the first to report the results of both 
CT-scanning of the abdomen (a single slice at the fourth lumber vertebrae) and 
anthropometric girth measurements (Ashwell et al., 1985). After adjustment for BMI 
and age, the WHR, but not WTR, was significantly associated with CT-determined 
lAF and the intra-abdominal-to-subcutaneous fat ratio. This study did not examine the
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relationship between waist girth and lAF, which has subsequently been shown to be a 
better predictor of lAF (Pouliot et aL, 1994).
Following the first attempt to determine fat volumes (Tokunaga et aL, 1983), 
Kvist, Sjostrom and Tylen (1986) analysed 22 CT-scans obtained from the foot to the 
hand (with arms stretched above the head) on 8 female subjects ranging in body mass 
from 46 to 119 kg. Subcutaneous fat volumes, determined using three different 
mathematical models, were greatest in the trunk (-49.0 litres), followed by the legs 
(-31.8 litres), arms (-7.5 litres) and head and neck (-1.7 litres). Visceral fat volume 
was approximately 10.0 litres. The different mathematical approaches yielded very 
similar results. Further analysis showed that the highest correlation between total 
adipose volume and one single AT area (r = 0.99) was found for the L4-L5 scan. 
However, the error in predicting total AT volume from this single scan was 4.6%. To 
reduce the error to approximately 1%, a minimum of 9 CT-scans had to be included.
Following the attempt by Ashwell et al. (1985) to predict lAF from 
anthropometric circumference measurements, Seidell et al. (1987) further investigated 
this possibility in a study of 71 males and 34 females subjected to a single-slice CT 
procedure at the L4-level. Several anthropometric measurements were performed, 
including circumferences at the levels of the smallest waist, umbilicus, widest hips, 
anterior superior iliac spine and largest thigh. Suprailiac and para-umbilical skinfolds 
were also measured. In men, WHR was a better correlate of lAF fat than WTR. In 
women, however, this situation was reversed. In stepwise multiple regression 
analysis, BMI, skinfolds, WHR and age explained 81.9% of the variation in lAF. In 
women, the best combination to predict lAF was BMI, menopausal status and WTR, 
explaining 79.5% of the variance.
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Using the multi-scan CT technique they had reported previously (Kvist et al., 
1986, 1988a; Sjostrom et al., 1986), Kvist et al. (1988b) examined the possibility of 
predicting total and visceral fat volumes in 17 men and 10 women from 
anthropometric measurements. However, only body mass and stature were true 
anthropometric measurements. The diameter, circumference and AT thickness 
measurements used to develop the predictive equations were taken from CT-images. 
Using approximately half of these men and women as cross-validation material, the 
lowest error in predicting visceral fat at the L3-L4 level was obtained using the 
"nonsubcutaneous ellipse", (1). The error was only marginally (and not
significantly) improved by adding W/H or the circumference at this level. The internal 
errors of prediction in men were 12-13% and the external errors 8-10%. In women, 
the internal errors were approximately 11% and the external errors 25-27%.
As Borkan et al. (1982) had shown that abdominal fat distribution was partly 
age-dependent in men, Seidell et al. (1988) extended this investigation in a larger 
group of subjects that included 66 men and 34 women. They also examined the 
influence of the degree of obesity on abdominal fat distribution and the association 
with various anthropometric measurements. lAF area and the ratio of intra-abdominal- 
to-subcutaneous fat (I:S ratio), measured from a single CT-scan at the L4-L5 level, 
was greater in the older men and women than the younger subjects. This increase was 
independent of BMI only in the men, as in women less than 40-years of age, lAF did 
not increase with obesity. Despite also showing markedly lower lAF in a group of
(1) where d] is the midsagittal diameter minus the sum of right and left lateral subcutaneous adipose 
tissue thicknesses and d4 is sagittal diameter minus the sum of dorsal and ventral subcutaneous adipose 
tissue thicknesses).
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7 adolescents, the cross-sectional design of this study is a limiting factor and changes 
in the distribution of abdominal fat remains to be shown in a prospective, longitudinal 
study. Intra-abdominal fat was highly correlated with waist circumference in women 
over the age of 40-years, and all men, but not with the sum of suprailiac and umbilical 
skinfolds or the WHR.
In a study of 130 patients aged 16- to 81-years, Weits et al. (1988) examined a 
single CT-scan at the umbilical level, and several anthropometric measurements. 
Waist circumference was again found to be a better correlate of lAF area than the 
WHR, and a one-year difference in age was associated with an approximately Icm^ 
larger lAF area in men and women.
A more detailed analysis of abdominal composition was performed by 
Baumgartner et al. (1988). CT-images of the thorax, abdomen and pelvis (2) of 43 
men and 53 women aged 20- to 83-years were analysed in an attempt to determine the 
total, subcutaneous, intra-abdominal and retroperitoneal fat areas (3). In males and
(2) The first CT-sIice (xiphoid) was taken at the extreme caudal tip of the xiphoid process and the 
fourth (lower abdomen) at the extreme cranial edges of the iliac crests. The second (midabdomen 1) 
and third (midabdomen 2) slices were those approximately one-third and two-thirds o f the distance 
(mm) between the first and fourth slices. The sixth slice was at the level of the pubic symphysis and the 
fifth slice was approximately midway between the fourth and sixth slices.
(3) Intra-abdominal adipose tissue was determined from an area bounded by the parietal 
peritoneum. The retroperitoneal adipose tissue was defined using an approach similar to that of 
Ash well et al (1985b) which draws two lines diagonally from the anterior edge of the inferior vena 
cava tangentially across the anterior aspects of each kidney to their intersection with a line 
circumscribing the intra-abdominal area. Subcutaneous adipose tissue was equal to the total adipose 
tissue area minus the intra-abdominal adipose area.
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females, lAF areas were larger for the mid-abdominal than lower or upper abdominal 
slices. Men had significantly greater lAF areas at the levels of the xiphoid process and 
mid-abdomen but not at the lower abdomen or pelvis. Retroperitoneal fat was also 
greater in the men, but subcutaneous fat was greater in the women at all levels. The 
principal difference between the sexes with respect to abdominal composition was in 
the proportions of intra-abdominal and subcutaneous fat. At the mid-abdominal level, 
lAF accounted for -14% of the total cross-sectional area and -50% of the total fat 
area in men. In women, however, the values were -11% and -33% respectively. Intra- 
abdominal, but not subcutaneous fat was positively associated with age in both sexes.
Ferland et al. (1989) studied 51 obese pre-menopausal women and found that 
the total, but not the proportion, of lAF could be reasonably well estimated from a 
combination of age and anthropometric measurements. This study also suggested that 
there was independence between total body fatness and the absolute amount of lAF in 
the fattest women. These authors concluded that in extremely obese women, increases 
in abdominal adiposity are a consequence of increasing subcutaneous fat. However, 
this observation was based on only four subjects. In at least two other subjects of 
equal total body fatness there was a linear increase in lAF.
Until the work by Rossner et al. (1990), the validity of CT-determinations of 
intra-abdominal fat was based upon information gained from phantoms. This provided 
the investigators with Hounsfield numbers characteristic for fat (4). Rossner et al.
(1990) analysed 1 cm thick abdominal cross-sections from two male cadavers, aged
(4) A Hounsfield number or unit (HU) is the attenuation or absorption value for a given substance. Fat 
has an attenuation value in the range of approximately -190 to -30 HU (van der Kooy and Seidell 
1993y
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78- and 77-years. Their data indicated a close correlation between CT-measurements 
and these direct determinations of fat (for absolute fat at the umbilical level, r = 0.93 
or 0.94 depending on the Hounsfield numbers used). However, the direct validation of 
CT-images in both males and females across the range of age and body fatness 
remains a challenge.
The difficulty predicting lAF from anthropometric measurements was further 
highlighted in a study of 110 men aged 18- to 42-years with BMl’s ranging from 16 to 
38 kg.m'^ (Despres et a l, 1991). Multivariate analysis showed that most measures of 
total or regional fat correlated with lAF in leaner men (BMl < 28.0 kg.m'^). This 
contrasted to the findings in obese men (BMl > 28.0 kg.m'^) for whom none of the 
measures of total fat, and only waist circumference, WHR and sagittal diameter were 
associated with deep abdominal fat. However, even the best combination of variables 
could predict lAF with only moderate accuracy. The prediction equations were more 
accurate in the leaner than the obese men, and accounted for approximately 70% of 
the variance, with standard errors of estimation in the region of 30 cm^ or 30 %.
In studies of obese subjects, Busetto et al. (1992) and Zamboni et al. (1992) 
confirmed the difficulty in estimating lAF from the WHR. These investigators 
concluded the following. WHR is greatly influenced by the degree of obesity. The 
accuracy of WHR, when assessing the distribution of visceral and subcutaneous fat, 
decreases with increasing fatness. The use of WHR may be misleading in obese 
subjects, particularly females, if the aim is the assessment of visceral fat. Furthermore, 
in a study of 119 women whose BMl’s ranged from 25 to 51 kg.m'^, Armellini et al. 
(1993) showed that WHR and ASD were not significantly different between the 
women in the second and third tertiles of visceral fat.
I l l
Koester et al. (1992) attempted to predict lAF from extensive anthropometric 
measurements (nine skinfolds and thirteen circumferences), ten derived 
anthropometric variables and total body fat determined from hydrostatic weighing. In 
a cohort of 61 male subjects aged 18- to 30-years (body fat range 2 to 36%), the best 
prediction of lAF was from a regression model that included the product of waist and 
hip circumferences and percentage body fat (R  ^= 0.73, SEE = 30.8 cm^). Abdominal 
subcutaneous fat could be predicted with slightly greater accuracy from waist 
circumference and percentage body fat (R  ^= 0.81, SEE = 29.3 cm^). Anthropometric 
measurements alone were unable to provide a satisfactory prediction of the 1:S ratio, 
but a preliminary study of the anthropometric ASD revealed high correlations with the 
CT-derived ASD.
In a study of men and women, Pouliot et al. (1994) examined the association 
between waist and hip girths, relative body fat and CT-determined lAF. This study is 
notable as it also examined the association between fat distribution and metabolic 
markers of CVD risk. In agreement with previous studies (Dixon 1983; Grauer et al., 
1984; Enzi et al., 1986; Seidell et al., 1987, 1988) women were found to have a 
greater relative body fat and total abdominal fat area than men. However, men had a 
greater visceral fat area, WHR and waist girth. Waist girth and sagittal diameter also 
exhibited higher correlations with total body fat and visceral fat than WHR. From 
these findings, it was suggested that waist girth and sagittal diameter were not only 
associated with total body fat but could discriminate between those with a 
predominant accumulation of fat at the abdominal level. A "threshold" waist girth 
value of > 100 cm was thought to be most likely associated with a metabolic profile 
commensurate with elevated CVD risk. As a given waist girth value indicated 
comparable levels of visceral fat in men and women, this threshold was reported to be
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applicable to both sexes. A subsequent study (Lemieux et al., 1996a), aimed to 
establish threshold values of waist girth and WHR that could identify individuals with 
a visceral fat area of > 103 cm^: a value above which substantial alterations in 
metabolic fitness may be found (Despres et al., 1993; Hunter et al., 1994). In both 
sexes, the "threshold" values for both parameters were age- and obesity-dependent. 
With regard to waist circumference, this amounted to 98.9 cm in younger men (< 40 
years) and 90.9 cm in older men (> 40 years). For WHR, these values were 0.96 and 
0.92 respectively. For men with a BMl < 25 kg.m'^, values were 93.9 cm and 1.02. 
For more overweight men (BMl > 27 kg.m'^) the critical waist girth was 96.2 cm and 
WHR 0.93.
A further examination of the ASD was performed by Armellini et al. (1997) in a 
large group of women with a mean age of -41 years. This study suggested that 
subtracting the thickness of abdominal subcutaneous fat (measured 5 cm from the 
umbilicus on the xiphoumbilical line) from the ASD improved the correlation with 
visceral fat. However, these measurements were derived from CT and ultrasound 
images. Whether a similar phenomenon exists with simple anthropometric 
measurements remains to be established. Furthermore, waist circumference remained 
the best predictor of fasting insulin and fasting TG concentrations. The same group of 
investigators provided further information on the validity and reliability of the 
anthropometric ASD in a study of 28 women and 23 men who ranged from lean to 
obese (Zamboni et al., 1998). Both inter- and intra-observer reliability was extremely 
high. The accuracy of the ASD as a predictor of visceral fat was, however, markedly 
less in obese subjects (r = 0.43, P < 0.05) than in lean to moderately overweight 
persons (r = 0.86, P < 0.001). The ASD was not an improvement on waist girth which 
was also highly correlated with visceral fat in the leaner subjects (r = 0.87, P < 0.001).
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Based on their findings from a study of 40 men and women characterised by a 
wide range of BMl, Schoen et al. (1998) questioned the accuracy of the CT- 
determined ASD as a predictor of total visceral fat. ASD was significantly correlated 
with total visceral fat when all subjects were analysed (R  ^ = 0.50, P < 0.001). 
However, when the analysis was restricted to a more homogeneous group (those with 
a BMl > 27.0 kg.m'^), sagittal diameter was independent of total visceral fat (R  ^ = 
0.04, P > 0.05). It was suggested that within a 2 cm range of ASD, there was a nearly 
three-fold variability in total visceral fat.
The only cadaver study to examine directly the association between excised lAF 
and several anthropometric measurements was reported by Pounder et al. (1998). In a 
series of 100 male cadavers, waist girth was found to account for the largest variation 
(61%) in lAF. Although this association was not especially strong, there was a clear 
increase in lAF for a given increase in waist girth.
Table I  (2.2). Weight o f intra-abdominal fa t in relation to waist circumference in 59 
non-obese male cadavers (Pounder et al., 1998).
Waist girth (cm) Number of subjects Mean (g) Median (g) Range (g)
74-77 10 556 484 207 to 1246
78-81 14 865 761 402 to 1759
824# 13 994 876 331 to 2170
8&j# 13 1243 1250 511 to 2220
90-93 9 2057 1963 1113 to 3626
The studies reviewed so far have relied primarily on regression and multiple 
regression procedures to evaluate the validity of anthropometric measurements as 
indicators of lAF. Rankinen et al. (1999) have recently examined the sensitivity
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(probability of correctly detecting true positives) and specificity (probability of 
correctly detecting true negatives) of waist circumference, WHR, BMl and relative 
body fat for identifying several critical visceral fat areas in men and women. This 
procedure relies on the construction of a ROC (receiver operating characteristic) 
curve, which plots sensitivity against specificity over a range of cut-off values. The 
cut-off value producing the best combination of sensitivity and specificity is then 
chosen as the optimal threshold for each predictor. The overall conclusion from this 
study was that waist circumference is the best overall predictor of abdominal visceral 
fat in younger (< 40 years) and older (> 40 years) men and women. WHR, however, 
was a poor predictor, especially in women. In younger men, an optimal waist girth 
cut-off point of 94.6 cm had a sensitivity of 90.5% and a specificity of 89.5% to detect 
a visceral fat area of 130 cm . In older men, these values were 94.5 cm, 81.0% and 
85.2% respectively.
Most imaging studies of fat distribution have used CT technology. The radiation 
associated with this technique limits its use in otherwise healthy individuals and 
prevents studies being conducted that require repeat exposure. MRI, whilst being 
prohibitively expensive, does not have this limitation. Staten et ah (1989) recognised 
this important feature of MRI in their study of 6 subjects (3 male and 3 female) who 
ranged in body fat from 14 to 44%. Following MR-imaging on two occasions 
separated by less than 3 weeks, lAF was found to be associated with the ratio of the 
widest circumferences of the waist and hips (r = 0.85, P < 0.05). These 
circumferences were derived from the MR-images and not anthropometry. The error 
of lAF measurement associated with duplicate images was calculated to be 
approximately 10%. This was reduced to approximately 5% when the two leanest 
subjects were omitted from the analysis.
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Following the study by Seidell et al. (1990) which compared the results of CT 
and MRI, Sobol et al. (1991) further explored this issue in 11 healthy subjects aged 
21- to 49-years. For reasons which are not clear, fat areas measured by MRI tended to 
exceed those measured by CT by 8-22%. However, the correlation between MRI- and 
CT-determined lAF was 0.93 (P < 0.001). As CT is the ’gold-standard’ method for 
determining lAF, this study suggests that MRI can be considered a valuable 
alternative.
In a study of diabetic (n = 24) and non-diabetic (n = 12) women, MRl- 
determined lAF at the umbilical level showed a low correlation (r = 0.21, P > 0.05) 
with the WHR (Gray et al., 1991). However, when the non-diabetic women were 
assigned to groups of either low (< 0.80) or high (> 0.85) WHR, there was a 
significant difference (P < 0.05) in the area of lAF. Women in the low WHR category 
had a mean (± SD) lAF area of 79 (14) cm^ compared to 127 (38) cm^ in the high 
WHR group. Interestingly, the subcutaneous fat areas were remarkably similar (P > 
0.05). Values of 473 (58) cm^ and 477 (99) cm^ were reported for the low and high 
WHR groups respectively.
Ross et al. (1992) conducted an extensive MRI and anthropometric study of 27 
healthy male subjects varying in age [40.8 ± 14.5 years (mean ± SD)], BMl (28.5 ± 
4.8 kg.m"^) and WHR (0.96 ± 0.07). Total fat volume was derived from 41, 10 mm 
slices taken consecutively from head-to-toe at 50 mm intervals. The best 
anthropometric model for the prediction of lAF area at the L4-L5 level was provided 
by a combination of age and WHR (P < 0.001). This prediction equation explained 
65% of the variance in lAF area, and had a SEE of 27.3cm^. This study also showed 
that the anthropometric prediction equation proposed by Seidell et al. (1987), did not 
perform well under cross-validation (R  ^ = 0.58, SEE = 40.1cm^, actual mean ± SD
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visceral fat area at the L4-L5 level = 117.9 ± 62.1cm^, predicted mean visceral fat 
area at the L4-L5 level = 80.9 ± 66.2cm^, P < 0.001).
A further examination of the usefulness of anthropometric measurements to 
predict abdominal adiposity in a sample of obese men and pre-menopausal women 
was undertaken by van der Kooy et al. (1993a). In this study of weight-loss, the 
correlation between MRl-determined visceral fat area and the sagittal and transverse 
abdominal diameters derived from either the MRl-scans or anthropometry were 
almost equal. In women, the correlation between visceral fat area and the MRI sagittal 
diameter was r = 0.76 (P = 0.007), whereas the correlation between visceral fat and 
the anthropometrically assessed supine diameter was r = 0.72 (P = 0.01). In men, 
these correlations were r = 0.66 (P = 0.04) and r = 0.61 (P = 0.06) respectively. In 
women, visceral fat area was most strongly associated with the WHR (r = 0.64, P < 
0.001). In men, the sagittal diameter showed the highest correlation with visceral fat 
area (r = 0.61, P < 0.001), with waist circumference showing the strongest association 
with abdominal subcutaneous fat area (r = 0.73, P < 0.001). Several of the 
anthropometric regression equations reviewed earlier in this critique, were also 
applied to this sample. The equations of Seidell et al. (1987) and Despres et al. (1991) 
performed best of all, yielding correlations between measured and predicted visceral 
fat areas of r = 0.66 (P < 0.001) and r = 0.75 (P < 0.001) respectively. The mean 
differences between the measured and predicted values were not significant (P > 
0.05). A further important finding in this study, was the lack of a strong association 
between changes in abdominal fat areas and changes in diameters and circumferences. 
The highest correlation was r = 0.56 (P < 0.001) between change in visceral fat area 
and change in sagittal diameter. This finding was further highlighted in a study of 40 
obese women and 38 obese men (van der Kooy et al., 1993b), that showed the WHR
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was insensitive to changes in visceral fat area. The only significant association with a 
change in visceral fat area was a change in waist circumference for men (r = 0.33, P < 
0.05).
In a similar study to that by Rankinen et al. (1999) outlined earlier, Ross et al. 
(1996) determined the associated sensitivity and specificity of a 100 cm waist 
circumference as a marker for a visceral fat area of 130 cm^ or greater. Waist 
circumference was significantly related to visceral fat area in both men and women [r 
= 0.65 and 0.70, (P < 0.01) respectively]. As there was no difference (P > 0.05) 
between the regression lines describing these relationships, the male and female 
subjects were combined to form one sample for the following analysis. A waist 
circumference of 100 cm was associated with a sensitivity of 83% for identifying 
subjects with a visceral fat > 130 cm^ and a specificity of 38% for identifying those 
with a visceral fat of < 130 cm^. That is, 29 of 35 subjects were correctly identified 
(true positives) but 24 of the 64 subjects with a visceral fat <130 cm^ also had a waist 
circumference > 100 cm (false positives).
2.2.2 Novel anthropometric indices of fat distribution
Since Vague (1956) first used anthropometry to describe human fat distribution, 
numerous investigators have proposed anthropometric alternatives. Whilst most of 
these studies have used the WHR, other combinations have been examined. The aim 
of this section is to outline these measurements and to examine their usefulness to the 
scientific community and general population.
In 1991, Valdez introduced a model-based index of abdominal obesity, referred 
to as the "conicity index" or C-index. Its aim is to standardise waist circumference for 
body shape. This index was based on the idea that, as people accumulate fat in the
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abdominal region, "the shape of their bodies seems to change from that of a cylinder 
to that of a double cone (two cones with a common base)" (Valdez, 1991). The 
outermost circumference of such a double cone is given by the formula:
C = V 12(77/D) V wt /h t
where: wt = weight of the subject (kg) 
ht = height of the subject (m)
D = body density (kg/m'^).
If the "average human body density of 1050 kg/m'^ is used" the formula for the C- 
index becomes:
C-index = AG / [0.109 (V  wt / ht)]
where: AG = abdominal girth (m)
0.109 is a constant that results from the conversion of 
units of volume and mass, to units of length.
Essentially, the C-index has no units and its predicted range is between 1.00 
(perfect cylinder) and 1.73 (perfect double cone). So, if a person has a C-index of 
1.25, it means that such a person has an abdominal girth which is 1.25 times larger 
than the circumference of a cylinder generated with the height and weight of that 
person (Valdez, 1991). Unfortunately, until Valdez et al. (1993) applied this index to 
CVD risk in a cohort of European and US men and women, there was no further 
description or justification of this method. It appears to be limited by the fact that it 
relies on a constant "average" body density, a value that is unknown. Furthermore, the 
C-index is probably too complicated to use in a public-health context and is difficult 
to interpret biologically (Molarius and Seidell, 1998).
As indicated previously, the close relationship between the ASD and visceral fat 
volume was first proposed by Kvist et al. (1988b). Kvist et al. (1988b) and later
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Sjostrom (1991) suggested that in subjects in the supine position, increasing 
accumulation of visceral fat would maintain the depth of the abdomen in a sagittal 
direction while subcutaneous abdominal fat would reduce the abdominal depth due to 
the force of gravity. Later investigations found that anthropometrically-assessed 
abdominal diameters in the standing and supine positions are strongly correlated with 
abdominal diameters extracted from images (van der Kooy et al., 1993a; Koester et 
a l, 1992).
In one study, the CT-derived ASD at the L4-L5 level, was the single best 
indicator of visceral fat volume (r = 0.90, P < 0.05), the error being in the region of 
15% for cross-validation males and females (Sjostrom et al., 1996). Ferland et al. 
(1989) and Despres et al. (1991), however, studied larger cohorts of men and women 
and found lower correlations between these parameters. All of these correlations were 
considerably greater than those observed between the anthropometrically-derived 
ASD and the visceral fat area (r = 0.51 and 0.61, P < 0.05, in men and women 
respectively) (van der Kooy et al., 1993a). In the absence of data showing that the 
anthropometric ASD is a better predictor of visceral fat, there is no justification for its 
use in place of waist circumference. The latter of these measurements has been 
examined extensively in clinical and epidemiological studies and threshold values 
exist. Furthermore, as the public is familiar with the measurement of waist girth, and 
it is easily understood, it has been suggested that the focus of body-weight regulation 
should remain on this variable (Seidell, 1996). The limitation of using waist 
circumference is that it is unclear what this measurement is actually measuring, i.e. it 
is comprised of visceral and subcutaneous fat, muscle, internal organs and bone. Kahn 
(1993) has suggested several anthropometric ratios depending on the hypothesis of the 
investigator(s). These include waist girth/height (WhtR), ASD/height (ASD/ht),
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ASD/thigh girth (ASD/Th) and the C-index. However, ratios have limitations that will 
be discussed in the following section.
2.2.3 Anthropometric classification of adipose tissue distribution and 
adjustment for body size variability.
The WhtR was initially proposed by Higgins et al. (1987) who explored its 
relationship with morbidity and mortality in Framingham participants. Data from 
large-scale studies of British and Japanese adults, subsequently suggested that this 
ratio is the most powerful anthropometric predictor of mortality (Cox et al., 1996) and 
CAD risk factors (Hsieh and Yoshinaga, 1995). Although Ash well et al. (1996a) have 
supported these claims and suggested that this ratio is a better predictor of lAF than 
waist circumference alone (Ashwell et al., 1996b) others have disagreed (Han et al., 
1996; Han et al., 1997). Kahn (1993) proposed that including height as a denominator 
acknowledges the larger bones and muscles that would be incorporated within either 
the waist girth or ASD in taller subjects.
Most ratios aim to control for the confounding influence of the denominator. In 
the case of the WhtR, the aim is to control for differences in stature. This ratio has 
been used to address the question of whether it is the absolute waist girth, or the 
relative size of the waist girth-to-height, that is the best predictor of cardiovascular 
morbidity and mortality. As discussed recently, however, ratios present problems with 
regard to their interpretation (Molarius and Seidell, 1998) and statistical analyses, 
where their use can introduce spurious correlations among the ratios and other 
variables (Allison et al., 1995). For example, a large WhtR, may result from a large 
waist circumference or alternatively to short stature. As height is inversely related to
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the risk of CAD (Williams et al., 1997) this makes it difficult to separate risk 
associated with increased waist girth from risk associated with shorter stature.
2.2.4 Sensitivity of girth measurements to reflect changes in intra-abdominal 
fat following weight loss
If anthropometric girth measurements are valid indicators of lAF, they should also be 
sensitive to changes in this particular tissue mass. In comparison to the subcutaneous 
and femoral sites, studies have shown that the visceral fat depot exhibits a larger 
relative decrease with dietary-induced weight loss (van der Kooy et al., 1993b; 
Zamboni et al., 1993). Using a 13-week, 4.2 MJ/d energy-deficit diet, van der Kooy et 
al. (1993b) induced an average (± SD) weight loss of 12.9 (3.5) kg (P < 0.001). The 
proportional reduction in visceral fat was 40% in men and 33% in women. At the 
trochanter level, the relative reduction in subcutaneous fat was 29% in men and 26% 
in women. The waist and hip circumferences decreased significantly in men and 
women after weight loss (P < 0.001), as did the WHR (P < 0.001). In men and 
women, the decrease in subcutaneous fat at the abdominal and femoral areas was 
significantly related to the change in waist and hip circumferences (r = 0.46 to 0.70, P 
< 0.05). The change in visceral fat area was related to the change in waist 
circumference in men only (r = 0.33, P < 0.05), whilst the WHR was a poor predictor 
of all MRl-determined fat areas except the subcutaneous abdominal fat in men (r = 
0.37, P < 0.05).
Zamboni et al. (1993) subjected 16 pre-menopausal women to a 2-week very- 
low energy diet (1286 kJ/d) and an additional 14-week low-energy diet (4200 kJ/d). 
After the full 16-week period, the average weight loss was 16 kg (SD not reported). 
Waist circumference, hip circumference, ASD, total fat, visceral fat, subcutaneous fat
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and the subcutaneous-to-visceral fat ratio all exhibited significant reductions (P <
0.05). The WHR, however, did not change (P > 0.05) and was not related to visceral 
fat reduction (P > 0.05).
A combination of dietary restriction (4.18 MJ/d) and exercise (5-days per week 
of aerobic activity or 3-days per week resistance training) was found to reduce 
visceral fat area by 34.8 ± 18.2% in obese men and 25.9 ± 16.8% in obese women 
(Ross et ah, 1996). Corresponding values for subcutaneous fat loss were 32.7 ±15.1% 
and 23.2 ± 11.9% respectively. Waist circumference was significantly (P < 0.05) 
reduced in men (11 ±3.1%) and women (8.3 ± 3.4%), but the WHR was reduced in 
the men only (4.7 ± 3.2%, P < 0.05). Regression analysis revealed a significant 
relationship between a decrease in waist girth and a reduction in visceral fat (r = 0.66, 
P < 0.01). There was no sex difference in this relationship and a 1 cm decrease in 
waist girth corresponded to a 4% reduction in visceral fat mass or 5 cm^ (3.5%) 
reduction in area. Although the WHR decreased with weight loss in the male subjects, 
this decrease was not related to the change in visceral fat (r = 0.33, P > 0.05).
After a 7-year period in women, Lemieux et al. (1996b) have shown that 
increases in waist girth, ASD and total fat mass were all highly correlated with an 
increase in visceral AT (r = 0.81 to 0.91, P < 0.0001). The relationship with WHR, 
however, was much weaker (r = 0.35, P < 0.05).
2.2.5 Conclusion
Epidemiological studies (Larsson et al., 1984; Lapidus et al., 1984) published almost 
two decades ago were the stimulus for a renewed interest in anatomical fat 
distribution. For reasons to be highlighted in the next section, the lAF depot now has
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particular significance for researchers investigating the health implications of obesity. 
It is of high importance, therefore, that techniques exist for the accurate and reliable 
measurement of lAF. Studies reviewed above suggest that both CT and MRI are 
capable of this. Studies performed in quite recent times have shown that lAF 
accumulation is affected by several factors including age, gender and degree of 
obesity. Biologically, body fat distribution is determined by many other factors 
including genetics, sex and stress hormones, hormone receptor density and local 
lipoprotein lipase activity to name but a few (Bouchard et al., 1993).
In order to facilitate larger-scale studies, it has been necessary to try and 
validate Indirect’ measurements of lAF. Furthermore, it is important that health 
professionals working in the community can make measurements that are relatively 
simple and inexpensive but at the same time scientifically meaningful. Thus, several 
anthropometric girth measurements have been evaluated. Initially the WHR was the 
measurement of choice. However, more recently the simple waist girth measurement 
has become pre-dominant. Although it only has a moderately strong correlation with 
lAF, it is capable of distinguishing individuals with high and low levels, it avoids the 
statistical pitfalls of ratios like the WHR, and threshold values have been proposed for 
both men and women. Furthermore, as will be highlighted in Section 2.3, it is closely 
associated with several risk factors for CVD.
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2.3 OBESITY AND FAT DISTRIBUTION: INDEPENDENT RISK
FACTORS FOR CORONARY ARTERY DISEASE OR COMPONENTS 
OF A MULTIFACTORIAL SYNDROME?
This section of the Literature Review aims to explain the association between obesity, 
fat distribution and CAD. Firstly, an examination of the relationship between 
glycaemia, blood lipids and lipoproteins, and CAD is presented, as disturbances in 
glucose and lipid metabolism are central to this discussion. A widely held belief is 
that insulin-resistance and compensatory hyperinsulinaemia are the key features of 
these metabolic disturbances. Thus, a brief description of the relationship between 
insulin and CAD is also given.
2.3.1 Glycaemia and CAD
In patients with type 2 diabetes, CHD is the most common cause of morbidity and 
mortality (Barrett-Connor, 1997). As people with type 2 diabetes have a risk of CVD 
that is two to four times greater than non-diabetic individuals (Coutinho et al., 1999), 
there is overwhelming agreement that this condition is a powerful risk factor for a 
cardiovascular event (Stem, 1997). Until recently, the relationship between CVD and 
glycaemia at levels of blood glucose below the diabetic thresholds (7.0 mmol.L'^ 
fasting and 11.1 mmol.L'^ 2-hour post-load) was less clear (Barrett-Connor, 1997). 
Two important publications of recent times (Coutinho et al., 1999; Khaw et al., 2001), 
however, have provided the most convincing data yet that the association between 
blood glucose concentration and CVD occurs throughout the normal glucose range.
Coutinho et al. (1999) conducted a meta-regression analysis of 95,783 
individuals followed for 12.4 years. In comparison to a fasting glucose level of 4.2 
mmol.L'\ fasting and 2-hour post glucose challenge levels of 6.1 mmol.L'^ and 7.8
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mmol.L'^ were associated with relative risks of a cardiovascular event of 1.33 (95% 
Cl 1.06 - 1.67) and 1.58 (95% Cl 1.19 - 2.10) respectively (P < 0.02 for the trend).
Khaw et al. (2001) showed that glycosylated haemoglobin was positively 
associated with the future risk of CHD. This is an important finding as glycosylated 
haemoglobin provides a reliable integrated estimate of glucose over the preceding 6  to 
12 weeks. Furthermore, this association was independent of other risk factors for 
CHD and there was no evidence of a threshold effect.
Thus, there is now evidence that elevated levels of fasting and post-load glucose 
below the diabetic thresholds, represent risk factors for CVD. This continuous 
relationship appears to exist in all people, and is therefore, similar to the relationship 
between cholesterol, blood pressure and CVD (Gerstein, 1997).
Several mechanisms have been proposed to explain the relationship between 
blood glucose and CVD (Gerstein, 1997). These include: a direct toxic effect of 
glucose on cell function and structure through advanced glycation end products; 
indirect effects due to insufficient insulin secretion to prevent hyperglycaemia and the 
associated metabolic abnormalities; a long history or pre-existing insulin resistance 
and hyperinsulinaemia; an association with both known and unknown risk factors for 
CVD. Amongst other risk factors that are associated with hyperglycaemia are 
hypertension, hyperinsulinaemia, abdominal obesity and dyslipidaemia (Gerstein, 
1997).
2.3.2 Insulin and CAD
The role of insulin as an ’independent’ risk factor for CAD has been the subject of 
intense debate (Jarret, 1994; Reaven and Laws, 1994; Fontbonne, 1994; Stem, 1994). 
Several studies have reported an increased fasting plasma insulin level is associated
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with an elevated risk of CAD in men (Ducimetiere et a l, 1980; Pyorala et a l, 1985; 
Eschwege et al., 1985; Welbom and Weame, 1979; Yamell et al., 1994; Fontbonne et 
al., 1991). However, in all of these studies this association could be explained 
predominantly by the presence of other risk factors, particularly an elevated TG 
concentration and a low HDL-C. This observation has been reaffirmed recently 
(Pyorala et al., 1998; Lakka et al., 2000). In these studies, the increased incidence of 
stroke (Pyorala et al., 1998) and cardiovascular mortality (Lakka et al., 2000) was 
dependent on the co-existence of other risk factors, including upper-body fat 
distribution.
In some instances, no effect of insulin on CAD risk has been found (Welin et 
al., 1992; Hargreaves et al. 1992; Orchard et al., 1994). This is surprising given that 
hyperinsulinaemia frequently occurs alongside other recognised risk factors (Reaven, 
1988).
In one study, the relationship between fasting plasma insulin and risk of IHD 
was reported to be independent of systolic blood pressure, medication use, a family 
history of IHD, TG, apo B, LDL-C and HDL-C (Despres et al., 1996).
The reasons for the discrepant findings are not clear, although several 
explanations have been proposed (Jarret, 1994; Reaven and Laws, 1994; Fontbonne, 
1994; Stem, 1994). One possibility centres around the accompaniment of other risk 
factors with hyperinsulinaemia. As will be outlined in the sections below, whilst 
hyperinsulinaemia and obesity are inexorably linked, it has become apparent that not 
all obese individuals have the cluster of metabolic and haemostatic factors that 
increase the risk of CAD. This means that elevated insulin levels may well be found 
in large numbers of obese individuals who are not at increased risk of CAD.
138
2.3.3 Dyslipidaemia and CAD
With regard to CAD risk factor identification, one of the least controversial subjects 
concerns the role of blood lipids and lipoproteins. Evidence gathered for several 
decades shows unequivocally that elevated total and LDL-cholesterol and reduced 
HDL-cholesterol are independently associated with CAD risk (Neil, 1997). 
Conversely, the role of plasma TG as a risk factor for CAD has remained poorly 
defined. However, a recent meta-analysis of 17 population-based prospective studies 
that represented 2445 cardiovascular events among 46413 Caucasian men found that 
elevated TG was associated with a 14% increased risk of a cardiovascular event 
(Austin et al., 1998). This association was independent of HDL-C. Subsequent studies 
have since confirmed this independent association (Stampfer et al., 1996; Gardner et 
al., 1996; Lamarche et al., 1997). Plasma TG and LDL particle size both predicted 
subsequent CAD in three different Caucasian populations.
2.3.4 The Insulin Resistance Syndrome
In 1988, the clustering of several variables frequently associated with an increased 
incidence of CVD, namely insulin resistance and reduced glucose tolerance, increased 
very low-density lipoprotein (VLDL), decreased HDL-C and hypertension, was given 
the term Syndrome X’ (Reaven, 1988). As this potentially atherogenic profile 
frequently co-exists with abdominal obesity, this latter characteristic was later added 
to the list’, leading to the term "the deadly quartet" (Kaplan, 1989). Recent data from 
a study of men and women in Finland illustrates the importance of considering the 
type of obesity in this syndrome (Vanhala et al., 1998). The prevalence of 
dyslipidaemia (increased TG and decreased HDL-C) and insulin resistance was 4% in 
non-obese subjects and 18% in those with a WHR >1.00 in men and >0.88 in women
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with a BMI < 30 kg.m'^. This increased to 28% in those with a BMI > 30 kg.m'^ but 
WHR’s lower than 1.00 and 0.88. The highest prevalence (46%) was found in those 
subjects who were both abdominally obese (WHR > 1.00 or 0.88) and obese (BMI > 
30 kg.m'^). A similar finding has also been reported recently in a large cohort of 
Canadian citizens (Connelly et al., 1999). Furthermore, Lemieux et al. (1994) have 
suggested that differences in several lipid risk factors between men and 
premenopausal women of equal body fat, can be partly explained by gender 
differences in lAF accumulation. The same group also suggested that visceral fat 
deposition is partly responsible for the deterioration in the lipoprotein profile 
associated with aging in men (Lemieux et al., 1995), and for the more cardio­
protective lipoprotein profile found in obese black versus obese white individuals 
(Despres et al., 2000).
Fnzi et al. (1994) suggested extending this list of variables with a tendency to 
cluster to a "deadly sextet", including intra-abdominal obesity, insulin resistance, 
hypertriglyceridaemia, hypoalphalipoproteinaemia, hyperuricaemia and hypertension. 
Despres (1993) proposed a syndrome that included abdominal obesity, elevated TG 
and reduced HDL-C, an elevated number of small, dense LDL particles and glucose 
intolerance. As insulin resistance and the ensuing compensatory hyperinsulinaemia is 
thought by many to be the cause of the many metabolic and circulatory disturbances 
characteristic of the syndrome, the term insulin resistance syndrome has also been 
proposed (Ferrannini, 1993). Irrespective of its name, it is now clear that intra­
abdominal obesity is a component of a cluster of abnormalities including glucose 
intolerance caused by insulin resistance, compensatory hyperinsulinaemia, 
hypertension, hypertriglyceridaemia and a lipoprotein profile that is highly 
atherogenic. Furthermore, a delayed post-prandial lipid clearance (Taira et al., 1999;
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Couillard et al., 1998), impaired vascular endothelial dysfunction (Steinberg et al., 
1996; Westerbacka et al., 1999), elevated plasminogen activator inhibitor (Vague et 
al., 1989) and increased C-reactive protein (Lemieux et al., 2001) are also observed in 
subjects with abdominal obesity. Until the exact pathophysiology of this syndrome is 
unravelled, a discussion of the best descriptive term is likely to continue (Reaven, 
1997). Presently, insulin resistance syndrome, syndrome-X, or simply ’metabolic 
syndrome,’ are all terms that are used. As the focus of this section is the association 
between abdominal obesity and disturbances in carbohydrate and fat metabolism, of 
which insulin resistance is undoubtedly a key element, the term insulin-resistance 
syndrome will be adopted.
2.3.5 Obesity, Fat Distribution and Metabolic Fitness
The relationship between abdominal adiposity and risk factors for CVD, including 
type 2  diabetes, glucose intolerance, insulin resistance and dyslipidaemia, has now 
been examined extensively in studies of both obese and non-obese males and females. 
Most of these studies have used anthropometric indices of fat distribution, although 
there are now a number that have more precisely estimated lAF with CT or MRI. 
Some studies have reported on the association between CVD risk factors and 
adipocyte morphology and metabolism following AT biopsy. The following sections 
review these studies. As this is an area that has received considerable attention in the 
last two decades, studies in women have been excluded so that greater details of 
studies in men can be presented. The exception to this is where the studies have 
examined adipose tissue morphology by the biopsy technique. In this case, the data 
are still sparse so studies of women have been included.
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(a) adipose tissue morphology, type 2 diabetes and glucose-insulin homeostasis in 
obese and non-obese men and women
In men, fasting insulin but not glucose has been found to be modestly associated with 
fat cell weight (FCW) from the gluteal, femoral and epigastric regions (r = 0.20, P < 
0.01) but not hypogastric FCW (Krotkiewski et al., 1983). In women, the incidence of 
type 2  diabetes, fasting levels of glucose and insulin, and the sum of glucose and 
insulin levels during an oral glucose tolerance test (OGTT), were greater in those 
subjects with larger epigastric fat cells compared to gluteal fat cells (Krotkiewski et 
al., 1983). Evans et al. (1983) proposed that, in premenopausal women, an increase in 
upper-body fat, enlargement of abdominal adipocytes and the accompanying 
imbalance in glucose-insulin homeostasis are attributable, in part, to an elevated level 
of free androgens.
(b) body fat distribution, type 2 diabetes and glucose-insulin homeostasis in obese and 
non-obese men
A comparison of two simple anthropometric indices of fat distribution (WHR and 
subscapular-to-triceps skinfold ratio, STR) suggested that WHR had the stronger 
relationship with type 2 diabetes (Haffner et al., 1987). Fasting concentrations of 
insulin and glucose have also been reported to be more strongly associated with the 
waist circumference (r = 0.61, P < 0.01) than the hip circumference (r = 0.47, P < 
0.01) (Krotkiewski et al., 1983). The European Fat Distribution Study (Cigolini et al., 
1992) reported a similar finding. After adjustment for BMI, waist circumference was 
more closely associated with fasting insulin than either the WHR or WTR.
A study of 126 men with a mean BMI of 40.9 ±8.9 kg.m'^ found no relationship 
between fasting glucose and BMI, but a significant association between fasting 
glucose and WHR (r = 0.347, P < 0.001) (Ditschuneit et al., 1994). In a study of 
trained and sedentary men, the abdomen-to-hip girth ratio (AHR) was related to the
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insulin sensitivity index in both groups (Houmard et al., 1991). However, there was a 
greater insulin response during an OGTT in the sedentary subjects (P < 0.01). This 
study, however, reported a closer association between insulin sensitivity and relative 
body fat (r = -0.68, P < 0.001) than with fat distribution.
Sparrow et al. (1986) randomly selected 41 men from the Normative Aging 
Study and found that CT-determined lAF was significantly related to the 2-hour post 
challenge serum glucose concentration (r = 0.44, P < 0.01). The relationship with 
BMI and CT-measurements of extremity fat were not significant (P > 0.05). In a 
similar study of obese men, Fujioka et al. (1987) found fasting plasma glucose and the 
glucose area following an OGTT were both significantly greater (P < 0.05) in subjects 
with visceral compared to subcutaneous-abdominal obesity. The plasma insulin area, 
however, was greater in subcutaneous-abdominal obese individuals (P < 0.05). Park et 
al. (1991) also found that insulin sensitivity was closely related to lAF (r = -0.88, P < 
0.01) in a small (n = 9) group of healthy, young men aged 28.6 ± 0.7 years (mean ± 
SEM).
Pouliot and co-workers (1992) found that obese subjects had significantly 
greater concentrations of fasting glucose, insulin and glucagon than their lean 
counterparts (P < 0.05). In these obese men, WHR was not related to fasting insulin, 
glucose or glucagon (P > 0.05). The area of visceral AT between the fourth and fifth 
lumbar vertebrae (L4 - L5) however, was related to fasting insulin (r = 0.45, P < 
0.001) as was the abdominal-to-femoral AT ratio (r = 0.48, P < 0.001). Following a 
75-g oral glucose dose, WHR had the closest relationship with the glucose area under 
the curve (r = 0.47, P < 0.001) and visceral AT the strongest association with the 
insulin area (r = 0.57, P < 0.0001).
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A study of men with a large variation in age and BMI, found a significant 
relationship between the area of visceral AT measured by a single CT-scan at the L4 
level and the insulin response during an OGTT (r = 0.43, P < 0.01) (Zamboni et al., 
1994). BMI, but not visceral AT, was associated with the plasma glucose response to 
the OGTT. Further analysis suggested a trend toward exacerbated glucose intolerance 
when a larger BMI is accompanied by an increased visceral AT mass.
Given the apparent association between visceral AT and insulin sensitivity 
described above, it is surprising that Abate et al. (1996) failed to show a greater intra- 
peritoneal fat mass in type 2 diabetic men compared to non-diabetic men. The diabetic 
men did, however, have increased amounts of subcutaneous truncal AT as determined 
from skinfolds, and this was an important determinant of insulin sensitivity. Abate et 
fl/.,(1995) have also shown that after adjusting for total body fat, glucose disposal rate 
and residual hepatic glucose output showed the highest correlation with the sum of 
trunk skinfolds (r = -0.40, P = 0.01 and 0.33, P = 0.04 respectively). Other measures 
of fat distribution including the WHR and MRl-determined lAF were unrelated to 
these measures of insulin sensitivity. A similar finding was noted in a study of 26 
healthy men who had their abdominal composition assessed by CT (Goodpaster et al., 
1997). Subcutaneous abdominal fat was inversely related to insulin sensitivity in a 
multiple regression model that included lAF while the converse was not found. A 
recent study has extended these findings with the suggestion that posterior abdominal 
subcutaneous AT, assessed by MRI, is a more important determinant of peripheral 
and hepatic insulin sensitivity than the anterior subcutaneous abdominal AT (Misra et 
a l, 1997)
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(c) adipose tissue morphology and fasting lipid and lipoprotein levels in obese and 
non-obese men and women
Studies indicate that fasting TG concentration is associated with subcutaneous 
abdominal fat-cell size (P < 0.01) (Krotkiewski et al., 1983; Stem et al., 1973) but not 
gluteal or femoral fat-cell size (Krotkiewski et al., 1983) or abdominal fat cell number 
(Stem et al., 1973). Plasma TC has been reported to be unrelated to either adipocyte 
size or number, or total body fat (Stem et al., 1973).
One study has reported a significant univariate relationship between fat-cell 
size, determined from a bilateral buttock biopsy, and semm TG in women (r = 0.27, p 
< 0.05), but found no such relationship in a smaller sample of men (Foster et al., 
1987). Fat cell size also related inversely to HDL-C (r = -0.17, P < 0.05) and HDL-C / 
TC (r = -0.17, p < 0.05) in women but not men. However, neither fat-cell size nor 
number was related to TG, LDL-C or HDL-C in a multiple regression model.
In 22 non-obese premenopausal women, subcutaneous abdominal FCW was 
found to be related to the LDL-apo B / LDL-C ratio (R = 0.58, P < 0.005), HDL-apo 
Al (r = -0.51, P < 0.05), HDL2-C (r = -0.51, P < 0.05), HDL-apo Al / LDL -apo B (r = 
-0.53, P < 0.01) and HDL2-C / HDL3-C (r = -0.52, P < 0.01) (Pouliot et a l, 1989).
In a recent study using both CT-scanning and biopsy techniques, Imbeault et al. 
(1999) showed that visceral AT and subcutaneous abdominal FCW were both 
positively related to fasting plasma insulin, TG, LDL-C, apo B and the TC : HDL-C 
ratio in men and women (P < 0.05). They also found that for a given amount of 
visceral AT, enlarged subcutaneous abdominal fat-cells were associated with a 
deterioration of the metabolic risk profile. Conversely, the hypertrophy of femoral 
adipocytes did not appear to have this effect.
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(d) body fa t distribution and related dyslipidaemias in obese and non-obese men 
One of the earliest investigations into the association between body composition, 
lipids, and lipoproteins found that BMI, skinfolds and body fat were almost equally 
related to TG and HDL-C (Leclerc et a l, 1983). Despite their statistical significance, 
after adjustment for several confounding variables, the size of the correlations were 
surprisingly low. The largest correlation with TG (r = 0.16) and HDL-C (r = -0.17) 
was with fat mass. A later study by the same group reported that, in comparison to 
women, body fatness was more closely related to serum lipids in men (Despres et al., 
1985). When six skinfolds were examined individually, the subscapular and 
abdominal sites were more powerfully related to TG and HDL-C. A similar finding 
was reported by Contaldo et al. (1986) in a study of middle-aged men in Southern 
Italy. Relative body fat and subscapular skinfold thickness were related to TC (r = 
0.37 and 0.41 respectively, P < 0.01), but BMI and triceps skinfold were not. TG was 
equally related to all measures of adiposity (P < 0.01). Among 2110 men participating 
in the Northwick Park Heart Study (Haines et al., 1987), there was essentially no 
difference in the magnitude of the partial correlations between TC and skinfolds at the 
forearm, subscapular and suprailiac sites (P < 0.0001). The partial correlation between 
TC and triceps skinfold, although still significant (P < 0.0001), was slightly lower.
It is well known that serum TG and HDL-C are inversely related (Albrink et al., 
1980). Thus, Despres et al. (1988) investigated the independence of the relationship 
between fat distribution and HDL-C in 429 healthy men after statistically adjusting 
for TG concentration. The distribution of subcutaneous fat, as reflected by the trunk- 
to-extremity skinfold ratio, and abdominal skinfold thickness were significantly 
related to TG (r = 0.27 and 0.35 respectively, P < 0.0001) and HDL-C (r -0.14, P < 
0.01 and -0.26, P < 0.001 respectively). The relationship between abdominal skinfold
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and HDL-C remained significant after adjustment for TG and BMI (r = -0.16, P < 
0.01) suggesting that a portion of the relationship between HDL-C and subcutaneous 
abdominal adiposity is independent of obesity and TG.
After the findings of the epidemiological studies in Gothenburg (Lapidus et al., 
1984; Larsson et ah, 1984), many groups of researchers were prompted to examine 
the relationship between lipids and body fat distribution assessed by the WHR. Some 
evidence suggests fasting plasma TG is unrelated to WHR in obese men after 
adjustment for age and relative body fat (Leenen et al., 1992). Other studies have 
found WHR is associated with fasting TG concentration independently of BMI 
(Haffner et al., 1987; Larsson et al., 1989).
Barakat et al. (1988) investigated the association between WHR and plasma 
lipids, lipoproteins and apolipoproteins in 1 0 0  male volunteers who ranged widely in 
age (19- to 6 8 -years) and WHR (0.89 to 1.09). WHR was significantly related to TC 
(r = 0.21, P = 0.04), LDL-C (r = 0.22, P = 0.03), TG (r = 0.25, P = 0.01) and the TC : 
HDL-C ratio (r = 0.30, P 0.002). Inverse associations were found with HDL-C (r = - 
0.19, P = 0.05), apo Al (r = -0.28, P 0.005) and apo Al : aop B (r = -0.26, P = 0.01). 
Further analysis showed that men with a high WHR were more likely to have a lipid 
profile suggestive of higher CVD risk than men with a lower WHR. This difference 
was regardless of age or the degree of obesity.
In a group of healthy, sedentary men, WHR had a stronger relationship with 
fasting TG concentration (r = 0.43, P < 0.0001) than either waist girth, STR, 
subscapular skinfold, relative body fat or BMI (Terry et al., 1989). WHR remained a 
significant predictor of TG concentration after adjustment for STR and relative body 
fat (r = 0.27, P < 0.05). Pouliot et al. (1992) also found that WHR, but not relative 
body fat, was related to fasting TG concentration in obese men (r = 0.28, P < 0.05). In
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a further study of overweight men, WHR and WTR both correlated with plasma TG 
concentration (r = 0.17 and 0.20 respectively, P < 0.05) (Terry et al., 1991). Thigh 
girth was also significantly related to TG concentration but in an inverse manner (r = - 
0.21, P < 0.05) (Terry et al., 1991). Fasting TG concentration has also been found to 
be higher in non-obese men with abdominal adiposity compared to non-obese men 
with gluteo-femoral adiposity after they were matched for age, body fat and BMI (P < 
0.05) (Peebles et al., 1989). Anderson et al. (1988) found that men who were in the 
upper tertiles of both BMI and WHR had the greatest TG concentration. WHR was 
related to fasting TG after adjustment for BMI, age, smoking, alcohol intake and 
exercise.
High-density lipoprotein in humans is composed of two principal fractions - 
HDL2 and HDL3. Of these, HDL2 has been most consistently linked with a protection 
against CVD (Musliner and Krauss, 1988). Using multiple regression procedures, 
Ostlund et al. (1990) reported that 41% of the variance in HDL2 level could be 
explained by the combined effect of the WHR (P < 0.0001), plasma insulin (P = 
0.0003) and glucose tolerance (P = 0.05). BMI and relative body fat were not related 
to HDL2 and subjects at the 25^  ^percentile for WHR had a HDL2 level 153 % of that 
in subjects at the 75^  ^percentile.
Studies conducted over the last 20-years or so, have used a wide variety of 
methods to describe fat distribution. Wallace et al. (1994), found that 29 different 
anthropometric methods had been used for this purpose, and several alternatives had 
been used to determine the WHR. Commonly, waist girth has been measured at either 
the level of natural narrowing between the lower rib and the superior iliac crest, 
midway between these points or at the level of the umbilicus. Hip girth has been 
measured at the level of the greater trochanters or the widest point around the
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buttocks. This can potentially lead to inconsistency when placing subjects into obese 
categories. In a study of 324 men, aged 36.5 ± 8.0 years and with a BMI of 27.4 ±3.4 
kg.m'^ (means ± SD), Jakicic et al. (1993) examined the relationship between blood 
lipids and five different WHR measurements. The waist girth measured at the level of 
the umbilicus, and at the midpoint between the lower rib and iliac crest were equally 
related to all lipid parameters (P < 0.05). The WHR’s derived from these waist 
measurements and hip girth measured at the greatest gluteal circumference were also 
related to lipids (P < 0.05). However, these relationships existed only in those men in 
the top quartile for BMI, indicating that obesity is a necessity for this association. 
Richelsen and Pedersen (1995) examined a small group (n = 58) of 44-year old non- 
obese men to investigate the association between the total body fat, BMI WHR, ASD, 
ASD/Ht, conicity index and blood lipids. Multiple regression analysis showed that 
ASD and ASD/Ht were the best predictors of the blood lipids with no significant 
influence of BMI. The conicity index was the weakest predictor. Thus, even a minor 
accumulation of abdominal AT was related to increased CVD risk in non-obese men. 
In a recent study of 165 men from the UK, however, no consistent relationship could 
be identified between blood lipids and five anthropometric measure of adiposity 
(BMI, WHR, WhtR, waist girth and conicity index) (Yasmin, 2000).
Han et al. (1996) adopted an alternative approach to regression analysis in their 
study of waist girth and blood lipids. Using ROC curves, they reported that with 
regard to identifying men with a low HDL-C, sensitivity and specificity were equal 
(-60%) at a waist circumference of -94.0 cm in men.
CT-scan studies have shown a positive relationship between lAF and the level 
of fasting TG (Pouliot et al., 1992; Zamboni et al., 1994; Fujioka et al., 1987,). 
Visceral AT area quantified by MRI was also shown to be related to fasting TG
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concentration in obese men following univariate analysis (P < 0.05), but not after the 
effects of age and relative body fat were considered (P > 0.05) (Leenen et al., 1992). 
A trend toward an increased TG concentration was demonstrated in men with visceral 
obesity compared to men with gluteo-femoral obesity, although this difference failed 
to reach significance (P> 0.05) (Fujioka et al., 1987). After adjustment for total body 
fat, visceral AT area has been found to be related to TG concentration (r = 0.28, P < 
0.05) (Pouliot et al., 1992). In the same study, multiple regression analysis showed the 
abdominal-to-femoral AT ratio was the best independent predictor of TG 
concentration (R  ^ = 0.366, P < 0.0001) and, in partial agreement with an earlier 
finding (Terry et al., 1991), the femoral AT area was inversely related to TG 
concentration. Zamboni et al. (1994) found the relationship between visceral AT and 
fasting TG was stronger than with any other metabolic variable (r = 0.47, P < 0.01).
A number of investigators have found that the WHR is related to TC and 
various other lipoproteins and lipoprotein-lipids. Larsson et al. (1989) reported a 
relationship between TC and WHR independently of BMI in a large-scale population 
survey. Terry et al. (1989) found WHR, but not STR or relative body fat, was 
positively related to TC and a number of lipoprotein-lipids including LDL-C, very 
low-density lipoprotein cholesterol (VLDL-C) (P < 0.01), small LDL (Sf 0-7),
intermediate-density lipoprotein (IDL) (Sf 12-20), smaller VLDL (Sf 20-60) (P <
0.001) and larger VLDL (Sf 60-100 and 100-400) (P < 0.05). WHR was also
inversely related to HDL-C (P < 0.01), HDL2 (P < 0.0001) and LDL peak flotation 
rate (P < 0.001). In a later study, these researchers reported similar findings in a group 
of moderately overweight men (Terry et al., 1991). WHR and WTR were positively 
related to small LDL (P < 0.01) and inversely related to HDL2-C, LDL peak flotation
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rate (P < 0.01), large LDL and HDL2 particle size (P < 0.05). Total VLDL was also 
positively related to both WHR (P < 0.05) and WTR (P < 0.01).
In a study of two groups of non-obese men matched for relative body fat (P > 
0.05) but differing in WHR (P < 0.001), TC and LDL-C levels were not different (P > 
0.05) (Peebles et al., 1989). HDL-C and apo Al, however, were greater and apo B was 
lower in subjects with gluteo-femoral adiposity. A smaller LDL particle size was also 
a characteristic of subjects with abdominal adiposity (P < 0.005).
Walton et al. (1995) found that abdominal adiposity assessed by DEXA was 
independently associated with elevated TG and decreased HDL2-C. Total adiposity 
and age were unrelated to a number of lipids and lipoproteins. However, DEXA is 
unable to distinguish intra-abdominal and subcutaneous AT. CT-scan studies, on the 
other hand, have shown that with respect to body fatness, visceral AT is the most 
important morphological determinant of an atherogenic lipid profile (Pouliot et al., 
1992; Zamboni et al., 1994; Fujioka et al., 1987; Tchemof et al., 1996). Results from 
an MRI study, however, suggested that visceral fat accumulation is associated with an 
adverse lipid profile in obese women but not obese men (Leenen et al., 1992). 
Visceral AT has been found to be positively associated with LDL-TG, apo B (P < 
0.05), VLDL-C and VLDL-TG (P < 0.01), and inversely with the HDL-C : LDL-C 
ratio (P < 0.01) in a group of subjects with a wide range of lAF (Zamboni et al., 
1994). In obese men, visceral AT but not subcutaneous abdominal AT was found to 
be inversely related to HDL-C, HDL2-C and the HDL2 : HDL3 ratio (Pouliot et al., 
1992). Independently of several fat distribution variables (total body fat, visceral AT 
area, subcutaneous abdominal AT area, femoral AT area), the abdominal-femoral AT 
ratio had the strongest association with HDL-C, HDL2-C and the HDL2 : HDL3 ratio. 
The level of significance of these relationships ranged from P < 0.05 to P < 0.0001.
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As indicated earlier, the lipoprotein phenotype associated with an increase in the 
number of small, dense LDL particles is highly prevalent amongst CHD patients 
(Austin et al., 1988; Campos et al., 1992). Tchemof et al. (1996) examined LDL- 
particle size in relation to visceral AT, other lipoproteins and hyperinsulinaemia in 79 
obese and non-obese men. Subjects classified as having the small, dense LDL 
phenotype had higher levels of TG, HDL-C, visceral AT and fasting insulin. In 
multivariate analysis, visceral AT was not a significant predictor of the small, dense 
LDL phenotype after insulin and the other lipoproteins were considered.
In one of the largest CT studies, Boyko et al. (1996) found a significant, 
independent association between lAF and TG (r = 0.22, P < 0.001), total HDL (r = - 
0.29, P < 0.001), HDLz-C (r = -0.30, P < 0.001) and HDL3-C (r = -0.19, P < 0.01) in 
290 second-generation Japanese Americans. Correlations with subcutaneous 
abdominal fat were low and not significant (P > 0.05).
Whilst visceral AT accumulation appears to be closely associated with 
disturbances in carbohydrate and lipoprotein metabolism that represent an increased 
risk of CVD, some evidence indicates that femoral AT may have a protective effect 
(Terry et al., 1991; Pouliot et al., 1992). Thigh girth adjusted for waist girth has been 
shown to be inversely related to TC, VLDL-C, small LDL (P < 0.01), IDL (P < 0.05), 
TG and total VLDL (P < 0.001) in overweight men (Terry et al., 1991). LDL peak 
flotation rate was positively related to thigh girth (P < 0.01). CT-scan results have also 
shown femoral AT area to be inversely related to fasting TG (P < 0.01), and positively 
associated with HDL (P < 0.05) and HDL2-C (P < 0.01) (Pouliot et al., 1992). Young 
and Gelskey (1995), however, have warned against ignoring people with ’non-central’ 
obesity. This warning is based on their findings from the Manitoba Heart Health
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Study. In a sample of 2339 adults, those with non-central obesity tended to have blood 
pressure, lipids and glucose between those of the non-obese and centrally obese.
Whilst abdominal adiposity is closely related to elevated TG levels and other 
lipoprotein-lipid variables associated with elevated CVD risk, investigators studying 
this relationship in a mixed group of sedentary and exercise-trained men, found that 
aerobic fitness was a better predictor of TG and HDL than the AHR (Houmard et a l,
1991). Abdominal adiposity was more closely associated with LDL particle diameter 
and HDL2b. The importance of physical activity as a lifestyle variable that attenuates 
the risk of CVD among the obese has received considerable support recently. This 
results from data suggesting a lower risk of cardiovascular and all-cause mortality in 
fit obese men in comparison to unfit and obese men (Lee et aL, 1999). This trend was 
apparent irrespective of whether obesity was defined by BMI, relative body fat or 
waist circumference.
In summary, it appears that an abdominal distribution of body fat, particularly 
an increased deposition of fat in the intra-abdominal cavity, is associated with 
hypertriglyceridaemia, an elevated number of small, dense LDL particles and apo B, 
and reduced HDL-C, especially HDL2-C (Kissebah and Krakower, 1997). The 
traditional lipid markers of CVD risk, TC and LDL-C are not commonly found in 
subjects with visceral obesity (Despres and Lamarche, 2000).
2.3.6 Mechanisms Linking Obesity and Body Fat Distribution with the 
Metabolic Disturbances of Lipid and Carbohydrate Metabolism 
Associated with Coronary Artery Disease
In recent years, many review papers have proposed evidence-based mechanisms to 
explain the relationship between obesity, particularly obesity associated with
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increased lAF, and CVD (Bjomtorp, 1993; Frayn, 1993; Frayn and Coppack, 1992; 
Reaven, 1995; Despres, 1991, 1993, 1998; Sniderman et a l, 1998; Kissebah and 
Krakower, 1994). Two central phenomena outlined in these papers as being of major 
importance for explaining the metabolic aberrations of abdominal obesity are insulin 
resistance and elevated non-esterified fatty-acids (NEFA’s). As a potential cause of 
insulin resistance, elevated NEFA’s in the hepatic portal circulation was first proposed 
by Bjomtorp (1990). Whilst it has not been possible to measure NEFA concentrations 
in the portal blood of humans directly, the mechanism proposed by Bjomtorp has 
received almost universal acceptance. Figure 1 (2.3) illustrates this proposed 
mechanism that links lAF and several metabolic disturbances associated with an 
increased risk of CVD. However, Bamard and Wen (1994), presented a compelling 
argument that physical inactivity, combined with a high fat and refined sugar diet, 
may well be the initiating factors for the insulin resistance of obesity, and that the 
elevated NEFA concentrations are, therefore, a consequence and not the cause of 
insulin resistance. In reality, it is likely that the insulin-resistance syndrome is a 
consequence of a sedentary, ’westemised’ lifestyle that is exacerbated by intra­
abdominal obesity. Although obesity plays a role in the development of insulin 
resistance, this condition can be found in lean individuals whilst some obese people 
can be relatively insulin sensitive (Reaven, 1997). Indeed, a recent study suggests that 
the association between hyperinsulinaemia and the cluster of metabolic abnormalities 
that define the insulin resistance syndrome is stronger in the lean than the obese 
(Nabulsi et al., 1995). Bjomtorp (1993) rather aptly referred to visceral obesity as a 
"Civilization Syndrome". In this section, Bamard and Wen’s model has been 
expanded by the inclusion of skeletal muscle fibre type and Bjomtorp's proposal that 
intra-abdominal adipocytes release a high concentration of NEFA's into the hepatic
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portal vein. The combination of these three factors is likely to present the most likely 
explanation for the increased incidence of CAD in men with abdominal obesity.
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+
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reduced hepatic insulin extraction
Figure 1 (2.3). The role o f a high fat, refined sugar diet, physical inactivity, 
skeletal muscle and visceral obesity in the insulin resistance syndrome.
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(a) effect o f a high fa t and refined sugar diet, physical inactivity and skeletal muscle 
morphology on insulin-mediated glucose uptake
During a euglycaemic clamp procedure, non-oxidative glucose storage i.e. glycogen 
synthesis, represents the major mechanism by which the increased circulating glucose 
is removed. Thus, skeletal muscle is the major target tissue for the restoration of 
insulin-mediated euglycaemia (DeFronzo et al., 1979). A defect in this mechanism is, 
therefore, likely to result in glucose intolerance, with an excessive and prolonged rise 
in post-load or post-prandial glycaemia (Felber, 1992). In subjects with adequate 
pancreatic P-cell function, this leads to elevated fasting and post-prandial insulin 
levels that can be thought of as ’compensatory’. That is, the greater than normal insulin 
response compensates for the apparent insulin resistance. The compensatory 
hyperinsulinaemia results in a normal fasting glucose level.
With regard to diet, Grimditch et al. (1987, 1988) have shown that within 10- 
weeks, rats fed a high fat, high sucrose diet develop skeletal muscle insulin resistance 
and hyperinsulinaemia without any increase in body fat. This has since been 
confirmed by other researchers (Storlien et al., 1993; Vrana et al., 1993) and has also 
been shown to occur in the liver (Davidson and Garvey, 1993). Furthermore, after a 2- 
year intervention period, in comparison to rats fed a low-fat, high-complex- 
carbohydrate diet, rats fed with a high-fat and sucrose diet were significantly fatter, 
had a greater fasting insulin and TG concentration, greater systolic blood pressure and 
had an enhanced blood clotting tendency (Bamard et al., 1993).
The mechanism by which a high fat and refined sugar diet promotes skeletal 
muscle insulin resistance is presently unclear. Steiner (1991) has argued that 
hypertriglyceridaemia is the cause and not a consequence of insulin resistance. 
However, diets that are low in fat and high in carbohydrate and lead to an elevated TG
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concentration (Coulston et al., 1983), have been found to have no effect (Garg et al.,
1992) or to increase insulin sensitivity (Kolterman et al., 1979). There appears to be 
no change in the number of insulin receptors, GLUT-4 glucose transporters or insulin 
receptor tyrosine kinase (Bamard and Youngren, 1992; Fryer and Kmszynska, 1993; 
Boyd et al., 1990). However, there is evidence to suggest a decrease in insulin 
receptor autophosphorylation and tyrosine kinase activity in rats fed a high-fat diet 
(Iwanishi and Kobayashi, 1993) and a reduced tyrosine kinase activity in skeletal 
muscle insulin receptors in patients with type 2 diabetes (Scheck et al., 1991).
Current available evidence suggests that the amount and type of dietary fat 
consumed, together with physical activity, are important determinants of skeletal 
muscle insulin sensitivity (Vessby, 2000). Several studies have indicated that a diet 
high in fat is associated with insulin resistance and greater risk of developing type 2 
diabetes (Marshall et al., 1994; Marshall et al., 1997; Mayer-Davis et al., 1997). A 
high fat diet may be especially deleterious in sedentary individuals (Mayer-Davis et 
al., 1997).
Systemic (Nikkari et al., 1995) and skeletal muscle membrane (Ayre and 
Hulbert, 1996; Vessby, 2000) lipid composition are a reflection of dietary fat 
composition. In a study of newly diagnosed type 2 diabetic patients, Salomaa et al.
(1990) were able to demonstrate a higher proportion of saturated fatty acids in the 
serum cholesterol esters in comparison to non-diabetics. A similar finding has been 
reported by Vessby et al. (1994) in a study of elderly men - insulin sensitivity was 
inversely related to the saturated fatty acid content of semm cholesterol esters. Laserre 
et al. (1985) found that if the dietary fat composition was changed from more 
saturated to more unsaturated fatty acids, the serum fatty acid profile changes to 
resemble one that is associated with greater insulin sensitivity.
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Several studies have demonstrated a relationship between skeletal muscle 
phospholipid composition and insulin sensitivity. Borkman et al. (1993) showed that 
insulin sensitivity was directly related to the sum of the proportions of long-chain 
polyunsaturated fatty acids with 20-22 carbon atoms. The similar results reported by 
Pan et at. (1995), and the inverse relationship between the proportion of palmitic acid 
and insulin sensitivity reported by (Vessby et al., 1994), suggest that an increased 
saturation of skeletal muscle membrane fatty acids adversely affects insulin 
sensitivity.
Physical inactivity is associated with a reduced muscle glycogen utilisation. 
Furthermore, some of the skeletal muscle characteristics associated with physical 
inactivity (reduced fibre size, capillary density, mitochondrial volume density, GLUT- 
4 content, insulin receptors, hexokinase isoforms) predispose this tissue to a reduced 
glucose uptake and insulin resistance (Simoneau, 1995). Muscle glycogen 
concentration is tightly regulated by two mechanisms. Glycogen synthesis is catalysed 
by the enzyme glycogen synthase, that is activated by glucose-6-phosphate and 
insulin (Nuttal et al., 1974), and by dephosphorylation (Felber, 1992). Conversely, an 
increased glycogen concentration and dephosphorylation inhibits glycogen synthase 
(Danforth, 1965; Villard-Palasi, 1969) but activates glycogen phosphorylase (Hers, 
1976). In figure 1 (2.3), a high dietary sugar intake leads to elevated blood glucose 
and, therefore, to pancreatic insulin secretion. However, glucose uptake for glycogen 
synthesis (the normal physiological pathway for the restoration of euglycaemia) is 
blocked due to inhibition of glycogen synthase by a high muscle glycogen 
concentration and also by the morphological characteristics of untrained skeletal 
muscle outlined above. This slowing of the glycogen cycle, due to a reduced emptying 
of the glycogen stores, leads to down-regulation of the number of insulin receptors
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and, therefore, to insulin resistance, glucose intolerance, compensatory 
hyperinsulinaemia, and in the longer-term type 2 diabetes in genetically-prone 
individuals (Felber, 1992).
This model also suggests that skeletal muscle fibre type is an important factor to 
consider in the overall development of the insulin-resistance syndrome. There have 
been several studies that have examined the association between obesity, skeletal 
muscle characteristics and insulin-mediated glucose uptake (Lillioja et al., 1987; 
Simoneau and Bouchard, 1993; Wade et al., 1990; Richelsen et al., 1993; Krotkiewski 
and Bjomtorp, 1986). A comprehensive review of the significance of skeletal muscle 
in obesity and the insulin resistance syndrome has been provided by Kelley and 
Simoneau, (1997).
Type n  muscle fibres, particularly type 11b fibres have a lower capillary-to-fibre 
ratio (Bassett, 1994). In obese men, the muscle fibre capillary density has been found 
to be inversely related to fasting glucose and insulin (Lithel et al., 1981). Furthermore, 
Lillioja et al. (1987) reported an inverse relationship between insulin-mediated 
glucose uptake and percentage of type 11b fibres in vastus lateralis muscle. This study 
also found a positive relationship between insulin sensitivity and capillary density. 
Studies of rat muscle conducted in vitro, have shown greater insulin binding and basal 
and insulin-stimulated glucose uptake in predominantly type 1 muscles compared to 
predominantly type 11 muscles (Bonen et al., 1981; Henriksen et al., 1990).
With regard to body fatness and fibre type, several studies have shown an 
association. Wade et al. (1990) reported a significant inverse relationship between 
body fatness and the percentage of type 1 fibres, whilst Lillioja et al. (1987) reported a 
similar finding with WHR. Simoneau and Bouchard (1993) found a positive 
relationship between body fatness and percentage type lib fibres. Others have found
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that males and females with android obesity had approximately 70% type II fibres, 
whereas gynoid obese females had approximately 50% type II fibres (Krotkiewski and 
Bjomtorp, 1986). Some of the properties of type 1 fibres, for example, increased 
GLUT-4 levels, capillary density per fibre, insulin receptors and enzyme activity, may 
explain the relationship between fibre type and insulin resistance. However, because 
of certain adaptive responses of skeletal muscle to habitual exercise training, for 
example an increased capillary density (Coggan et al., 1992; Ingjer, 1979), it may be 
more desirable to have a predominance of aerobically trained type 11 fibres than 
untrained type 1 fibres. A single bout of moderate- to high-intensity exercise has a 
significant and positive effect on skeletal muscle insulin sensitivity that may persist 
for several days (King et ah, 1995; Kang et al., 1999). However, a return to sedentary 
existence causes a decrease in insulin sensitivity (Mikines et al., 1991). Likely 
explanations for the improved insulin sensitivity in skeletal muscle and adipose tissue 
associated with exercise are increased translocation and quantity of GLUT 4 
transporters (Ferrara et al., 1998; Hansen et al., 1998; Hirshman et al., 1993). Devlin 
et al. (1987) have also shown that exercise can positively influence splanchnic insulin 
sensitivity in type 2 diabetic men.
As a possible explanatory factor of the insulin resistance associated with 
obesity, substrate competition has received considerable attention. Some time ago, 
Randle and colleagues demonstrated the existence of decreased glucose oxidation and 
glycogenesis in skeletal muscle in the presence of elevated NEFA’s (Randle et al., 
1963). This was attributed to increased NEFA oxidation, driven by a concentration- 
dependent NEFA uptake, that reduced insulin sensitivity and glucose uptake. In 
obesity, conditions exist that suggest the existence of this "glucose-fatty acid" cycle 
could explain the insulin resistance. First, total fat mass is enlarged, thereby.
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providing ample substrate i.e. NEFA’s. Second, as will be discussed later, intra­
abdominal adipocytes have a lively basal and catecholamine-stimulated lipolysis that 
presents the circulation with high levels of NEFA’s. However, studies indicate that 
insulin resistance in obesity is not caused by increased uptake and oxidation of fatty 
acids (Kelley and Simoneau, 1997). Rather, a decreased oxidative capacity of fat in 
the skeletal muscle of obese subjects leads to the accumulation of intra-muscular fat 
that reduces insulin sensitivity and causes a defect in glycogen synthesis (Kelley and 
Simoneau, 1997). This leads to the intriguing thought that, due to their morphological 
and metabolic characteristics, a high proportion of untrained type II skeletal muscle 
fibres predisposes to both obesity, insulin resistance and the CVD risk factors of these 
conditions (Bassett, 1994).
(b) abdominal adipose tissue fat storage and lipolysis
It is well established that a high intake of dietary fat contributes to the development of 
obesity (Astrup et al. 2000). Furthermore, obesity per se can lead to a decrease in 
insulin-mediated glucose uptake and hyperinsulinaemia, that can be corrected by 
weight loss (Olefsky et al., 1974).
Figure 1 (2.3) proposes that the hyperinsulinaemia secondary to chronic 
insulin resistance is associated with reduced lipoprotein lipase (LPL) in skeletal 
muscle (Pollare et al., 1991; Kiens et al., 1989). Conversely, insulin within the normal 
physiological range has been shown to stimulate LPL and inhibit hormone sensitive 
lipase in adipocytes (Farese et al, 1991; Ong et al., 1988; Fried et al., 1993; Sadur 
and Eckel, 1982). These changes in lipase activity favour fat storage in the AT fat 
cells as opposed to fat metabolism by skeletal muscle and, therefore, has a causal role 
in the development of obesity (Kem, 1996). Furthermore, regional LPL activity partly
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explains differences in body fat distribution. In men, visceral AT-LPL activity is 
lowest whilst femoral and abdominal subcutaneous activities are equal. In women, 
femoral AT-LPL activity is greatest and subcutaneous abdominal LPL activity is 
higher than visceral (Poirier and Eckel, 2000).
As outlined previously, the deposition of fat varies between individuals 
according to genetic and local biological factors (Bouchard et al., 1993). Adipocytes 
from the abdominal region, particularly from the intra-abdominal cavity (omental and 
mesenteric adipose tissues) have unique lipolytic properties related, in part, to the 
distribution and adrenergic receptors and sensitivity to insulin. Under normal 
conditions, the release of NEFA’s from AT is suppressed by insulin (Frayn, 1993). 
However, studies have shown that intra-abdominal adipocytes have a low 
concentration of insulin receptors and are relatively insulin resistant in comparison to 
subcutaneous fat cells (Bolinder et al., 1983; Manege et al., 1995). Therefore, despite 
the presence of hyperinsulinaemia in visceral obesity, the condition is associated with 
a hyperlipolytic state (Despres and Lamarche, 2000). This elevated lipolysis is 
compounded by the presence of the enlarged intra-abdominal adipocytes that also 
exhibit a high-rate of lipolysis because of their adrenoceptor characteristics. Thus, 
visceral obesity is characterised by elevated NEFA concentrations, because of the 
reduced antilipolytic effect of insulin and an increased lipolytic effect of 
catecholamines. This second lipolytic feature is discussed in more detail below.
The omental and mesenteric adipose tissues have a very high rate of lipolysis 
due to a preponderance of P-adrenergic receptors and little a-adrenergic inhibition 
(Rebuffe-Scrive et al., 1989, 1990). These AT depots drain directly into the hepatic 
portal vein, thereby exposing the liver to high concentrations of NEFA’s. This has two 
effects. Firstly, the hepatic extraction of insulin is reduced resulting in a further
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increase in the hyperinsulinaemia of visceral obesity (Hennes et al., 1990; Svedberg et 
al., 1990). The mechanism here is thought to involve interference in the binding 
process of insulin with its receptor (Svedberg et al., 1989, 1990). This is due to a 
decreased number of insulin receptors caused by receptor internalization followed by 
a parallel decrease in insulin degradation (Svedberg et al., 1989, 1990. Secondly, the 
NEFA’s are the substrate for the production of TG-rich lipoproteins (Despres, 1994, 
Bjomtorp, 1990). The preponderance of P-receptors compared to a-receptors means 
that intra-abdominal adipocytes are highly sensitive to the lipolytic effects of 
circulating catecholamines. Specifically, Lonnqvist et al. (1997) have shown with an 
in vitro preparation that this phenomenon is due to an increase in the function of Ps- 
adrenoceptors, a decrease in the function of (%2-adrenoceptors and an increased ability 
of cyclic AMP to activate hormone sensitive lipase. When combined with the insulin- 
resistant state, the NEFA mobilisation capacity of the portal AT of abdominally obese 
men and women is markedly elevated. In psychologically stressful situations, exercise 
and smoking this effect is even more pronounced (Bjomtorp, 1993). Therefore, figure 
1 (2.3) suggests that the relative insulin resistance of intra-abdominal AT is both a 
cause and consequence of abdominal obesity.
(c) the effect o f excess non-esterifed fatty acids in the portal circulation on lipoprotein 
kinetics
Exposure of the liver to elevated NEFA’s has been shown to have effects on insulin 
extraction, gluconeogenesis and VLDL-TG secretion. The increased appearance of 
systemic VLDL-TG has repercussions for ’downstream’ lipoprotein metabolism 
resulting in the formation of an atherogenic profile as described below. The, secretion
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of VLDL seems to be mainly regulated by the synthesis of TG, that in turn is 
dependent on substrate availability, in this instance NEFA’s (Kissebah et al., 1974; 
Byme et al., 1991). Insulin inhibits the secretion of VLDL-TG from isolated liver 
cells and this inhibition is blunted in insulin-resistant hepatocytes (Durrington et al., 
1982, Bartlett and Short, 1988). Exposing the liver to elevated NEFA concentrations 
in vivo, results in hepatic insulin resistance (Wiesenthal et al. 1999), increased 
gluconeogenesis (Ferrannini et al., 1983) and an overproduction of VLDL-TG 
(Carlson et al., 1965). The increased gluconeogenesis presents a further glucose load 
that exacerbates the hyperinsulinaemia.. A further way in which elevated portal 
NEFA’s influence hepatic VLDL-TG secretion appears to be the excess synthesis of 
apolipoprotein (apo) B-lOO, the protein backbone of VLDL and LDL (Bjomtorp, 
1990; Kissebah and Krakower, 1997). This is partly due to an unusually long half-life 
of the mRNA for apo B-lOO that secures translation of apo B-lOO for a long time 
(Bjomtorp, 1990).
This production of hepatic TG in the fasting state may contribute to the 
impaired clearance of dietary fat (Lewis, 1997), because in addition to the increased 
production of VLDL-TG, obesity and other insulin resistant states are associated with 
a reduced responsiveness of AT-LPL to insulin (Eckel, 1987). This leads to a reduced 
catabolism of chylomicrons and other TG-rich lipoproteins during post-prandial 
lipaemia (Bmnzell et al., 1979; Ooi et al., 1992129-132). As the retention of LDL in 
the circulation is dependent on both the rate of production and removal, an increased 
VLDL secretion lends itself to increased concentrations of VLDL, LDL and apo B- 
100 in the circulation (Bjomtorp, 1990; Sniderman et al., 1998). Many of the LDL 
particles will be smaller and denser than normal due to increased exchange of core 
lipids (Sniderman et al., 1998).
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The insulin resistance, hypertriglyceridaemia of hepatic origin and reduced LPL 
activity may also explain the low HDL-C of subjects with visceral obesity (Despres, 
1991). Through the action of the cholesteryl-ester transfer protein (CETP), the 
prolonged residence of TG-rich lipoproteins in the circulation leads to an increased 
exchange of TG from these particles to LDL and HDL at the expense of cholesterol 
(Despres et a/., 1989a, 1989b). Disturbance in this LPL-mediated mechanism may 
well underlie the association between hypertriglyceridaemia and low HDL-C as 
weight loss is associated with increased LPL activity and HDL-C and a reduced TG 
concentration (Frayn and Coppack, 1992). Further mechanisms that may be important 
factors in the association between visceral obesity and low HDL-C levels are, an 
elevated hepatic-TG lipase action which is related to a decreased HDLz-C level 
(Despres et ah, 1989a), an increased catabolism of apo AI and All (Barnard and Wen, 
1994), and apolipoprotein E (apo E) polymorphisms (Kissebah and Krakower, 1997).
Insulin resistance and obesity are also related to the occurrence of small dense 
LDL particles in the circulation (Barakat et al., 1990; Reaven et al., 1993; Tchemof et 
al., 1996). Thus, the relationship between abdominal adiposity and the atherogenic 
small dense LDL particle, the so-called type B phenotype (Austin et al., 1990; 1992), 
may also be explained by the effect of hepatic insulin resistance and increased VLDL- 
TG secretion. Based on recent studies, Frayn (1993) has suggested a possible 
mechanism by which insulin resistance may affect the formation of small dense LDL 
particles. The presence of larger TG-rich particles in the circulation, particularly in the 
post-prandial period, offers a high potential for CETP-mediated neutral lipid 
exchange. This is shown by an increase in their cholesteryl ester content during this 
period (Fisher et al., 1993). If this exchange occurs not just with HDL, as is normally 
considered, but also with LDL, then the result will be cholesteryl ester-depleted, TG-
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enriched LDL particles. The TG may then be removed by the action of hepatic lipase, 
leading to a lipid depleted, atherogenic, small dense particle.
(d) concluding remarks
Two eminent researchers in the field of obesity have proposed that insulin resistance 
is an adaptive change in obesity to protect against further fat deposition (Ravussin and 
Swinbum, 1996). Insulin stimulates AT LPL that results in adipocyte fatty acid 
uptake. The elevated NEFA’s seen in obesity, partly as a consequence of the 
diminished anti-lipolytic effect of insulin, lead to increased fat oxidation and 
decreased post-prandial storage of TG. Other equally eminent obesity researchers 
(Sims, 1996) have argued that insulin resistance is a result of our genetic inheritance 
and the modem environment in which we live. Obesity, argues Sims, develops as a 
consequence of the anti-lipolytic action of compensatory hyperinsulinaemia. 
Whichever comes first, one thing is now clear - individuals with abdominal obesity 
are at increased risk of CVD and type 2 diabetes and this risk is mediated through a 
cluster of metabolic, thrombotic and haemodynamic factors. Thus, features that may 
once have provided a survival advantage via the so-called ’thrifty gene’, now may be 
responsible for the most prevalent morbid conditions of our time (Sims, 1996).
Bamard and Wen (1994), Basset (1994) and Bjomtorp (1990) produced papers 
outlining the importance of diet and physical inactivity, skeletal muscle characteristics 
and intra-abdominal adiposity respectively in the development of the insulin- 
resistance syndrome. This section of the Review of Literature has attempted to bring 
these areas together, and has presented a model suggesting a ‘vicious circle’ of events 
leading to insulin resistance, chronic hyperinsulinaemia, glucose intolerance, an 
atherogenic dyslipidaemia and obesity.
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CHAPTER 3 
METHODOLOGY
194
3.1 SUBJECT SELECTION
3.1.1 Coronary artery disease patients
Patients for the studies outlined in this thesis were 70 men who reported consecutively 
for cardiac catheterisation at the Department of Cardiology, University Hospital of 
Wales, Cardiff. Catheterisation was undertaken as part of a series of investigations 
into suspected atherosclerotic CAD. Five men had angiography scores of zero for both 
of the scoring systems used in this study. These men were excluded from analyses 
involving either a comparison with control subjects or when only patients with CAD 
were required. They were included, however, in any regression procedures as the aim 
was to examine the relationship between anthropometry and CAD across the range of 
CAD i.e. no CAD to severe CAD. All participants gave their written informed consent 
and the study was approved by the South Glamorgan Local Research Ethics 
Committee. Other than subjects whose body mass had not been stable (± 3 kg) for six 
months prior to the study, no patients were excluded from participation. 
Anthropometry was performed on the hospital ward at the patients’ bedside prior to 
angiography.
3.1.2 Controls
Subjects were 72 men who volunteered to participate in a university health-screening 
programme. Four men did not provide blood samples and were excluded from 
analyses when these data were required. All subjects gave their written informed 
consent and the study was approved by the South Glamorgan Local Research Ethics 
Committee. Details of medical history, past and present smoking and alcohol habit, 
family history of all cardiovascular diseases and diabetes, and employment and 
educational status were recorded by questionnaire. Any subject whose body mass had
195
not been stable (± 3kg) for 6 months prior to the study, who was taking lipid-lowering 
medication or with physician-diagnosed diabetes was excluded from any further 
analysis.
3.2 CORONARY ANGIOGRAPHY
In conjunction with symptoms and clinical evaluation, diagnostic coronary 
angiography was undertaken via the right femoral artery (Judkins, 1967) to assess the 
presence of CAD. A scoring system (Brandt et al., 1977) was applied to each 
angiogram to take into account the degree of stenosis, the number of arterial branches 
affected, and their anatomical distribution to the myocardium as follows. Following 
angiography, a black and white two-dimensional image of the coronary tree was 
produced. Each coronary vessel was then graded according to the following 
guidelines. A complete blockage in a coronary artery (100% cross-sectional area loss) 
was graded ’a’. Cross-sectional area losses of 90-99%, 75-89%, 50-74% and <50% 
were graded V, ’c’, ’d’ and ’e’ respectively. A myocardial value ranging from 1 to 10 
was then given to each vessel depending on the proportion of myocardium being 
supplied by that artery. A final myocardial score that was dependent on the grade and 
myocardial value was then given to each vessel. Thus, this system accounts for the 
location of coronary atherosclerotic lesions as well as the degree of stenosis. A score 
of zero represented no detectable coronary atheroma in any vessel. A maximal score 
of 15 represented severe three-vessel disease with blockages near the top of the left 
anterior descending, left circumflex and right coronary arteries.
A ventricular score was also determined based on the movement of the left 
ventricular wall that was divided into five segments according to American Heart
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Association (Brandt et a l, 1977). These five segments are described as the superior 
basal, antero-lateral, apical, diaphragmatic and inferior basal. The movement of each 
segment was then scored as follows: 0, normal; 1, hypokinetic; 2, akinetic and 3, 
dyskinetic. Thus, a ventricular score of 0 would mean normal movement of all 5 
segments. A score of 15 would mean irregular movement in all segments.
3.3 ANTHROPOMETRY
Body mass and stature were measured with a beam balance (Seca 710) and 
stadiometer (Seca 220). Mass was measured to the nearest 0.1 kg and stature to the 
nearest 0.1 cm. Anthropometry was performed following standard guidelines 
(Lohman et al., 1991). Four limb skinfolds (biceps, triceps, front mid-thigh and 
medial calf) and four torso skinfolds (subscapular, suprailiac, supraspinale and 
abdominal) were measured on the right side of the body with Harpenden skinfold 
callipers (Holtain Ltd, Crymych, UK). Skinfolds were recorded to the nearest 0.2 mm 
within 2-seconds of the full pressure of the callipers being applied. Girths (hip, 
abdominal, waist, contracted upper-arm, mid-thigh, medial calf) were measured with 
a flexible metallic tape measure (Holtain Ltd) and standing ASD with a large sliding 
anthropometer fitted with straight branches (Holtain Ltd). Girths and the ASD were 
recorded to the nearest 0.1 cm. To measure the ASD, the subject was asked to stand 
upright with the shoulders relaxed. One branch of the anthropometer was positioned 
on the skin immediately above the umbilicus. With the anthropometer held 
horizontally, the other branch was then pressed against the spinous process of a 
vertebra. The antero-posterior diameter of the abdomen at this level was then recorded 
at the end of a normal expiration. Supraspinale skinfold was measured as part of the
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somatotyping procedure (Carter and Heath, 1990) and was used in this study as an 
additional torso skinfold so that there were equal numbers of torso and limb skinfolds. 
As there is no published Phantom value for supraspinale skinfold it was not 
normalised for stature or body mass.
Body mass index, WHR, AHR, WHtR, WTR, ASD/Ht and the ratio of the E4 
torso-to-E4 limb skinfolds (TLR) were calculated from the anthropometric 
measurements.
Intra-observer reliability coefficients, derived from duplicate measurements of 
each variable on 20 subjects, were all > 0.99. Standard errors of measurement (SEM = 
SDVl-r^) ranged from 0.17 mm for the triceps skinfold to 0.32 cm for the waist girth.
Biceps skinfold
This vertical skinfold was measured on the anterior aspect of the arm midway 
between the acromion process and the olecranon process.
Triceps skinfold
This vertical skinfold was measured on the posterior surface of the arm midway 
between the acromion process and the olecranon process.
Front mid-thigh skinfold
This vertical skinfold was measured in the midline of the anterior aspect of the thigh, 
midway between the inguinal crease and the proximal border of the patella.
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Medial calfskinfold
This vertical skinfold was measured with the subject in a seated position with the right 
knee flexed at about 90°. The skinfold was lifted on the medial aspect of the calf at 
the level of maximal circumference.
Subscapular skinfold
This diagonal (-45°) skinfold was measured at a point immediately below the inferior 
angle of the scapula. The skinfold was lifted following the natural cleavage lines of 
the skin.
Suprailiac skinfold
This diagonal (-45°) skinfold was measured in the midaxillary line immediately 
superior to the iliac crest.
Supraspinale skinfold
This diagonal (-45°) skinfold was lifted at the intersection of the anterior-superior 
iliac crest and the superior iliac crest in the midaxillary line.
Abdominal skinfold
This horizontal skinfold was measured at a point 1cm below and 3cm laterally to the 
mid-point of the umbilicus.
Hip girth
For this measurement, the tape measure was placed over the subjects underwear at the 
level of maximal circumference around the buttocks.
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Abdominal girth
For this measurement, the tape measure was placed in contact with the skin at the 
level of the umbilicus following a normal expiration.
Waist girth
For this measurement, the tape measure was placed in contact with the skin at the 
level of the narrowest part of the torso as viewed from the anterior aspect. In some 
obese subjects it was not possible to identify a waist narrowing, so the measurement 
was made as the smallest horizontal circumference between the iliac crest and lower 
ribs.
Upper-arm girth (contracted)
For this measurement the subject was asked to maximally contract the biceps muscle 
with the arm flexed at the elbow to approximately 45°. The tape measure was 
positioned around the upper-arm and the maximal circumference recorded.
Mid-thigh girth
This measurement was recorded at the level of the mid-thigh skinfold with the tape 
measure positioned horizontally around the thigh. The subject stood upright for this 
measurement with the weight equally distributed over both feet.
Medial calf girth
The tape measure was positioned horizontally around the calf at the level of maximal 
circumference. The subject stood with weight equally distributed over both feet.
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3.4 SOMATOTYPING
Heath-Carter anthropometric somatotypes were determined following standard 
procedures and using the equations presented below (Carter and Heath, 1990). Intra­
observer reliability coefficients (correlations), derived previously from duplicate 
measurements of each variable on 20 subjects, were all greater than the values 
recommended by Carter and Heath (1990).
Somatotype components were calculated using the following equations:
Endomorphy = -0.7182 -t- 0.1451(X) - 0.00068(X^) -t- 0.0000014(X^)
X = sum of triceps, subscapular and supraspinale skinfolds.
Mesomorphy = [(0.858 x  humerus breadth) + (0.601 x  femur breadth) -f- 
(0.188 X corrected arm girth) + (0.161 x  corrected calf girth)] - (height x
0.131) + 4.5.
Ectomorphy = (HWR x 0.732) - 28.58.
HWR = height / cube root of weight. If HWR was less than 40.75 but more than 
38.25, ectomorphy = HWR x 0.463 - 17.63. If HWR was equal to or less
than 38.25 a rating of 0.1 was given.
3.5 PROPORTIONALITY
As outlined in Chapter 1, proportionality refers to the relationship of body parts to one 
another or to the whole body (Ross and Marfell-Jones, 1991). Proportionality scores, 
or z-values, for skinfold and girth measurements were calculated using the approach 
devised by Ross and Wilson (1974).
To adjust for differences in body size the following formula was employed 
(Ross and Wilson, 1974):
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Z =  1/s [V(170.18/h/-P]
Where Z is the proportionality score, 1 is a constant, S is the standard deviation of the 
Phantom measurement, V is the variable being scaled (in this case a skinfold or girth), 
170.18 is the Phantom height, h is the obtained height of the subject,  ^ is a 
dimensional exponent (1) and P is the Phantom value for the variable V.
This formula geometrically scaled the skinfolds to the Phantom stature (170.18 
cm), obtained the difference from the given Phantom value, and expressed this value 
in terms of the SD of the Phantom. A z-value of 0.00 indicated that the variable V was 
proportionally the same as the Phantom and z-values of <0.00 or >0.00 indicated that 
V was proportionally smaller or larger than the Phantom respectively.
When scaling for body mass the same procedure was used, except that the 
Phantom stature was replaced by the Phantom body mass (64.58 kg) and the subject’s 
stature was replaced by their body mass.
3.6 BLOOD SAMPLING AND DETERMINATION OF SERUM GLUCOSE, 
LIPIDS AND LIPOPROTEINS
Following a 12-hour overnight fast, venous blood samples were drawn from an ante- 
cubital vein into SST Vacutainer tubes (Becton Dickinson, Oxford UK). Subjects 
assumed a supine position for the blood withdrawal and a tourniquet was fixed around 
the upper-arm. The site of venupuncture was first cleansed with a sterilised swab 
containing 70% v/c isopropyl alcohol (Medi Swab, Smith and Nephew, UK.). Serum
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glucose, TC and TG were analysed by dry chemistry slide technology (Kodak 
Ektachem Clinical Chemistry Slides, Kodak Clinical Diagnostics, Rochester, USA), 
on an Ortho Vitros 750 analyser (Ortho Clinical Diagnostics, Amersham, UK.). The 
between batch coefficient of variation for TC was 2.09% at 4.25 mmoLL'^ and 2.64% 
at 6.65 mmol.L'\ The corresponding figures for TG measurement were 1.25% at 1.10 
mmol.L'^ and 1.35% at 3.09 mmol.L"\ For glucose these figures were 2.05% at 6.10 
mmol.L'^ and 1.12% at 14.7 mmol.L'\ HDL-C was determined after precipitation of 
the non-HDL lipoproteins with 10% polyethylene glycol 6000 (Wamick et al., 1985). 
The between batch coefficient of variation was 4.47% at an HDL-C concentration of
1.33 mmol.L'\ Concentrations of LDL-C were calculated using the Friedewald (1972) 
method other than where TG were found to be > 4.0 mmol.L'\
3.7 STATISTICAL ANALYSIS
3.7.1 General statistical procedures
Kolmogorov-Smimov test’s of normality revealed all variables were normally 
distributed. Significance of all differences and relationships was accepted at the 5% 
probability level (P < 0.05). Other than where specified, data are presented as mean ± 
SD. All analyses were performed using SPSS software (SPSS Inc, 1999).
3.7.2 Statistics used in Chapter 4
Pearson product-moment correlation coefficients were determined to show the 
relationship between the angiographic findings and age, body mass, stature, skinfolds, 
girths and the indices of AT distribution. This technique was also used to investigate 
the relationship between fasting serum glucose, lipids, lipoproteins and 
anthropometric measurements.
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A form of factor analysis known as principal component analysis was used to 
explore the anatomical distribution of subcutaneous AT in the men with CAD and the 
healthy control men. The aim of the principal component analysis was the reduction 
of variables and the identification of AT distribution components.
With this method, a set of correlated variables (in this case skinfolds) is replaced 
by a set of uncorrelated variables (principal components), which are linear 
transformations of the original variables. The extent to which a single principal 
component can explain the bulk of the variance depends on the extent to which the 
original variables are correlated. From a set of n variables, there are n possible 
principal components. Subsequent components are uncorrelated with the first 
component and each explains less of the multivariate variance than the one preceding 
it. With regard to finding specific AT pattems, it is the components subsequent to the 
first that are interesting, as the first is likely to reflect variation in total adiposity 
(Mueller and Reid, 1979).
In the principal component analysis, the first step was to compute a simple 
correlation matrix between the skinfolds. Next, the suitability of the data for principal 
component analysis was assessed using the correlation matrix, the Kaier-Meyer-Olkin 
Measure of Sampling Adequacy and Bartlett’s Test of Sphericity. Scree plots and 
eigenvalues were then computed to determine the number of identifiable principal 
components. Usually, only components with eigenvalues greater than 1.0 are 
interpreted (Tabachnick and Fidell, 1996). Finally, inspection of the loadings 
(correlation’s) of the original variables on the principal components was performed in 
order for this interpretation to take place.
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Differences in anthropometric measurements (raw scores and size-adjusted) 
between the CAD patients and the healthy men were investigated using t-tests for 
independent samples.
3.7.3 Statistics used in Chapter 5
Differences in somatotype between the CAD patients and healthy, age-matched men 
were investigated using the procedures outlined by Cressie et al. (1986). A 
mulitvariate analysis of variance (MANOVA) was performed on the mean 
somatotypes of each group using Wilk’s lambda as the test statistic. A univariate F- 
test was then used to identify differences in the somatotype components.
Second-order partial correlation’s were used to assess the strength of the 
relationship between each somatotype component and anthropometric measures of AT 
distribution. This technique examines this relationship whilst statistically controlling 
for the effects of the other two somatotype components.
The relationship between the individual somatotype components and the 
indicators of metabolic fitness were determined using third-order partial correlation’s. 
This technique was used to adjust for the effect of the interrelationship between the 
somatotype components and also for differences in age.
Multivariate non-linear canonical correlation analysis was used to investigate 
the relationship between metabolic fitness and the somatotype treated as a gestalt. The 
canonical correlation is interpreted as Pearson product-moment correlation 
coefficient. Bartlett’s (1947) test, where the canonical correlation’s are evaluated as a 
chi-square variable, was used to test the significance of these correlation’s. The aim of 
canonical correlation analysis is the formation of linear combinations of the variables 
that have maximum correlation. The combinations of the variables are known as 
canonical variâtes and the correlation between the two canonical variâtes is the
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canonical correlation. The correlation’s between the original, standardised (z- 
transformed) variables and the canonical variâtes were calculated to determine the 
strength of their contribution to that variate. The squared canonical correlation 
indicates the level of explained variance between the pairs of variâtes. For this 
analysis, the dependent variate was metabolic fitness (serum glucose, TC, LDL-C, 
HDL-C, TG) and the independent variate somatotype (endomorphy / mesomorphy / 
ectomorphy).
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CHAPTER 4 
RESULTS & DISCUSSION
STUDIES FOCUSING ON OBESITY AND ADIPOSE 
TISSUE DISTRIBUTION
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4.1 SUBCUTANEOUS ADIPOSITY AND GIRTH MEASUREMENTS IN 
MEN: THE ASSOCIATION WITH ANGIOGRAPHIC FINDINGS
The aim of this study was to examine the relationship between a variety of 
anthropometric measurements and the findings of coronary angiography. Tables I 
(4.1) and II (4.1) show the mean values (± SD) of the angiography procedure, age, 
height, body mass, BMI, skinfolds and girths. Angiography revealed a range of 
coronary atherosclerosis ranging from zero (no detectable atheroma in any of the 
major coronary arteries) to 14.1 (severe stenosis in one or more major vessel). There 
was a significant correlation between the myocardial score and the LV score (r = 
0.347, P = 0.003).
TABLE I (4.1) Means ±  standard deviations (SD) o f the results from coronary 
angiography (N = 70).
Mean (SD) Range
Myocardial score 6.22 (3.86) 0.00 to 14.10
LV score 2.04 (1.99) 0.00 to 7.00
The range of BMI scores (20.0 to 41.7 kg.m'^) shows there was a wide variation 
in the degree of overweight amongst these men. Forty-three (62%) were overweight 
(BMI > 25.0 kg.m'^) and 15 of these (21%) were obese (BMI > 30.0 kg.m'^). The ratio 
of torso-to-limb skinfolds (1.91 ± 0.50) indicates a two-fold greater subcutaneous 
adiposity on the torso compared to the limbs. With regard to some of the WHR and 
waist girth cut-off points discussed in Chapter 1 (section 1.1.3), twenty-seven men 
(38%) had a WHR greater than 1.00, 24 (34%) had a waist girth greater than 100 cm, 
18 (26%) were greater than 102 cm and 44 (63%) were above 94 cm for waist girth.
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TABLE II (4.1) Means ±  standard deviations (SD) for age, height, body mass, BMI, 
skinfolds and girths for men undergoing coronary angiography (N = 70).
Variable Mean ± (SD)
Age (yr) 60.5(9.3)
Height (cm) 173.4 (6.2)
Body mass (kg) 82.0 (14.8)
BMI (kg.m'^) 2%2(43)
Skinfolds (mm)
Triceps 15.2 (6.8)
Biceps 9.2 (4.0)
Front mid-thigh 15.2 (6.6)
Medial calf 10.2 (4.0)
Subscapular 26.7 Ok9)
Suprailiac 25.9 (8.4)
Supraspinale 16.8 (7.9)
Abdominal 25.9 (8.4)
E 8 skinfolds 145.1 (45.5)
Z 4 torso skinfolds 95.3 (29.4)
E 4 limb skinfolds 49.8 (18.4)
E torso / E limb skinfolds 1.91 (0.50)
Girths (cm)
ASD 26.4 (3.4)
Waist 97.4 (10.0)
Abdomen 99.8 (10.2)
Hip 99.5 (8.1)
Mid-thigh 50.7 (4.6)
ASD/Ht 0.15 (0.02)
WHtR 0.56 (0.06)
WHR 0.98 (0.06)
AHR 1.00 (0.05)
WTR 1.79 (0.13)
ASD, abdominal sagittal diameter; ASD/Ht, abdominal sagittal diameter/height; 
WHtR, waist-to-height ratio; WHR, waist-to-hip ratio; AHR, abdomen-to-hip ratio; 
WTR, waist-to-thigh ratio.
Table HI (4.1) shows the relationship (using simple correlation analysis) between 
body mass and height, skinfolds, girth measurements and the angiographic findings.
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Only the relationship between myocardial score and mid-thigh girth was significant (r 
= -0.258, P < 0.05).
TABLE HI (4.1). Pearson product-moment correlations showing the relationship 
between skinfolds, girths and angiographic findings in men with CAD (N = 70).
Skinfolds Myocardial score Ventricular score
Body mass -0.176 -0.067
Height -0.125 0.089
Skinfolds
Triceps 0.057 -0.044
Biceps -0.119 -0.061
Front mid-thigh -0.035 -0.082
Medial calf -0.058 0.028
Subscapular -0.027 -0.039
Suprailiac 0.017 -0.148
Supraspinale -0.107 0.033
Abdominal -0.097 -0.012
E 8 skinfolds -0.050 -0.057
E 4 torso skinfolds -0.059 -0.056
E 4 limb skinfolds -0.030 -0.053
E torso / E limb skinfolds -0.069 -0.074
Girths
ASD -0.094 -0.124
Waist -0.125 -0.064
Abdomen -0.119 -0.082
Hip -0.114 -0.029
Mid-thigh -0.258* -0.212
ASD/Ht -0.010 -0.041
WHtR -0.077 -0.093
WHR -0.056 -0.074
AHR -0.067 -0.145
WTR 0.135 0.127
* P < 0.05.
Several prospective studies have shown a relationship between skinfolds, 
particularly torso skinfolds, and future risk of CHD (Ducimetiere et al., 1986;
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Donahue et al., 1987; Hargreaves et al., 1992; Stokes III et a l, 1985). However, as far 
as can be established, no study has ever examined the association between skinfolds 
and the severity of atherosclerosis determined with coronary angiography. This 
investigation clearly suggests that skinfolds are not related to the degree of coronary 
artery stenosis assessed with a relatively sensitive scoring system or to impaired left 
ventricular function. This may be due in part to the sample size employed in this 
study. However, the relationships are so weak as to suggest that even with a larger 
sample, significance would be attached to small correlation coefficients and would, 
therefore, be of questionable value.
Several investigators have in the past examined the association between 
anthropometric girth measurements and angiographic findings (Hauner et al., 1990; 
Hodgson et al., 1994; Ley et al., 1994; Flynn et al., Thompson et al., 1991 Kahn et 
al., 1996; Hartz et al., 1990). These studies have provided mixed findings. This 
investigation has attempted to extend these studies by using an angiogram scoring 
system. Previously, the decision of who does, and who does not, have CAD was based 
on an arbitrary decision in terms of arterial occlusion i.e. > or < 50% narrowing. Thus, 
it was possible that subjects with small differences in arterial occlusion were allocated 
to either disease or control group. Furthermore, no consideration was given to the 
anatomical location of the occlusion within the coronary arteries. The scoring system 
employed in this study overcomes these limitations by treating CAD as a continuous 
rather than dichotomous variable. It also considers the anatomical location of the 
occlusion.
As for body mass, height and skinfolds, this investigation failed to show a 
relationship between anthropometric girth measurements used to assess body fat 
distribution and CAD severity. One significant relationship did appear, however.
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between mid-thigh girth and myocardial score (r = -0.258, P < 0.05). There are several 
potential explanations for this, including the possibility of a type I statistical error. As 
a significant portion of the skeletal muscle is located in the thigh, another possibility 
is that mid-thigh girth may reflect muscle mass. Bjomtorp (1993) postulated that 
atrophied gluteal muscles could be responsible for high WHR’s and explain some of 
the relationship between WHR and CVD. In the same way, a larger mid-thigh girth 
may be a marker of greater (or more active) muscle mass, and, therefore, a reduced 
susceptibility to the atherogenic consequences of insulin-resistance associated risk 
factors.
To summarise, this investigation found no relationship between a multitude of 
anthropometric measurements that provide information of adiposity, the severity of 
coronary atherosclerosis and left ventricular function. Mid-thigh girth showed a weak, 
inverse but significant association with atherosclerosis severity. Further research is 
required to evaluate the physiological significance of this finding. Likely explanations 
for the findings in this are the multi-factorial nature of CAD, and a ’mismatch’ 
between the sensitive angiogram scoring system and the anthropometric 
measurements.
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4.2 SUBCUTANEOUS ADIPOSE TISSUE PATTERN IN MEN W ITH CAD 
AND HEALTHY CONTROLS: A PRINCIPAL COMPONENT
ANALYSIS
The aim of this investigation was to examine subcutaneous adipose tissue distribution 
in men with CAD (N = 65) and also in a group of apparently healthy men (N = 72) 
using principal component analysis. For this analysis, five men with zero scores from 
angiography were excluded to produce a group with indisputable CAD. The mean 
values (± SD) from the angiography were 6.70 (3.58) and 2.20 (2.00) for myocardial 
and left ventricular scores respectively.
TABLE I (4.2). Mean values ±  standard deviations for age and anthropometric 
characteristics o f men with angiogrdphically-documented CAD and healthy controls.
CAD patients 
(N = 65)
Healthv men 
(N = 72)
Age (yr) 61.5 (8.7) 43.5 (9.4)
Body mass (kg) 81.0 (13.0) 75.7 (9.5)
Stature (cm) 173.1 (6.1) 174.2 (5.6)
BMI (kg.m'^) 27.0 (4.0) 25.7(3.1)
Skinfolds (mm)
Triceps 15.2 (6.8) 15.6 (5.2)
Biceps 9.2 (4.0) 8.5 0L8)
Front mid-thigh 15.2 (6.5) 20.8 (7.3)
Medial calf 10.2 (4.0) 11.1 (4.0)
Subscapular 26.7 (8.9) 21.6 (8.2)
Suprailiac 25.9 (9.8) 32.7 (9.7)
Supraspinale 16.8 (7.9) 21.6 (8.6)
Abdominal 25.8 (8.4) 27.6 (9.2)
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Tables II (4.2) and III (4.2) show the inter-relationships between skinfolds in 
men with CAD and healthy controls respectively. The data demonstrate that 
significant associations exist between all of the skinfolds (P < 0.01). In the CAD men, 
the strongest relationship was between the biceps and triceps skinfolds (r = 0.766) and 
the weakest between the abdominal and triceps skinfolds (r = 0.320). In the healthy 
men, the strongest relationship was between the mid-thigh and triceps skinfolds (r = 
0.719) and the weakest was between the mid-thigh and supraspinale skinfolds (r = 
0.300). Examination of the correlations suggest that, in all but a few cases, linear 
relationships amongst skinfolds were stronger in the CAD patients.
The initial step in assessing the suitability of data for the application of 
principal component analysis is an inspection of the correlation matrix (Tabachnick 
and Fidell, 1996). Correlations greater than 0.30 suggests appropriateness, but is not 
indisputable proof that components exist. Bartlett’s test of sphericity and the Kaier- 
Meyer-Olkin (KMO) measure of sampling adequacy are more robust tests of the 
suitability of the data for principal component analysis.
TABLE II (4.2) Correlation matrix showing the relationships between skinfolds in 
CAD men. Values are Pearson product-moment correlation coefficients (N = 65).
Biceps Subscapular Suprailiac Supraspinale Abdominal Mid­
thigh
Calf
Triceps 0.766 0.652 0.707 0.723 0.320 0.711 0.572
Biceps 0.735 0.641 0.732 0.460 0.561 0.614
Subscapular 0.591 0.693 0.535 0.483 0.529
Suprailiac 0.712 0.552 0.644 0.514
Supraspinale 0.539 0.568 0.628
Abdominal 0.473 0.440
Mid-thigh 0.602
All correlation coefficients are statistically significant (P < 0.01).
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TABLE III (4.2) Correlation matrix showing the relationships between skinfolds in 
healthy men. Values are Pearson product-moment correlation coefficients (N = 72).
Biceps Subscapular Suprailiac Supraspinale Abdominal Mid­
thigh
Calf
Triceps 0.609 0.591 0.539 0.534 0.602 0.719 0.669
Biceps 0.427 0.452 0.327 0.378 0.427 0.385
Subscapular 0.522 0.515 0.541 0.422 0.426
Suprailiac 0.604 0.496 0.349 0.369
Supraspinale 0.548 0.300 0.436
Abdominal 0.490 0.497
Mid-thigh 0.664
All correlation coefficients are statistically significant (P < 0.01).
Table IV (4.2) presents the results of these tests. With respect to the KMO test, 
a critical value of 0 .6  is recommended for a satisfactory principal component analysis 
to take place (Tabachnick and Fidell, 1996). Values of 0.872 and 0.877 for the CAD 
men and controls respectively, indicate a high level of correlation between the 
skinfolds and, therefore, the appropriateness of the data for principal component 
analysis. Bartlett’s test of sphericity, which tests whether correlations between the 
skinfolds are sufficiently high to indicate the existence of factors (components), is 
also highly significant (P = 0.000) and justifies the application of this analysis.
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TABLE IV (4.2). Initial results generated from the principal component analysis 
showing the Kaier-Meyer-Olkin Measure o f Sampling Adequacy and Bartlett’s Test o f 
Sphericity.
CAD patients 
(N = 65)
healthy controls 
(N = 72)
Kaier-Meyer-Olkin
Measure of Sampling Adequacy 0.872 0.877
Bartlett’s Test of Sphericity:
Chi-square 352.3 271.3
Degrees of freedom 28 28
Significance 0 .0 0 0 0 .0 0 0
As only eigenvalues greater than 1 were selected for interpretation, Figures 1 (4.2) 
and 2 (4.2), known as scree plots in principal component analysis, together with 
Tables V (4.2) and VI (4.2), support the conclusion that there is only one identifiable 
principal component in each group of subjects. This component is interpreted as one 
of subcutaneous adiposity as it correlates uniformly with all of the skinfolds entered 
into the analysis [Table VII (4.2)]. Figures 1 (4.2) and 2 (4.2) show a clear ’flattening’ 
of the curve subsequent to the consideration of the first principal component. In the 
CAD patients this component explained approximately 65% of the variance in 
skinfold thickness. In the healthy men, this value was approximately 56%. Table VI 
(4.2) shows the variable loadings (correlations) with the first component. All skinfolds 
loaded positively on this component. The triceps skinfold had the greatest 
contribution to the component in the control subjects (r = 0.889) and supraspinale 
skinfold the greatest contribution in the CAD patients (r = 0.874).
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FIGURE 1 (4.2). Scree plot showing the eigenvalues associated with each component 
identified by the principal component analysis in CAD men (N = 65).
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FIGURE 2 (4.2). Scree plot showing the eigenvalues associated with each component 
identified by the principal component analysis in healthy men (N =72).
TABLE V (4.2). Unrotated solution from principal components analysis o f skinfolds in 
CAD men (N = 65).
Component Total
Initial Eigenvalues 
% of Explained Cumulative % 
Variance
1 5.208 65.103 65.103
2 0.735 9.182 74.286
3 0.606 7.571 81.857
4 0.511 6387 88.244
5 0.340 4.255 92.499
6 0.235 :1939 95.439
7 0.228 2355 98.293
8 0.137 1.707 1 0 0 .0 0 0
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TABLE VI (4.2). Unrotated solution from principal component analysis o f skinfolds in 
healthy men (N = 72).
Component Total
Initial Eigenvalues 
% of Explained Cumulative % 
Variance
1 4.488 56.094 56.064
2 0.976 1 2 .2 0 1 68.295
3 0.704 8.804 77.099
4 0.506 6.321 83.419
5 0.436 5.447 8 8 .8 6 6
6 0.391 4392 93.759
7 0.300 3.754 97.513
8 0.199 2.487 1 0 0 .0 0 0
TABLE VII (4.2). Skinfold loadings (correlations) with principal component extracted 
from men with CAD and healthy controls.
CAD men 
(N = 65)
Healthy men 
(N = 72)
Triceps 0.821 0.694
Biceps 0.863 0.662
Subscapular 0.813 0.743
Suprailiac 0.835 0.719
Supraspinale 0.874 0.709
Abdominal 0.651 0.764
Mid-thigh 0.780 0.737
Calf 0.757 0.748
Principal component analysis is a form of factor analysis that has been used to 
describe subcutaneous AT pattern in children and adults of differing age, sex and 
ethnic background (Baumgartner et al., 1986; Mueller and Reid, 1979; Mueller and 
Wohlleb, 1981; Mueller et al., 1986). The aim of this analysis is the identification of
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’fatness factors’ (principal components) that allow the reduction of information gained 
from many skinfold sites to be reduced to a more manageable number of variables 
(the components). In general, these studies have extracted two stable principal 
components. The first component typically explains about 70 to 80% of the variance 
in subcutaneous AT and has been termed an obesity component, as all skinfolds load 
positively on it. The second component that explains about 15% of the variance in 
subcutaneous AT has been termed a trunk-to-extremity component. This component 
has been interpreted as a fat pattern that contrasts subcutaneous AT on the trunk with 
AT on the limbs. These components were stable with variations in age, sex, and 
ethnicity (Mueller and Wohlleb, 1981) and fatter subjects appear to be more patterned 
than leaner subjects (Mueller and Reid, 1979). Mueller et al. (1986) studied a large 
sample of Canadian men (N = 12,446) and women (N = 7,018) and revealed a first 
component that contrasted trunk skinfolds (subscapular and suprailiac) with limb 
skinfolds (triceps and calf). This component of "centralized fatness" was associated 
with less subcutaneous fat than "peripheral fatness". It was also suggested that 
centralized obesity was associated with enlarged intra-abdominal fat deposits.
This investigation revealed only one principal component in both the CAD men 
and the healthy men. This is interpreted as a subcutaneous obesity component. Thus, 
in contrast to other studies, principal component analysis was unable to identify any 
pattern of subcutaneous adiposity in either group of men.
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4.3 SKINFOLDS AND ANTHROPOMETRIC GIRTH MEASUREMENTS 
OF MEN WITH CAD AND HEALTHY AGE-MATCHED CONTROLS: 
THE EFFECTS OF ADJUSTING FOR BODY SIZE VARIATION.
The aim of this study was to compare the skinfold and girth measurements of men 
with CAD and men who were apparently healthy and matched for age. A further 
investigation took place to consider the effect of differences in body size on these 
variables.
TABLE I (4.3). Angiographic scores, age and skinfolds o f men with CAD and healthy 
controls. Values are means ±  (standard deviations).
Variable CAD men 
(n = 27)
Controls 
(n = 38)
significance
Age (years) 53.2 (6.5) 51.2 (4.0) NS
Myocardial score 6.4 (3.3)
Ventricular score 1.9 (1.7)
Body mass (kg) 85.4 (15.7) 76.0 (8.3) P < 0.01
Stature (cm) 173.1 (6.2) 173.3 (5.3) NS
BMI (kg.m‘^ ) 28.4 (4.6) 25.7 (2.9) P < 0.01
Skinfolds (mm)
Triceps 18.3 (8 .6 ) 15.1 (3.6) NS
Biceps 11.0 (4.6) 8.5 0L2) P < 0.05
Front mid-thigh 18.2 (8 .2 ) 20.2 (6.3) NS
Medial calf 11.1 (3.8) 10.9 (3.4) NS
Subscapular 30.4 (8.5) 22.2 (7.7) P <  0.001
Suprailiac 30.8 (11.0) 32.3 (8.4) NS
Supraspinale 18.9 (8.20 2 2 .2  (8 .fO NS
Abdominal 28.6 (8 wO 26.6 (9.0) NS
E 8 skinfolds 167.5 (47.5) 157.9 (35.5) NS
E 4 torso skinfolds 108.8 (27.8) 103.2 (26.1) NS
E 4 limb skinfolds 58.6 (22.2) 54.6 (13.3) NS
E torso / E limb skinfolds 1.98 (0.50) 1.94 (0.50) NS
NS = P > 0.05
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Table I (4.3) presents the results of a comparison of age, body mass, height, 
BMI and skinfolds between the CAD patients and a group of age-matched healthy 
men. The CAD patients were heavier and had a greater BMI (P < 0.01). They also had 
significantly greater biceps (P < 0.05) and subscapular (P < 0.001) skinfolds. There 
were no statistical differences for any other skinfold variables.
Table II (4.3) shows differences in torso, hip and leg girths. Differences in 
several ratios formed from these measurements are also shown. The CAD patients had 
significantly greater abdomen and waist girths, ASD, WHR, AHR, WTR, WHtR, and 
ASD/Ht (P < 0.001). Hip and mid-thigh girths were not different (P > 0.05).
TABLE II (4.3). Anthropometric girth measurements and ratios in men with CAD and 
healthy controls. Values are means ±  (standard deviations).
Variable CAD men 
(n =27)
Controls 
(n = 38)
significance
Waist 99.5 0^6) 903 (8.50 P <  0.001
Abdomen 102.6 (9.9) 93.7 (7.8) P < 0.001
Hip 1 0 0 .6  (8 .6 ) 98.6 (4.6) NS
Mid thigh 52.2 0L8) 53.7 (4.5) NS
ASD 27.1 (3.2) 24.4 (2.8) P < 0.001
WHR 0.97 (0.08) 0.91 (0.05) P < 0.001
AHR 1.02 (0.04) 0.94 (0.05) P < 0.001
WTR 1.91 (0.13) 1.68 (0.13) P < 0.001
WHtR 0.57 (0.05) 0.52 (0.04) P <  0.001
ASD/Ht 0.16 (0 .0 2 ) 0.14 (0.02) P < 0.001
NS = P > 0.05. ASD, abdominal sagittal diameter; WHR, waist-to-hip ratio; AHR, 
abdomen-to-hip ratio; WTR, waist-to-thigh ratio; WHtR, Waist-to-height ratio; 
ASD/Ht, abdominal sagittal diameter/height.
224
In order to consider the effect of body size, many of the variables contained in 
Tables I (4.3) and II (4.3) were adjusted to the Phantom stature and body mass. The 
resultant z-values are, therefore, proportionality scores i.e. they represent the size of 
the variable in relation to size. Table III (4.3) contains the corrected skinfolds and 
girths normalised to the Phantom stature. These z-values are also presented in Figure 
1 (4.3), which shows similar proportionality profiles of the patients and controls. For 
both groups, mean z-values for the triceps and abdominal skinfolds were close to 0 .0 0  
and, therefore, proportional to stature. The subscapular skinfold of the CAD patients 
had a z-value of 2.49 ± 1.64. The suprailiac skinfold of both groups had mean z- 
values greater than 3.00. The front mid-thigh and medial-calf skinfolds exhibited 
negative z-values that were close to 1.00. Compared to the controls, the patients had 
proportionally greater subscapular and biceps skinfolds (P < 0.01).
The mean z-values for stature-normalised waist and abdomen girths indicate 
that these parameters were proportionally large. Both girths were significantly (P < 
0.001) larger in the CAD patients compared to the controls. The mean stature- 
normalised waist girth of the CAD patients was 5.28 ± 2.05 i.e. more than five 
standard deviations greater than the Phantom.
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Figure 1 (4.3) Proportionality profile o f skinfolds and girth measurements normalised 
to the phantom stature. Data are shown as means +/- SEM. (N = 27 fo r  the patients 
and 38 for the controls).
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TABLE III (4.3). Means ±  (standard deviations) o f corrected skinfolds, waist and
abdominal girths (z-values) normalised to the Phantom stature (170.18 cm).
Variable CAD patients 
(n = 27)
Controls 
(n = 38)
significance
Skinfolds
Triceps 0.57 (1.87) -0.12(0.80) NS
Biceps 1.40 (2.25) 0.17(2.02) P < 0.05
Front mid-thigh -1.10 (0.93) -0.86 (0.73) NS
Medial calf -1.09 (0.77) -1.12(0.72) NS
Subscapular 2.49 (1.64) 0.91 (1.47) P < 0.001
Suprailiac 3.32 (2.32) 3.64(1.84) NS
Abdominal 0.35 (1.08) 0.10(1.15) NS
Girths
Waist 5.28 (2.05) 3.78 (1.93) P < 0.001
Abdomen • 3.13 (1.32) 1.87(1.13) P < 0.001
NS = P > 0.05
Table IV (4.3) and Figure 2 (4.3) contain skinfold and girth z-values after they 
were normalised to the Phantom body mass. With the exception of the subscapular 
and suprailiac sites, all of the mean z-values are either zero or negative. The triceps, 
biceps and abdominal skinfolds are all less than 1.00. The z-values for the front mid­
thigh and medial-calf skinfolds, however, although negative were between 1 .0 0  and 
2.00 i.e. proportionally small for the body mass. The patients had significantly smaller 
body mass normalised front mid-thigh and suprailiac skinfolds (P < 0.05) but larger 
subseapular skinfold (P < 0.01). The body mass normalised waist girth was more than 
one SD greater than the Phantom in the patients and controls. The mean z-values for 
the abdominal girth were both close to zero. There was no significant difference 
between patients and controls when the body mass normalised girths were compared.
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TABLE IV (4.3). Means ±  (standard deviations) o f corrected skinfolds (z-values)
normalised to the Phantom body mass (64.58 kg).
Variable CAD patients 
(n = 27)
Controls 
(n = 38)
significance
Skinfolds
Triceps -0.40 (1.05) -0.55 (0.68) NS
Biceps 0 .0 0  (1 .2 0 ) -0.41 (1.54) NS
Front mid-thigh -1.60 (0.74) -1.17 (0.64) P < 0.05
Medial calf -1.63 (0.52) -1.41 (0.66) NS
Subscapular 1.16(1.11) 0.30 (1.16) P < 0.01
Suprailiac 1.80 (1.67) 2.70 (1.55) P<0.05
Abdominal -0.40 (1.03) -0.35 (0.97) NS
Girths
Waist 1.07 (2.02) 1.19(1.88) NS
Abdomen -0 .0 1  (1.28) 0.16 (1.14) NS
NS = P > 0.05
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Figure 2 (4.3) Proportionality profile o f skinfolds and girth measurements normalised 
to the Phantom body mass. Data are shown as means +/- SEM. (N = 27 for the 
patients and 38 for the controls).
This study examined subcutaneous fat pattern and abdominal obesity in CAD by 
comparing a group of men undergoing investigative coronary angiography and a 
group of apparently healthy controls. Anthropometric differences of men with CAD 
and controls have been investigated previously (Hauner et al., 1990; Hodgson et al., 
1994; Ley et al., 1994; Thompson et al., 1991; Kahn et al., 1996; Flynn et al., 1994) 
The association of intra-abdominal visceral fat and CAD has also been examined 
using this type of study design (Nakamura et al., 1994).
The present study used an approach to adjust for differences in body size that 
was originally devised to assess proportional growth (Ross and Wilson, 1974). The 
method has been subsequently revised (Ross and Ward, 1982; Ross and Marfell-
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Jones, 1991), and applied to athletic performance (Ross and Ward, 1984; Sovak et a l, 
1992; DeRose et al., 1989.
The simplest procedure to account for differences in body size is to use a ratio 
(i.e. weight / height). However, as ratios are a function of both the denominator and 
numerator, their interpretation is not simple (Ross and Wilson, 1974). Furthermore, 
questions have been raised about their ability to detect changes in body composition 
(Molarius and Seidell, 1998) and their suitability for statistical analysis (Allison et al., 
1995). The method proposed by Ross and Wilson (1974) advocates the use of a 
single, unisex reference human as a calculation device for quantifying proportional 
differences that avoids the use of ratios. A z-value, which is interpreted as a SD, is 
determined for each anthropometric measurement. A z-value of 0.00 indicates that the 
variable in question is proportionally the same as the Phantom. Z-values of < 1.00 or 
> 1.00 indicate that the variable is proportionally smaller or greater than the Phantom 
respectively. Thus, this technique addresses the issue of the magnitude of 
anthropometric variables in relation to body size. For example, a skinfold of 20 mm in 
two subjects is the same in absolute terms. However, if these subjects differ in size i.e. 
height and weight, then this skinfold thickness is relatively smaller in the larger 
person.
The significance of body size as a confounding variable of the relationship 
between girth measurements and CAD risk has attracted some attention in the past 
(Cox et al., 1996; Hsieh and Yoshinaga, 1995; Ashwell et al., 1996a, 1996b, Han et 
a l, 1996, 1997). These studies attempted to study the influence of height in the 
relationship between waist circumference and CHD by using height as the 
denominator in a ratio with waist girth. Some of these researchers suggested that 
WHtR was a better predictor of mortality (Cox et al., 1996) CAD risk (Hsieh and
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Yoshinaga (1995) and lAF (Ashwell et al., 1996b). However, Han et al. (1996, 1997) 
did not support this proposition. No study has previously used a proportionality 
strategy to examine this issue.
Usually all anthropometric measurements are geometrically scaled to the 
Phantom stature (170.18 cm). An implicit assumption with this technique is a perfect 
correlation between the variable being scaled and stature; although this is generally 
not the case the differences are seldom great enough to invalidate the technique (Ross 
and Wilson, 1974). In this study, only the thigh skinfold (r = 0.266, P < 0.05) was 
significantly related to stature. As all skinfolds (except abdominal) and girth 
measurements were significantly related to body mass (r = 0.263 to 0.781, P < 0.05), 
and body mass was significantly different between the two groups, it was also decided 
to geometrically scale all measurements to the Phantom body mass.
The anthropometric characteristics presented in Table I (4.3) show that the 
patients were heavier but not taller. Consequently, the BMI of the patients was also 
greater. As there was no difference in the sum of eight skinfolds, factors other than 
increased subcutaneous adiposity are likely to be responsible for the difference in 
body mass. A speculative suggestion is that an increased fat mass in another depot 
(i.e. the intra-abdominal depot) may well explain the difference in body mass. This is 
supported by the greater ASD, waist and abdominal girths in patients compared to 
controls, as waist girth may be the best anthropometric predictor of intra-abdominal 
adipose tissue (Pouliot et al., 1994).
The stature-normalised skinfolds for both groups show that the triceps and 
abdominal skinfolds are proportionally similar. Also in both groups, the suprailiac 
skinfold was proportionally much greater than the Phantom and the thigh and calf 
skinfolds smaller. A proportionally large subscapular skinfold also appears to be a
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physical characteristic of the patients. Subscapular skinfold thickness has been 
reported previously to be an independent predictor of CAD (Stokes III et al., 1985; 
Ducimetiere et al., 1986; Donahue et al., 1987) and a correlate of low HDL-C 
(Despres et al., 1985). Given that several investigations have pointed to an increased 
’central’ or abdominal fat deposition as being an important predictor of CAD, the 
finding of a proportionally large suprailiac skinfold in the patients is not surprising. 
However, this finding is confounded by the equally large suprailiac skinfold in the 
healthy men. Compared to the Phantom, the profile of z-values suggests a particular 
phenotype with regard to subcutaneous fat pattern in the patients. This phenotype is, 
with the exception of the abdominal site, one of proportionally large skinfolds on the 
torso, proportionally small skinfolds on the lower limb and proportional skinfolds on 
the upper limb. The importance of this is lessened by the fact that a similar pattern 
exists in the apparently healthy men, with the notable exception of the difference in 
subscapular skinfold.
Prominent findings in this study were the significant differences between 
patients and controls for all girth measures of abdominal obesity and the very large 
stature-normalised z-values for the waist and abdominal girths of the patients. These 
stature-normalised z-values were also significantly greater in the patients than the 
controls. Waist circumference cut-off points for men of 94.0 cm (Lean et ah, 1995) 
and 100cm (Lemieux et al., 1996) have been proposed. The mean waist girth of the 
patients, but not the controls, was much greater than the lower of these figures and 
almost equal to the higher. The SD of the stature-normalised waist girth of the patients 
indicates that more than 95 % of these men had proportionally large waist girths (z- 
value > 1.0). When these girth measurements were normalised to body mass the
232
deviations from the Phantom were still positive but much smaller. This is due to the 
increased body mass of both groups, particularly the patients.
The body-mass normalised skinfolds showed no difference between the 
patients and controls with regard to the direction of the z-values. The front mid-thigh, 
subscapular and suprailiac sites were significantly different with respect to the size of 
the z-values. Normalised for body mass, the suprailiac and thigh skinfolds were 
proportionally smaller in the patients than the controls but the subscapular skinfold 
was greater in the patients. Except for the subscapular skinfold in the controls and the 
negative deviation of the abdominal skinfold, the skinfold pattern for both groups was 
essentially one of proportionally small skinfolds on the limbs and large skinfolds on 
the torso. An interpretation of the relatively small abdominal skinfold is that in 
genetically-susceptible men, increasing age is associated with the accumulation of 
intra-abdominal AT (Bouchard et a l, 1993). This augments the pressure within the 
abdomen, which increases the tension of the skin and reduces the skinfold thickness. 
This is analogous to increasing the pressure within a cylinder, which increases the 
circumferential tensile stress on the wall.
Other studies that have used angiography patients in comparison to controls 
have reported no difference in skinfold thickness (Flynn et al. 1994), waist and 
abdominal girths (Hauner et al., 1994; Flynn et al., 1994; Hodgson et al., 1994). The 
difference in the findings of this study appears to be due to the size of the girth 
measurements in the controls, as the values of the patients are very similar to these 
previous studies. Our control subjects were recruited from a University health- 
screening programme and were asymptomatic with regard to CAD. The controls of 
these other studies were patients who, having undertaken angiography, were found to 
have clinically insignificant coronary stenosis. In effect, whilst some of these controls
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may have had no CAD, others had angiographic evidence of CAD but below an 
arbitrary value. This may explain the lack of a statistical difference between the 
groups. In our study, this was avoided by using a scoring system that allowed us to 
exclude from the analysis only those patients who had a zero myocardial score. Kahn 
et al. (1996) also found a significant difference between patients and controls when 
they recruited asymptomatic control subjects from the same community as the 
patients. Thus, it appears that waist circumference is able to discriminate between 
CAD patients and healthy controls, but not between patients who are all hospitalised 
for investigative coronary angiography and who may have greater or lesser degrees of 
CAD. Enlarged waist circumference may be an indicator of visceral fat accumulation 
as this depot, but not the abdominal subcutaneous, seems to be enlarged in CAD 
patients compared to controls (Nakamura et a l, 1994).
With regard to skinfolds, Flynn et al. (1994) found no difference between 
CAD patients and controls at several sites. Furthermore, Kahn et al. (1996) suggested 
that a greater sum of 3 skinfolds actually conferred some protection against CAD in 
older individuals. With regard to unadjusted subcutaneous adiposity, this study 
revealed that CAD patients differed from controls only in biceps and subscapular 
skinfold thickness. Thus, in agreement with other studies, an increased subscapular 
skinfold thickness appears to be a prominent feature of CAD. When normalised for 
stature or body mass, a large subscapular skinfold remained a prominent feature of 
CAD patients compared to controls.
These results suggest that increased body mass, ASD, waist and abdominal 
girths, and subscapular skinfold thickness are features of CAD patients but not 
increased subcutaneous adiposity. Adjusting for stature had no effect on these results 
but adjusting for body mass removed the difference in the girth measurements.
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Following the adjustment for differences in body mass, subscapular skinfold remained 
significantly larger in the patients but front mid-thigh and suprailiac skinfolds became 
significantly greater in the controls. Thus, CAD patients have proportionally large 
waist and abdominal girths for their stature but not for their mass.
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4.4 SKINFOLDS AND ANTHROPOMETRIC INDICES OF ABDOMINAL 
OBESITY IN MEN. THE INFLUENCE ON SERUM GLUOCSE AND 
LIPIDS AND THE EFFECT OF ADJUSTING FOR BODY SIZE 
VARIATION.
The aim of this study was an examination of the relationship between 
anthropometric indices of adiposity and serum glucose, lipids and lipoproteins in the 
healthy men (it was not possible to perform this analysis in the CAD men as a 
significant number were taking lipid-lowering medication). This was done using 
regression analysis and by investigating potential differences in these metabolic 
variables in the upper and lower halves of the distribution for the anthropometric 
variables. The 50* percentile or median value of each anthropometric variable was 
used to divide the entire sample (N = 6 8 ) into two groups of equal number i.e. 34 men 
with a skinfold or girth equal to or below the median and 34 men with a skinfold or 
girth greater than the median value. Differences in the metabolic variables between 
these two groups were then tested for statistical significance.
As in the previous section, a proportionality technique was also applied to the 
anthopometric variables to see whether this had any effect on the ability of the 
anthropometric variables to discriminate between men with higher and lower glucose 
and lipid levels. In other words, it was of interest to discover whether the absolute or 
relative size of the adiposity measurements were most closely related to metabolic 
fitness.
Table I (4.4) presents mean values ± (SD) of age, body mass, stature, BMI, 
skinfolds, waist and abdominal girths, and metabolic variables. Median values that 
were calculated for all skinfolds and girths are also shown.
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Means, SD’s and median values for the size-adjusted variables are shown in 
table II (4.4). With the exception of the suprailiac, mid-thigh and calf skinfolds, waist 
girth and stature-adjusted abdominal girth, the anthropometric measurements were 
within ± 1 .0 0  of a z-value of zero, i.e. these variables were of similar proportions to 
the hypothetical model.
TABLE I (4.4). Age, anthropometric and metabolic characteristics o f the subjects (N 
= 68).
Variable Mean ± (SD) Median
Age (years) 43.9 (9.1)
Body mass (kg) 75.9 (9.4)
Stature (cm) 174.4 (5.6)
BMI (kg.m'^) 25.8 (3.2i)
Skinfolds (mm)
Triceps 15.4 (5.2) 14.6
Biceps 8 .6  (4.9) 7.3
Subscapular 21.4 (8.1) 2 0 .0
Suprailiac 32.5 (9.9) 33k5
Supraspinale 21.6 (8.7) 20.5
Abdominal 27.5 (9.5) 26.3
Mid-thigh 20.5 (7.2) 2 0 .2
Medial calf 10.9 (3.3) 1 1 .0
E 8  skinfolds 158.2 (43.2) 156.0
E 4 torso skinfolds 103.0 (29.4) 1 0 2 .0
E 4 limb skinfolds 55.2 (17.7) 52.0
E torso / E  limb skinfold ratio 1.95 (0.51) 1 .8 8
Girths (cm)
Waist 89.2 (8.4) 87.0
Abdominal 93.4 (8.3) 91.6
Metabolic variables
Glucose (mmol.L'^) 5.30 (0.36)
Total cholesterol (mmol.L'^) 4.97 (0.93)
Triglyceride (mmol.L'*) 1.58 (1.16)
HDL-cholesterol (mmol.L'^) 1 .2 1  (0.26)
LDL-cholesterol (mmol.L'^) 3.09 (0.86)
LDLiHDL 2.65 (0.95)
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TABLE II (4.4) Descriptive statistics o f the anthropometric characteristics following 
adjustment for differences in stature and body mass. Skinfolds and girths were 
adjusted to the Phantom stature (170.18 cm) and body mass (64.58 kg). (N = 68).
Mean ± (SD) Median
Skinfolds
Triceps (stature) -0.07 (1.1) -0.29
Triceps (mass) -0.51 (0.95) -0 .6 8
Biceps (stature) 0.15 (2.38) -0.41
Biceps (mass) -0.39 (2.13) -0.84
Subscapular (stature) 0.72 (1.55) 0.45
Subscapular (mass) 0.17(1.27) -0.04
Suprailiac (stature) 3.66(2.16) 3.71
Suprailiac (mass) 2.73 (1.78) 2 .8
Abdominal (stature) 0.19(1.19) 0.04
Abdominal (mass) -0.25 (1.00) -0.33
Mid-thigh (stature) -0.84 (0.85) -0.83
Mid-thigh (mass) -1.15 (0.72) -1.16
Calf (stature) -1.14 (0.80) -1 .1 0
Calf (mass) -1.43 (0.70) -1.38
Girths
Waist (stature) 3.43 (1.98) 3.44
Waist (mass) 1.06 (1.97) 0.98
Abdominal (stature) 1.74 (1.22) 1.57
Abdominal (mass) 0.15 (1.24) 0 .2 1
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Tables III (4.4) to IX (4.4) show differences in the serum concentrations of 
glucose, TC, TG, HDL-C and LDL-C according to skinfold thickness. Differences in 
the LDL-C : HDL-C ratio are also shown in each table. For all skinfolds, the 
mathematical direction of all the differences in these metabolic variables was in 
accordance with the hypothesis that greater adiposity is associated with higher levels 
of glucose, TC, TG and LDL-C and lower HDL-C. For unadjusted limb skinfolds 
[Table III (4.4)], the biceps was the best discriminator for revealing significant 
differences in glucose and lipids. Serum concentrations of glucose (P < 0.05), TC (P < 
0.01), TG (P < 0.01) and LDL-C (P < 0.01) were all significantly higher in the group 
of men comprising the upper 50% of the biceps skinfold distribution. The LDL-C : 
HDL-C ratio was also significantly higher in this group (P < 0.001), whereas the 
HDL-C concentration was lower (P < 0.01). Other significant differences in glucose 
and lipids found using limb skinfolds were as follows. The LDL-C : HDL-C ratio was 
significantly greater (P < 0.05) in men with thicker triceps and calf skinfolds. LDL-C 
concentration was greater (P < 0.05) in the men above the median value according to 
calf skinfold.
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TABLE III (4.4) Metabolic variables (mmol.L^) in men according to limb skinfold
thickness. Values are means ±(SD). (N = 68).
Triceps 
(14.6 cm /
Biceps 
(7.3 cm)
Mid-thigh 
(20.2 cm)
Calf
(11.0 cm)
Glucose 1^ 5.24 (0.33) 5.19 (0.32)* 5.28 (0.37) 5.26 (0.31)
2" 5.36 (0.39) 5.40 (0.38) 5.31 (0.36) 5.34 (0.41)
TC 1 4.80 (0.90) 4.64 (0.85)** 4.90 (0.96) 4.78 (1.03)
2 5.13 (0.94) 5.30 (0.90) 5.04 (0.91) 5.16(0.77)
TG 1 1.63 (1.39) 1.20 (0.77)** 1.63 (1.35) 1.67 (1.39)
2 1.53 (0.91) 1.96(1.37) 1.52 (0.93) 1.48 (0.87)
HDL-C 1 1.24 (0.23) 1.30 (0.24)** 1.24 (0.24) 1.24 (0.24)
2 1.17 (0.29) 1.11(0.26) 1.17 (0.28) 1.17 (0.28)
LDL-C 1 2.89 (0.84) 2.81 (0.76)** 3.00 (0.93) 2.84 (0.93)*
2 3.29 (0.85) 3.40 (0.87) 3.18 (0.79) 3.33 (0.71)
LDL-C : HDL-C 1 2.36 (0.83)* 2.18(0.60)*** 2.50 (1.01) 2.35 (0.95)*
2 2.92(1.00) 3.14 (1.01) 2.79 (0.88) 2.94 (0.86)
* P <0.05, * * P < 0.01, ***P <0.001 between 1 and2.
“Values in italics are median values for skinfold.
**1 represents the sub-group of subjects with skinfold thickness equal to or less than the median value 
for that skinfold.
2^ represents the sub-group of subjects with skinfold thickness greater than the median value for that 
skinfold.
Using the unadjusted torso skinfold values [Table IV (4.4)], there were 
significant differences in TC (P < 0.05), TG (P < 0.01), HDL-C (P < 0.05) and the 
LDL-C : HDL-C ratio (P < 0.01) for the supraspinale site. The only other significant 
difference was for TC (P < 0.05) using the suprailiac skinfold.
240
TABLE IV (4.4) Metabolic variables (mmol.L^) in men according to torso skinfold
thickness. Values are means ±(SD). (N = 68).
Subscapular 
(20.0 cm /
Suprailiac 
(33.5 cm)
Supraspinale 
(20.5 cm)
Abdominal 
(26.3 cm)
Glucose I*’ 5.26 (0.34) 5.23 (0.33) 5.23 (0.35) 5.26 (0.36)
2" 5.33 (0.40) 5.35 (0.39) 5.36 (0.37) 5.33 (0.37)
TC 1 4.86 (0.96) 4.74 (0.99)* 4.72 (0.92)* 4.86 (1.03)
2 5.08 (0.90) 5.19(0.81) 5.21 (0.89) 5.07 (0.81)
TG 1 1.34 (0.81) 1.36 (0.82) 1.22 (0.75)** 1.37 (0.96)
2 1.85 (1.43) 1.80 (1.40) 1.93 (1.38) 1.78(1.32)
HDL-C . 1 1.26 (0.24) 1.23 (0.27) 1.27 (0.22)*. 1.26 (0.26)
2 1.15 (0.28) 1.18 (0.25) 1.13 (0.28) 1.16 (0.26)
LDL-C 1 3.02 (0.92) 2.92 (0.93) 2.91 (0.90) 3.02 (0.99)
2 3.18 (0.79) 3.27 (0.75) 3.28 (0.78) 3.17 (0.70)
LDL-C : HDL-C 1 2.48 (0.91) 2.48 (0.98) 2.32(0.81)** 2.50 (1.02)
2 2.85 (0.97) 2.83 (0.90) 3.00 (0.98) 2.81 (0.86)
* P <0.05, * * P < 0.01 between 1 and2.
“Values in italics are median values for skinfold.
’’1 represents the sub-group of subjects with skinfold thickness equal to or less than the median value 
for that skinfold.
2^ represents the sub-group of subjects with skinfold thickness greater than the median value for that 
skinfold.
Table V (4.4) shows differences in the metabolic variables according to E  8 
skinfolds, E 4 torso skinfolds, E 4 limb skinfolds and the torso-to-limb skinfold ratio. 
Men with a lower total subcutaneous adiposity (lower E 8 skinfolds) had a greater 
HDL-C concentration (P < 0.05) and lower LDL-C : HDL-C ratio (P < 0.01). 
Similarly, men with greater torso subcutaneous adiposity (E 4 torso skinfolds) had a 
greater serum TG concentration (P < 0.05) and ratio of LDL-C-to- HDL-C (P < 0.05).
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TABLE V (4.4) Metabolic variables (mmol.L^) in men according to the 2)8 skinfolds, 
2  4 torso skinfolds, 2  4 limb skinfolds and the ration o f torso-to-limb skinfolds. 
Values are means ±(SD). (N = 68).
E 8 skinfolds 
(156.0 cm)^
E 4 torso 
skinfolds 
(102.0 cm)
E 4 limb 
skinfolds 
(52.0 cm)
torso-to- 
limb ratio 
(7.88)
Glucose 1^ 5.26 (0.35) 5.27 (0.35) 5.24 (0.34) 5.29 (0.37)
2" 5.34 (0.38) 5.32 (0.38) 5.35 (0.38) 5.30 (0.36)
TC 1 4.77 (0.98) 4.79 (0.99) 4.86 (0.98) 5.08 (1.02)
2 5.16 (0.84) 5.14 (0.84) 5.06 (0.89) 4.84 (0.82)
TG 1 1.43 (1.10) 1.31 (0.82)* 1.70 (1.40) 1.35 (0.81)
2 1.72 (1.22) 1.85 (1.39) 1.48 (0.91) 1.81 (1.43)
HDL-C 1 1.27 (0.24)* 1.26 (0.26) 1.23 (0.23) 1.23 (0.28)
2 1.14 (0.27) 1.15 (0.26) 1.19(0.29) 1.19 (0.24)
LDL-C 1 2.90 (0.93) 2.96 (0.93) 2.94 (0.93) 3.25 (0.90)
2 3.27 (0.74) 3.23 (0.77) 3.21 (0.79) 2.91 (0.79)
LDL-C : HDL-C 1 2.32 (0.83)** 2.43 (0.91)* 2.44 (0.95) 2.73(0.97)
2 2.98 (0.96) 2.89 (0.96) 2.82 (0.93) 2.55 (0.94)
* P <0.05, * * P < 0.01 between 1 and2.
“Values in italics are median values for skinfold.
1^ represents the sub-group of subjects with skinfold thickness equal to or less than the median value for that 
skinfold.
“2 represents the sub-group of subjects with skinfold thickness greater than the median value for that skinfold.
After adjusting the limb skinfolds for differences in stature, a similar pattern of 
differences can be seen with respect to the metabolic variables [Table VI (4.4)]. Men 
with greater stature normalised biceps skinfold thickness had higher serum 
concentrations of glucose, TC and LDL-C (P < 0.05) and a lower HDL-C 
concentration (P < 0.01). The LDL-C : HDL-C ratio was also significantly greater in 
these men (P < 0.001) as it was when the stature normalised calfskinfold was used.
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TABLE VI (4.4) Metabolic variables (mmol.L^) in men according to limb skinfold
thickness following adjustment to the Phantom stature o f 170.18 cm. Values are
means ±(SD). (N = 68).
Triceps
(-0.29/
Biceps 
(-0.41 cm)
Mid-thigh 
(-0.83 cm)
Calf
(-1.10 cm)
Glucose 5.24 (0.33) 5.20 (0.32)* 5.29 (0.36) 5.24 (0.31)
2" 5.36 (0.39) 5.37 (0.36) 5.30 (0.37) 5.34 (0.40)
TC 1 4.80 (0.90) 4.69 (0.88)* 4.90 (0.97) 4.80 (1.04)
2 5.13 (0.94) 5.19(0.85) 5.02 (0.90) 5.13 (0.78)
TG 1 1.66 (1.38) 1.37 (1.11) 1.66 (1.36) 1.69(1.40)
2 1.50 (0.92) 1.81 (1.19) 1.49 (0.93) 1.46 (0.80)
HDL-C 1 1.24 (0.23) 1.29 (0.23)** 1.23 (0.24) 1.23 (0.24)
2 1.19(0.30) 1.11(0.25) 1.19(0.28) 1.18 (0.28)
LDL-C 1 2.89 (0.83) 2.82 (0.78)* 3.00 (0.94) 2.86 (0.93)*
2 3.28 (0.85) 3.30 (0.81) 3.18 (0.78) 3.30 (0.73)
LDL-C : HDL-C 1 2.38 (0.81) 2.19 (0.60)*** 2.52 (1.02) 2.83 (0.95)*
2 2.90 (1.02) 3.09 (1.04) 2.76 (0.88) 2.90 (0.89)
* P <0.05, * * P < 0.01, ***P <0.001 between 1 and2.
“Values in italics are median values for skinfold.
1^ represents the sub-group of subjects with skinfold thickness equal to or less than the median value 
for that skinfold.
'^ 2 represents the sub-group of subjects with skinfold thickness greater than the median value for that 
skinfold.
Using the stature-adjusted torso skinfolds, the only significant difference in 
either serum glucose or lipid concentrations was for HDL-C (P < 0.05) using the 
subscapular skinfold [Table VII (4.4)].
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TABLE VU (4.4) Metabolic variables (mmol.L^) in men according to torso skinfold
thickness following adjustment to the Phantom stature o f 170.18 cm. Values are
means ±(SD). (N = 68).
Subscapular 
(0.45 cm /
Suprailiac 
(3.71 cm)
Abdominal 
(0.04 cm)
Glucose 5.25 (0.34) 5.27 (0.34) 5.26 (0.36)
2" 5.34 (0.38) 5.32 (0.39) 5.33 (0.37)
TC 1 4.88 (0.98) 4.80 (1.03) 4.86 (1.03)
2 5.05 (0.88) 5.13 (0.79) 5.07 (0.82)
TG I 1.33 (0.83) 1.51 (1.19) 1.37 (0.96)
2 1.83 (1.39) 1.65 (1.15) 1.79 (1.32)
HDL-C 1 1.27 (0.24)* 1.23 (0.27) 1.26 (0.26)
2 1.14 (0.27) 1.18 (0.25) 1.16 (0.26)
LDL-C 1 3.03 (0.94) 2.92 (0.95) 3.02 (0.99)
2 3.16(0.77) 3.25 (0.74) 3.17 (0.70)
LDL-C : HDL-C 1 2.46 (0.92) 2.49 (1.00) 2.50 (1.02)
2 2.85 (0.95) 2.81 (0.89) 2.81 (0.86)
* P < 0.05 between 1 and 2.
“Values in italics are median values for skinfold.
1^ represents the sub-group of subjects with skinfold thickness equal to or less than the median value 
for that skinfold.
2^ represents the sub-group of subjects with skinfold thickness greater than the median value for that 
skinfold.
Table VIII (4.4) shows the values of serum glucose and lipids according to the 
body mass normalised limb skinfold values. Again the biceps skinfold was the best 
for revealing significant differences in these metabolic variables. Men with smaller 
mass-adjusted biceps skinfolds had significantly lower fasting values for serum 
glucose (P < 0.05), TC (P < 0.05), LDL-C (P < 0.05) and the LDL-C : HDL-C ratio (P 
< 0.001). HDL-C was significantly higher in these men (P < 0.01). TC (P < 0.05) and
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LDL-C (P <0.01) were also significantly higher in men with greater mass-adjusted 
calf skinfold. Using mass-adjusted torso skinfolds, the only significant difference was 
found using the suprailiac skinfold and was for LDL-C concentration (P < 0.05), 
which was lower in men with smaller suprailiac skinfolds [Table IX (4.4)].
TABLE VIII (4.4) Metabolic variables (mmol.L^) in men according to limb skinfold 
thickness following adjustment to the Phantom body mass o f 64.58 kg. Values are 
means ±(SD). (N = 68).
Triceps Biceps 
(-0.84 cm)
Mid-thigh 
(-1.16 cm)
Calf
(-1.38 cm)
Glucose 5.27 (0.35) 5.20 (0.32)* 5.33 (0.36) 5.33 (0.32)
2 " 5.32 (0.38) 5.39 (0.38) 5.26 (0.36) 5.37 (0.40)
TC 1 4.87 (0.96) 4.73 (0.89)* 4.90 (0.97) 4.69 (0.96)*
2 5.06 (0.91) 5.20 (0.93) 5.03 (0.90) 5.26 (0.81)
TG 1 1.67 (1.37) 1.34(1.11) 1.75 (1.37) 1.62 (1.28)
2 1.49 (0.93) 1.82 (1.18) 1.40 (0.90) 1.53 (1.03)
HDL-C 1 1 .2 2  (0 .2 1 ) 1.30 (0.23)** 1.18 (0.23) 1.20 (0.24)
2 1.19(0.31) 1 .1 2  (0.26) 1.23 (0.29) 1 .2 2  (0.28)
LDL-C I 2.97 (0.89) 2.88 (0.79)* 3.01 (0.94) 2.80 (0.87)**
2 3.21 (0.83) 3.30 (0.88) 3.17 (0.78) 3.40 (0.73)
LDL-C : HDL-C 1 2.45 (0.84) 2 .2 2  (0.61)*** 2.65 (1.08) 2.46 (1.07)
2 2.83 (1.03) 3.07 (1.04) 2.66 (0.83) 2.85 (0.76)
* P < 0.05, * * P < 0.01, ***P < 0.001 between 1 and 2.
“Values in italics are median values for skinfold.
*’1 represents the sub-group of subjects with skinfold thickness equal to or less than the median value 
for that skinfold.
'^ 2 represents the sub-group of subjects with skinfold thickness greater than the median value for that 
skinfold.
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TABLE IX (4.4) Metabolic variables (mmol.L^) in men according to torso skinfold
thickness following adjustment to the Phantom body mass o f 64.58 kg. Values are
means ±(SD). (N = 68).
Subscapular 
(-0.04 cm /
Suprailiac 
(2.80 cm)
Abdominal 
(-0.33 cm)
Glucose 5.28 (0.35) 5.26 (0.36) 5.30 (0.38)
2 " 5.31 (0.38) 5.33 (0.36) 5.29 (0.35)
Total Cholesterol 1 4.79 (1.00) 4.76 (1.02) 4.97 (1.09)
2 5.14 (0.83) 5.18 (0.78) 4.97 (0.76)
TG 1 1.38 (0.82) 1.53 (1.17) 1.39 (0.94)
2 1.78 (1.41) 1.63 (1.17) 1.76 (1.34)
HDL-C 1 1.23 (0.23) 1.21 (0.25) 1.24 (0.26)
2 1.17 (0.29) 1 .2 0  (0.28) 1.17 (0.26)
LDL-C 1 2.95 (0.95) 2.89 (0.93)* 3.13 (1.03)
2 3.24 (0.74) 3.30 (0.73) 3.05 (0.65)
LDL-C : HDL-C 1 2.46 (0.94) 2.51 (1.00) 2.62 (1.05)
2 2.84 (0.94) 2.80 (0 .8 8 ) 2.68 (0.85)
* P < 0.05 between 1 and 2.
“Values in italics are median values for skinfold.
*’1 represents the sub-group of subjects with skinfold thickness equal to or less than the median value 
for that skinfold.
represents the sub-group of subjects with skinfold thickness greater than the median value for that 
skinfold.
Differences in serum glucose and lipids according waist and abdominal girths 
are shown in Table X (4.4). With the exception of serum glucose concentration, 
significant differences in all metabolic variables were found. TC, TG and LDL-C 
were significantly lower in the men characterised by a smaller waist and abdominal 
girth (P < 0.05). LDL-C : HDL-C was also significantly lower in men with smaller 
waist (P < 0.001) and abdominal girths (P < 0.01). HDL-C was significantly higher in 
the men with narrower waist (P < 0.001) and abdominal girths (P < 0.01).
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Table X  (4.4). Metabolic variables (mmol.L^) in men with different levels o f 
abdominal obesity determined using waist and abdominal girth measurements. (N =
Variable Waist girth Abdominal girth 
(97.6)
Glucose 1" 5.23 (0.31) 5.24(0.31)
2 ^ 5.36 (0.40) 5.36 (0.40)
TC 1 4.73 (0.96)* 4.74 (0.92)*
2 5.20 (0.84) 5.20 (0.90)
TG 1 1.15 (0.43)* 1.31 (0.83)*
2 2.01 (1.47) 1.85 (1.38)
HDL-C 1 1.31 (0.22)*** 1.29 (0.25)**
2 1.10(0.26) 1 .1 2  (0.26)
LDL-C 1 2.90 (0.90)* 2.87 (0.92)*
2 3.30 (0.77) 3.32 (0.79)
LDL-C : HDL-C 1 2.27 (0.83)*** 2.31 (0.92)**
2 3.07 (0.92) 3.01 (0.86)
* P < 0.05, **P < 0.01, *** P < 0.001 between 1 and 2.
“Values in italics are median values for waist and abdominal girth.
*’1 represents the sub-group o f subjects with a waist or abdominal girth equal to or less than the median 
value for that girth.
*^2 represents the sub-group with a girth measurement greater than the median.
After adjustment for the variation in stature, the magnitude of the differences in 
serum glucose and lipids appeared to be diminished. Significant differences remained 
for TC (P < 0.05) using stature normalised waist girth, TG (P < 0.01) and HDL-C (P < 
0.05) using both waist and abdominal girths, and LDL-C : HDL-C (P < 0.05 using 
stature normalised waist girth and P < 0.01 using stature normalised abdominal girth) 
[Table XI (4.4)].
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Table XI (4.4). Metabolic variables (mmol.L^) in men with different levels o f
abdominal obesity determined using waist and abdominal girth measurements
normalised to a Phantom stature (170.18 cm). (N = 68).
Variable Waist girth Abdominal girth
(7.^7)
Glucose 5.21 (0.31) 5.24 (0.32)
2 " 5.37 (0.40) 5.34 (0.40)
TC 1 4.73 (0.98)* 4.77 (0.99)
2 5.20 (0.84) 5.13 (0.85)
TG 1 1.16 (0.49)** 1.15 (0.44)**
2 1.97(1.45) 1.96 (1.45)
HDL-C 1 1.29 (0.23)* 1.28 (0 .2 1 )*
2 1.13(0.27) 1.14 (0.28)
LDL-C 1 2.92 (0.91) 2.98 (0.92)
2 3.26 (0.78) 3.20 (0.79)
LDL-C : HDL-C 1 2.35 (0.89)** 2.37 (0.83)*
2 2.96 (0.92) 2.92 (0.99)
* P < 0.05, **P < 0.01 between 1 and 2.
“Values in italics are median values for stature normalised waist and abdominal girths.
'’I represents the sub-group o f subjects with a waist or abdominal girth equal to or less than the median 
value for that girth.
*^2 represents the sub-group with a girth measurement greater than the median.
Following adjustment for differences in body mass, there were no significant 
differences between any of the metabolic variables using either waist or abdominal 
girths [Table XII (4.4)].
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Table XII (4.4). Metabolic variables (mmol.L^) in men with different levels o f 
abdominal obesity determined using waist and abdominal girth measurements 
normalised to a Phantom body mass (64.58 kg). (N = 68).
Variable Waist girth 
(O.Pg/
Abdominal girth 
(A27)
Glucose 5.23 (0.30) 5.22 (0.31)
2 " 5.36 (0.41) 5.37 (0.39)
TC 1 4.90 (0.96) 4.95 (0.97)
2 5.03 (0.91) 4.99 (0.90)
TG I 1.43 (1.00) 1.40 (0.99)
2 1.72 (1.30) 1.74(1.29)
HDL-C I 1.18 (0.23) 1.18 (0.23)
2 1.24 (0.29) 1.23 (0.29)
LDL-C 1 3.12(0.91) 3.17 (0.90)
2 3.07 (0.82) 3.00 (0.82)
LDL-C : HDL-C 1 2.75 (1.04) 2.79 (1.03)
2 2.55 (0.86) 2.51 (0.86)
All differences not significant (P > 0.05)
“Values in italics are median values for stature normalised waist and abdominal girths.
represents the sub-group of subjects with a waist or abdominal girth equal to or less than the median 
value for that girth.
2^ represents the sub-group with a girth measurement greater than the median.
Table XIII (4.4) shows simple bivariate correlations between fasting serum 
glucose and lipid concentrations and skinfold measurements. Glucose was related to 
abdominal skinfold only (r = 0.268, P < 0.05). Fasting TC, however, was significantly 
related to all torso skinfolds as follows: subscapular (r = 0.258); suprailiac (r = 0.267); 
abdominal (r = 0.277) (all P < 0.05); supraspinale (r = 0.312, P < 0.01). HDL-C was 
inversely correlated with all skinfolds. This relationship was significant (P < 0.05) 
with respect to biceps (r = - 0.239), suprailiac (r = - 0.264), abdominal (r = - 0.242)
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and mid-thigh (r = - 0.326, P < 0.01) skinfolds. LDL-C was also significantly related 
to biceps (r = 0.270), suprailiac (r = 0.239), supraspinale (r = 0.299) and abdominal 
skinfolds (all P < 0.05). The largest correlations were between biceps (r = 0.341), 
suprailiac (r = 0.370) and abdominal (r = 0.377) skinfolds with the LDL-C : HDL-C 
ratio (all P < 0.01). This ratio was also related to the mid-thigh (r = 0.313) and calf (r 
= 0.307) skinfolds (both P < 0.05).
TABLE XIII (4.4). Correlation coefficients showing the relationship between fasting 
serum glucose and lipid concentrations and skinfolds in healthy men (N = 68).
Glucose TC TG HDL-C LDL-C LDL-C : 
HDL-C
Triceps -0.229 -0.016 0.016 -0.058 -0.024 0.042
Biceps 0.088 0.206 0.068 -0.239* 0.270* 0.341**
Mid-thigh -0.007 0.156 0.213 -0.326** 0.151 0.313*
Calf -0.016 0.129 -0.038 -0.233 0.204 0.307*
Subscapular 0.191 0.258* 0.247* -0.139 0.177 0 .2 0 0
Suprailiac 0.092 0.267* 0.307* -0.264* 0.239* 0.370**
Supraspinale 0.176 0.312* 0.127 -0.055 0.299* 0.219
Abdominal 0.268* 0.277* 0.148 -0.242* 0.301* 0.377**
* P < 0.05; * * P < 0.01
Table XIV (4.4) shows correlations between the metabolic variables and the 
sum of eight skinfolds, the sum of torso skinfolds, the sum of limb skinfolds and the 
torso-to-limb skinfold ratio. Although individual limb skinfolds were unrelated to TC, 
when the sum of limb skinfolds was used, a significant relationship was observed (r = 
0.311, P < 0.01). Other significant (P < 0.01) correlations were found between HDL-C 
and the sum of eight skinfolds (r = - 0.417) and between LDL-C : HDL-C with the 
sum of eight skinfolds (r = 0.355), the sum of torso skinfolds (r = 0.412), the sum of 
limb skinfolds (r = 0.389) and the torso : limb skinfold ratio (r = 0.359).
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TABLE XIV (4.4). Correlation coefficients showing the relationship between fasting
serum glucose and lipids and various skinfold parameters in healthy men (n = 68).
Glucose TC TG HDL-C LDL-C LDL-C : 
HDL-C
E 8  skinfolds 0 .1 2 2 0.156 0.307* -0.417** 0.152 (1355**
E 4 torso 
skinfolds
0.154 0.305* 0.193 -0.285* 0.320** 0.412**
E 4 limb 
skinfolds
0.162 0.311** 0.240* -0.268* 0.306* 0.389**
Torso : limb 
skinfold ratio
0.107 0.228 0.073 -0.249* 0.272* 0.359**
* P < 0 .0 5 ;* * P < 0 .0 1
Correlations between fasting serum glucose, lipids and stature-normalised 
skinfolds are shown in Table XV (4.4). TC was significantly related to biceps (r = 
0.251), subscapular (r = 0.263) and suprailiac (r = 0.302) skinfolds (P < 0.05). TG was 
significantly related to biceps (r = 0.244) and subscapular (r = 0.301) skinfolds (P < 
0.05), and HDL-C was inversely related to abdominal skinfold (r = -0.323, P < 0.01). 
LDL-C : HDL-C showed the greatest association with the stature-normalised 
subcutaneous adiposity. Abdominal (r = 0.300), mid-thigh (r = 0.296) (both P < 0.05), 
triceps (r = 0.331), subscapular (r = 0.360) and medial-calf (r = 0.353) (all P < 0.01) 
skinfolds were all significantly related to this CAD risk ratio.
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TABLE XV (4.4.). Correlation coefficients showing the relationship between fasting
serum glucose and lipid concentrations and stature-normalised skinfolds in healthy
men (N = 68).
Glucose TC TG HDL-C LDL-C LDL-C : 
HDL-C
Triceps 0.109 0.199 0.071 -0.237 0.264* 0.331**
Biceps 0.204 0.251* 0.244* -0.140 0.173 0.195
Mid-thigh 0.004 0 .1 2 1 -0.040 -0.232 0.197 0.296*
Calf 0.218 0.233 -0.003 -0.197 0.306* 0.353**
Subscapular 0 .1 1 1 0.263* 0.301* -0.259 0.237 0.360**
Suprailiac 0 .2 0 1 0.302* 0.118 -0.047 0.291* 0.203
Abdominal 0.013 0.148 0.209 -0.323** 0.197 0.296*
*P<0.05; * * P < 0 .0 1
The relationship between the metabolic variables and skinfolds adjusted for 
body mass are presented in Table XVI (4.4). Significant relationships were found 
between subscapular skinfold and TG concentration (r = 0.301), abdominal skinfold 
and HDL-C (r = - 0.298), and between LDL-C : HDL-C and both subscapular (r =
0.293) and calf (r = 0.254) skinfolds (all P < 0.05).
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TABLE XVI (4.4). Correlation coefficients showing the relationship between fasting
serum glucose and lipid concentrations and body mass-normalised skinfolds in
healthy men (N = 68).
Glucose TC TG HDL-C LDL-C LDL-C : 
HDL-C
Triceps 0.097 0 .1 2 1 0.052 -0.177 0.158 0.205
Biceps 0.196 0.186 0.214 -0.097 0 .1 0 0 0.117
Mid-thigh -0 .0 1 1 0.046 -0.056 -0.191 0.105 0 .2 0 1
Calf 0.195 0.164 -0.014 -0.145 0.215 0.254*
Subscapular 0 .1 0 1 0 .2 1 0 0.301* -0.234 0.161 0.293*
Suprailiac 0 .2 1 1 0 .2 2 2 0.094 0.028 0.184 0.071
Abdominal 0 .0 0 2 0.062 0.209 -0.298* 0.034 0.206
*P < 0.05
The final results in this section are presented in table XVII (4.4). This shows the 
relationship between the metabolic variables and waist and abdominal girths. Also 
shown are the results obtained following adjustment of these girth measurements by 
the Phantom stature and body mass. Generally, the relationship between waist and 
abdominal girths and the lipid variables was stronger than the relationship with 
skinfolds. This relationship was strongest using the unadjusted waist and abdominal 
girths. After adjustment for stature the magnitude of the correlations were slightly 
reduced. However, after adjustment for body mass, correlations were dramatically 
reduced and only one remained significant. Fasting serum glucose was associated 
with stature-normalised waist (r = 0.260, P < 0.05) and abdominal girths (r = 0.243, P 
< 0.05) but was independent of these girth measurements in the unadjusted or body 
mass-adjusted forms.
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TABLE XVII (4.4). Correlation coefficients showing the relationship between fasting 
serum glucose and lipid concentrations and waist and abdominal girths. Also shown 
are the correlations with stature and body mass-normalised waist and abdominal 
girths (N = 68).
Glucose TC TG HDL-C LDL-C LDL-C : 
HDL-C
Waist 0.196 0.253* 0.414** -0.440** 0.226 0.421**
Abdomen 0.169 0.289* 0.384** -0.437** 0.276* 0.464**
Waist / Ht 0.260* 0.235 0.378** -0.394** 0.213 0.372**
Abdomen / Ht 0.243* 0.272* 0.356** -0.396** 0.263* 0.417**
Waist / Wt 0.197 -0.035 0.252* -0.182 -0.124 -0.005
Abdomen / Wt 0.172 -0.029 0.217 -0.162 -O.Ill -0 .0 0 1
Waist / Ht and Abdomen / Ht are waist and abdominal girths normalised to the Phantom stature 
(170.18cm).
Waist / Wt and Abdomen / Wt are waist and abdominal girths normalised to the Phantom body-mass 
(64.58 kg).
*P <0.05, * * P < 0.01
Many studies have, in the past, examined the relationship between 
anthropometrically-described AT distribution and indices of metabolic fitness. 
However, none have adjusted for differences in body size as this study has done.
The mathematical direction of the differences in glucose and lipids between the 
two groups formed for this analysis were as expected. Whether using skinfolds or 
girth measurements, leaner men were more likely to have a metabolic profile that 
presents them with less risk of CVD than fatter men. In many instances in this study, 
these differences were statistically significant and in line with previous research. 
However, a few surprising results were also generated. For example, when skinfolds 
were used in their unadjusted form, biceps appeared to be the best skinfold for 
identifying differences in all of the metabolic variables tested. With this kind of 
analysis, torso skinfolds were relatively insensitive to differences in glucose and 
lipids. As stated previously, subscapular skinfold has appeared as an independent
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predictor of CVD in several prospective studies. However, when men were divided 
according to subscapular skinfold thickness, there were no differences in any of the 
metabolic variables. Supraspinale was the best torso skinfold for identifying men 
more likely to have an adverse metabolic profile.
Previously, Pouliot et al. (1992) found a higher fasting glucose concentration in 
obese compared to lean men. Rates of glucose disposal and hepatic glucose output 
have also been found to be related to torso skinfolds (Abate et ah, 1995). Krotkiewski 
et al. (1983) found a highly significant relationship between waist girth and fasting 
glucose. In this study however, fasting glucose was not higher in men with greater 
subcutaneous adiposity nor was it related to skinfolds or girths. The one exception to 
this finding was with respect to the waist and abdominal girths adjusted for stature. 
Both of these measurements had a significant, if low, correlation with fasting glucose. 
Why men with a relatively large waist or abdominal girth for their height have a 
higher fasting glucose concentration is not immediately clear. Bearing in mind that 
skeletal muscle is the major site of non-oxidative glucose disposal, one possibility is 
that these men have an increased hepatic glucose output associated with their 
abdominal obesity but a low muscle mass.
With the exception of the consistent, if surprising, finding that biceps was the 
best skinfold for identifying differences in serum lipids, individual skinfolds seemed 
to be of little use for this purpose. Sums of skinfolds were no better, although E  torso 
skinfolds was able to identify a difference in serum TG that E limb, or E 8  skinfolds 
was not. The torso-to-limb skinfold ratio was equally ineffective. In the past, Leclerc 
et ah, (1983) found that BMI, skinfolds and total body fat were equally related to TG 
and HDL-C. Despres et al. (1985) found that abdominal and subscapular skinfolds 
were highly related to TG and HDL-C. The relationship between torso skinfolds and
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HDL-C was independent TG (Despres et a l, 1988). Of the lipid variables measured in 
this study, differences in the ratio of LDL-C to HDL-C were the most consistently 
identified using skinfolds and girths. Triceps, biceps, calf, supraspinale, E  8 skinfolds, 
E  4 torso skinfolds, waist and abdominal girths were all able to identify a difference 
in this CVD risk ratio. The difference in LDL-C : HDL-C, observed using biceps 
skinfold and waist girth to distinguish the men, was highly significant (P < 0.001). 
Standardising biceps skinfold for stature and body mass, and waist girth for stature 
had no effect on this finding. However, when waist girth was adjusted for body mass, 
no difference existed. Likewise, waist and abdominal girth were significantly related 
to the LDL-C : HDL-C ratio, TG and HDL-C in the non-standardised and stature- 
adjusted forms. When these girths were standardised for body mass, the size of the 
correlations was significantly diminished and they were no longer significant. The 
same phenomena could be observed for HDL-C, and to a lesser extent TG. Exactly 
why this occurs is unclear. Intuitively, the magnitude and consistency of the changes 
in the correlations seem too great to be explained as a random event. This finding 
illustrates the complexity of the relationship between blood lipids and physique and 
presents an intriguing opportunity for future research.
In summary, this study found that segregating individuals on the basis of 
anthropometric measures of total and regional subcutaneous adiposity was not a valid 
way of identifying subjects with elevated fasting serum glucose. With simple 
regression analysis, glucose was related to abdominal skinfold and also the waist and 
abdominal girths standardised for stature. However, these relationships were only 
weak. With regard to fasting serum lipids and lipoproteins, TC, TG, LDL-C, HDL-C 
and the LDL-C : HDL-C ratio all had significant relationships with subcutaneous 
adiposity. TC, TG, LDL-C and LDL-C : HDL-C are all positively associated with
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adiposity. HDL-C is inversely related to adiposity. No discernible subcutaneous AT 
pattern appeared with respect to the relationship with lipids. Rather, it appeared that 
total subcutaneous adiposity was important. Abdomen and waist girths were also 
significantly related to the metabolic variables examined in this study. A physique 
characterised by a greater abdominal girth is evidently associated with increased CVD 
risk via elevated TG, LDL-C, LDL-C : HDL-C and a decreased HDL-C. 
Standardising these anthropometric methods for variation in body size did not 
improve the ability to identify subjects with an adverse risk profile, nor did it increase 
the strength of relationships. However, adjusting for variation in body mass did result 
in the appreciable decrease in the relationship between serum lipids, waist and 
abdominal girths. The physiological significance of this finding requires further 
analysis.
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CHAPTER 5 
RESULTS & DISCUSSION .
STUDIES FOCUSING ON SOMATOTYPE
264
5.1 SOMATOTYPE AND ADIPOSE TISSUE DISTRIBUTION OF MEN 
WITH ANGIOGRAPHICALLY-DETERMINED CAD
The aim of this study was to describe the somatotype of men with angiographically- 
determined CAD and to investigate the relationship between somatotype, adipose 
tissue distribution and CAD. Descriptive statistics of the anthropometric 
characteristics and angiographic assessment are presented in Table I (5.1).
TABLE I (5.1). Means and standard deviations for age, body size, somatotype, fa t 
distribution and angiography results (N = 65).
Variable Mean SD
Age, years 61.5 8.7
Body mass, kg 81.02 13.00
Stature, cm 173.15 6 .1 0
BMI, kg.m'^ 27.0 4.0
Abdominal circumference, cm 99.9 10.7
Hip circumference, cm 1 0 0 .0 8 .0
AHR 1 .0 0.05
ASD, cm 26.4 3.6
Endomorphy 5.7 1.7
Mesomorphy 5.6 1 .2
Ectomorphy 1 .2 1 .0
Sum of 8  skinfolds, mm 153.8 53.2
Sum of torso skinfolds, mm 100.7 34.4
Sum of limb skinfolds, mm 53.1 2 1 .1
Torso/limb skinfold ratio 1.97 0.46
Myocardial score 6.70 3.58
Ventricular score 2 .2 0 2 .0 0
BMI - body mass index 
AHR - abdomen-to-hip ratio 
ASD - abdominal sagittal diameter
A mean somatotype (± SD) of 5.7 / 5.6 / 1.2 (1.7 / 1.4 / 1.0) illustrates a clear 
and equal dominance of endomorphy and mesomorph y with ectomorphy of only
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minor significance. A breakdown of the somatotypes into defined categories (Carter 
and Heath, 1990) was as follows: mesomorphic-endomorphs (N = 24); endomorphic- 
mesomorphs (N = 20); mesomorph-endomorphs (N = 10); balanced endomorphs (N = 
2); balanced mesomorphs (N = 1) and ectomorphic-endomorphs (N = 1). 
Furthermore, 35 (60%) somatotypes could be considered as extremes for their 
particular category (Carter and Heath, 1990).
The results of a zero-order correlation analysis between the somatotype 
components, indices of obesity and adipose tissue distribution, and the angiographic 
findings are shown in table II (5.1).
TABLE II (5.1). Pearson product-moment correlation coefficients between the 
somatotype components, indices o f obesity and adipose tissue distribution, and 
angiographic findings.
Variable
somatotype component 
Endomorphy Mesomorphy Ectomorphy
Age -0.37** -0.08 0.19
BMI 0.71*** 0.74*** -0.82***
Abdominal circumference 0.77*** 0.50*** -0 .6 6 ***
Hip circumference 0.64*** 0.53*** -0.59***
AHR 0.64*** 0.18 -0.47***
ASD 0.74*** 0.56*** -0.70***
E of 8 skinfolds 0.94*** 0.42** -0.51***
E of torso skinfolds 0.92*** 0.38** -0.52***
E of limb skinfolds 0.85*** 0.44*** -0.45***
Torso/limb skinfold ratio 0 .0 1 -0 .1 1 -0.05
Myocardial score 0 .0 1 0 .1 2 -0.08
Ventricular score -0.08 -0.06 0.08
*** P < 0.001, ** P < 0.01, * P < 0.05
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Mesomorphy and ectomorphy, but not endomorphy, were independent of age. 
The somatotype components were not related to the torso-to-limb skinfold ratio, but 
endomorphy, as expected, was highly significantly correlated with the sum of 8  
skinfolds (r = 0.94, P < 0.001), the sum of 4 torso skinfolds (r = 0.92, P < 0.001) and 
the sum of 4 limb skinfolds (r = 0.85, P < 0.001). Endomorphy was also related to 
abdominal adiposity as indicated by the correlations with abdominal circumference (r 
= 0.77, P < 0.001), AHR (r = 0.64, P < 0.001) and ASD (r = 0.74, P < 0.001). 
Mesomorphy was significantly related to BMI (r = 0.74, P < 0.001), this correlation 
being slightly greater than the coirelation between endomorphy and BMI (r = 0.71, P 
< 0.001). Mesomorphy was equally related to an increased abdominal circumference 
(r = 0.50, P < 0.001), ASD (r = 0.56, P < 0.0Ô1) and hip circumference (r = 0.53, P < 
0.001) but was not associated with the AHR (r = 0.18, P > 0.05). Ectomorphy was 
inversely associated with all measures of adiposity. None of the zero-order 
correlations between the somatotype components and the angiography findings were 
statistically significant (P > 0.05).
As the somatotype components were significantly interrelated (P < 0.01) 
(correlations shown later) further correlation analysis was performed using second- 
order partial correlations [(Table III (5.1)]. These correlations indicate the strength of 
the relationship between each somatotype component and the dependent variables 
after statistically controlling for the effects of the other two somatotype components. 
Generally, this had the effect of reducing the strength of the correlations.
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TABLE III (5.1). Partial correlation coefficients showing the relationship between 
each somatotype component, indices o f obesity and adipose tissue distribution, and 
angiographic findings after statistically controlling for the other two somatotype 
components.
Variable
somatotvpe component 
Endomorphy Mesomorphy Ectomorphy
Age -0.32* -0.05 0 .0 1
BMI 0.62*** 0.58*** -0.52***
Abdominal circumference 0.65*** 0.17 -0.26*
Hip circumference 0.49*** 0.29* -0.15
AHR 0.53*** -0 .2 2 -0.26*
ASD 0.60*** 0.25 -0.32*
E 8  skinfolds 0.92*** 0.37** 0.27*
E torso skinfolds 0.90*** 0.19 0 .1 2
E limb skinfolds 0.83*** 0.39** 0.31*
Torso/limb skinfold ratio -0 .0 2 -0.19 -0.15
Myocardial score -0.04 0.09 -0 .0 2
Ventricular score -0.08 -0.06 0.08
*** P < 0.001, ** P < 0.01, P < 0.05
Canonical correlation analysis revealed no significant relationship (P > 0.05) 
between the first or second pairs of canonical variâtes with only 3% of the variance in 
angiography results explained by the Heath-Carter anthropometric somatotype [(Table 
IV (5.1)].
268
TABLE IV (5.1). Results o f canonical correlation analysis between somatotype and 
angiographic findings.
Canonical Squared Chi-square Degrees of Significance 
correlations canonical freedom
correlations
First 0.168 0.03 1.790 6  0.938
Second 0.067 0.00 0.245 2 0.885
Table V (5.1) presents the loadings (correlations) between the original variables 
and their first and second canonical variâtes.
TABLE V (5.1). Correlations (loadings) between the somatotype components and the 
angiography results with their respective first and second canonical variâtes.
First canonical Second canonical
variate variate
Endomorphy 0.390 -0.860
Mesomorphy 0.966 0 .1 1 0
Ectomorphy -0.825 0.424
Myocardial score 0.721 0.693
LV function -0.419 0.908
For the first canonical variâtes, mesomorphy and endomorphy load positively (r 
= 0.966 and 0.390 respectively) and ectomorphy negatively on the somatotype variate 
(r = -0.825). On the variate that describes the angiography results, myocardial score 
loaded positively (r = 0.721) and ventricular score negatively (r = -0.419). These
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correlations suggest that the first somatotype variate is best interpreted as one of high 
mesomorphy, moderate endomorphy and low ectomorphy. The first angiography 
variate is one of a high myocardial score and low ventricular score. The loadings on 
the second somatotype variate suggest that this should be interpreted as a measure of 
low endomorphy and moderate ectomorphy, and the second angiography variate is 
one of high myocardial and ventricular scores.
This is the first investigation into the somatotypes of men undergoing 
investigative coronary angiography, although other investigators have used this 
approach to study the influence of overweight, fat distribution and subcutaneous 
adiposity (Hauner et al., 1990; Thompson et al., 1991; Flynn et al., 1993; Hodgson et 
al., 1994; Ley et al., 1994).
Previous studies by Gertler et al. (1950, 1951, 1967) and Spain et al. (1953, 
1955) suggested that mesomorphy was the most significant somatotype component 
with regard to predisposition to CAD. However, this conclusion should be viewed 
with caution as these studies examined the somatotype not as a gestalt, but focused 
only on the dominant component. In a later study, Spain and colleagues stated that 
endo-mesomorphic individuals had the highest prevalence rate for CAD, suggesting 
that body fatness was also a characteristic of at risk individuals (Spain gr al., 1963). 
However, Spain et al. suggested that “relative muscle mass rather than an increase in 
adipose tissue probably has a more direct association with the prevalence of coronary 
atherosclerotic heart disease, especially in the absence of hypertension”. One other 
study at this time also highlighted the precedence of endomorphy and mesomorphy in 
describing the physique of coronary cases (Paul et al., 1963). These latter findings 
were supported by the study of Smit et al. (1979) who used the Heath-Carter 
technique and reported a mean somatotype of 4 - 5.5 - 1 for a group of cardiac
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infarction patients. Using the same somatotype technique, this study has found an 
almost equal number of patients who are dominant in endomorphy and mesomorphy 
(30 patients were dominant in endomorphy, 26 dominant in mesomorphy and 2  
exhibited equality of endomorphy and mesomorphy). Whilst there was a clear 
dominance of endomorphy and mesomorphy, men who exhibit ectomorphic 
dominance appear to be at little risk of CAD. Thus, patients with angiographically- 
determined CAD are characterised by a physique of relative muscularity and 
adiposity, whereas linearity of physique is evidently not a physical characteristic of 
CAD patients. These data would, therefore, appear to support the recent conclusion 
that with regard to CAD risk, linearity in males appears to be advantageous (Malina et 
a l, 1997).
In an attempt to explain the observations outlined above, the relationship 
between somatotype and angiographic findings was investigated with canonical 
correlation analysis. The aim was to consider all three components together rather 
than treat each component as an independent variable. This approach to the analysis 
of somatotype data has been used previously by Gordon et a l  (1987) and Katzmarzyk 
et a l (1998). Gordon et a l (1987) found that somatotype was related to a set of serum 
lipids that included TC, LDL-C, HDL-C and TG in a group of young adult males. 
Katzmarzyk et a l  (1998) reported that a Heath-Carter anthropometric somatotype 
characterised by high endomorphy and mesomorphy was associated with higher levels 
of TG, LDL-C and fasting glucose, and lower levels of HDL-C in male and female 
youths aged 9- to 18-years. This analysis showed that the two pairs of canonical 
variâtes representing somatotype and angiography results were not related. However, 
examination of the pattern of loadings between the original variables and their 
respective first canonical variâtes indicated that a somatotype of high mesomorphy.
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moderate endomorphy and low ectomorphy, and an angiography variate represented 
by an increased myocardial score and a lower ventricular score were the linear 
combinations that provided the strongest possible correlation. Simple correlations 
between the somatotype components and the angiographic findings were also not 
significant. The absence of a significant relationship between somatotype and CAD 
may be due to the fact that CAD is an extremely complex disease with many 
biological, environmental and lifestyle risk factors. Also, rather than simply using 
clinical diagnostic criteria, a highly sensitive angiographic scoring system was 
employed to assess the severity of an occlusion. Variation in CAD severity 
established with this technique was clearly not of sufficient magnitude to be 
identifiable between different somatotypes.
Using simple correlation coefficients in this way is somewhat problematic as the 
relationship is confounded by the inter-relationship between somatotype components. 
In this study, correlations between the components were as follows: endomorphy and 
mesomorphy (r = 0.36, P < 0.01), endomorphy and ectomorphy (r = -0.56, P < 0.001) 
and ectomorphy and mesomorphy (r = -0.66, P < 0.001). Therefore, a partial 
correlation technique was used to investigate the relationship between the somatotype 
components and the dependent variables. This technique statistically controls for the 
confounding effect of the other two components. As recently noted, data analysis in 
which the components are treated individually, “dilutes the somatotype gestalt” 
(Malina et a l, 1997). However, it allows an evaluation of the relationship between the 
angiographic findings, adiposity indices and a somatotype component independently 
of the other two components.
In a study of 824 men, it was reported that those with an android fat distribution 
were more often classed as obese than gynoid fat men (Mueller and Joos, 1985).
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Furthermore, the android obese men were significantly more mesomorphic and less 
endomorphic than the gynoid obese. This, it was suggested, means that android 
obesity is associated with “deep body obesity” (presumably referring to intra­
abdominal adiposity) and “excess lean body mass”. Interestingly, several case-control 
studies employing angiographic assessment, and data presented previously in this 
thesis, suggest that an android fat distribution is a notable characteristic of men with 
CAD (Hauner et al., 1990; Thompson et al., 1991; Flynn et al., 1993; Hodgson et al., 
1994; Ley et al., 1994). Other anthropometric indicators of upper trunk, android or 
abdominal obesity, have also been shown to be predictors of CVD or increased CVD 
risk. These include the ASD (Seidell et al., 1994), waist circumference (Han et al., 
1995) and trunk skinfold thickness (Donahue et al., 1987). In this study, the simple 
correlations between the somatotype components and the anthropometric 
measurements of total subcutaneous adiposity and AT distribution indicate that 
endomorphy is strongly and positively related to all indices. Mesomorphy is 
moderately and positively related to all indices except the AHR. Ectomorphy is quite 
strongly and inversely related to all indices. The exception to this finding is the torso- 
to-limb skinfold ratio that is not correlated with any of the somatotype components 
when analysed in this way. After adjustment for the inter-relationship between 
components, the correlations are generally reduced. However, endomorphy remained 
significantly positively related to abdominal circumference, AHR and the ASD, whilst 
mesomorphy was not significantly associated with any of these variables and, in fact, 
became inversely related to the AHR. Of further note is the finding that BMI, which is 
a widely used indicator of obesity in many epidemiological and clinical settings, was 
almost equally related to endomorphy and mesomorphy after partial adjustment.
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This investigation has shown that men with angiographically-documented CAD 
exhibit an almost equal dominance of endomorphy and mesomorphy. Ectomorphy, 
however, is a physical characteristic that appears to be beneficial in terms of CAD 
risk. Probably the largest published samples of men of similar age who have been 
somatotyped with the Heath-Carter anthropometric technique are those of Canadian 
(Bailey et al., 1982) and British men (King cited in Carter and Heath, 1990). These 
data showed the mean somatotype (± SD) of the Canadian men aged 50- to 59-years 
to be 4.1 - 5.4 -1.6 (1.2 -1.2 - 0.9) and the British men aged 50- to 64-years to be 3.9 
- 5.9 - 1.3 (1.0 - 1.1 - 0.9). Recent data from the Quebec Family Study reported a 
mean somatotype of 4.0 - 5.6 - 1.5 (1.5 - 1.0 - 1.0) for 233 men aged 40 to 49-years 
(Malina et al., 1997). In comparison to these data, the CAD patients in this study are 
approximately equal in mesomorphy, slightly less in ectomorphy and between 1.5 to
2.0 units greater in endomorphy. In general, the CAD patients in this study are also 
older than the Quebec subjects. It is possible, therefore, that increasing body fatness 
with age in mesomorphic individuals predisposes to CAD in later life. This conclusion 
is in agreement with an opinion forwarded more than 30 years ago suggesting that 
mesomorphs are prone to excessive weight gain and should adopt an active lifestyle to 
maintain energy balance (Gertler, 1967).
The biological mechanisms that associate obesity (represented by a high 
endomorphy rating) with CAD have been delineated in some detail (Kissebah and 
Krakower, 1994). A biological role for mesomorphy (representing lean body mass), 
however, is less clear. Two possible explanations are proposed.
As obese individuals also have a large absolute lean body mass (Forbes, 1977), 
the high mesomorphy rating reported for CAD patients is simply an artefact. That is, 
endomorphy is biologically relevant in CAD risk and mesomorphy is coincidental.
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Given the substantial body of evidence that is now available suggesting that 
skeletal muscle plays an important role in metabolic disease risk (Basset, 1994), this 
seems unlikely. Therefore, the following explanation is more likely.
The physiological significance of skeletal muscle fibre-type in the aetiology of 
insulin resistance and a metabolic syndrome that includes hypertension, insulin 
resistance and android obesity has been outlined by several authors (Basset, 1994; 
Kelley and Simoneau, 1997; Simoneau and Kelley, 2000). Type Ub skeletal muscle 
fibre proportion has been shown to be negatively correlated with insulin-stimulated 
glucose uptake (Lillioja et a l, 1987). Furthermore, in comparison to type I fibres, type 
II fibres have a lower capillary density (Lillioja et al., 1987) and reduced capacity for 
the oxidation of NEFA’s (Kelley and Simoneau, 1997). Theoretically, therefore, 
individuals with a high proportion of type Ilb fibres are predisposed to insulin 
resistance and fat accumulation in adipose tissue. Mesomorphy may, therefore, have a 
more direct role in CAD risk if, in genetically susceptible individuals, it is associated 
with this particular fibre type. Conversely, ectomorphs would be ’protected’ against 
obesity, insulin resistance and their consequences by a having a high proportion of 
type I fibres. They are ectomorphic because they are high fat ’burners’. Current 
evidence from studies of skeletal muscle characteristics, obesity and insulin resistance 
suggests that this is a reasonable supposition and would explain the predisposition of 
mesomorphs for body fat gain.
Thus, chronically inactive, ageing mesomorphs may be susceptible to 
abdominal obesity, insulin resistance, hypertension and a dyslipidemia that includes 
elevated TG, apo B and the atherogenic small dense LDL particles and reduced HDL-
C. This cluster of metabolic factors has been described previously (Despres, 1995). It 
was not possible to assess insulin sensitivity in these patients, but this metabolic
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derangement has been previously documented in patients undergoing angiography 
(Shinozaki et a l, 1996). Individuals characterised by ectomorphic dominance appear 
to have a low risk of CAD as this component is associated with leanness and a 
favourable risk factor profile.
With regard to application of these findings, it would seem sound advice to endo- 
mesomorphs and meso-endomorphs that they endeavour to become leaner (more 
ectomorphic) at the cost of endomorphy and that the mesomorphic component, i.e. the 
lean body mass, should be kept physically active. Interestingly, recent findings from 
the Aerobics Center Longitudinal Study in Dallas, Texas have suggested a lower 
relative all-cause mortality risk in obese men (% body fat > 25) classified as ’fit’ in 
comparison to lean (% body fat < 16.7), ’fit’ men (Lee et al., 1999). Individuals 
characterised by higher levels of ectomorphy should aim to maintain this 
characteristic and avoid becoming more endomorphic with advancing age. A study of 
CAD risk factors in individuals high in mesomorphy but low in endomorphy and 
ectomorphy is needed to completely delineate the relevance of mesomorphy in CAD.
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5.2 SOMATOTYPE OF MEN WITH CAD AND HEALTHY AGE- 
MATCHED CONTROLS.
The aim of this study was the somatotype comparison of the men with CAD and a 
group of men who were apparently healthy and matched for age. The mean (± SD) 
ages of the CAD patients and healthy men were 53.2 (6.5) and 51.2 (4.0) respectively 
(P = 0.77). As MANOVA revealed a significant difference in somatotype between 
these men (Wilks’lambda = 0.887; F (3, 71) = 3.013; P = 0.036), further examination 
was undertaken using a univariate F-test to reveal which components where 
significantly different. These results are presented in table I (5.2) below.
Table I  (5.2). Means ±  standard deviations o f the somatotypes o f men with 
angiographically-documented CAD (n — 27) and healthy, age-matched men (n = 38)
Variable Mean ± (SD) F(df) Significance
Endomorphv
CAD 6.32 (1.62) 4.456 (1,73) 0.038
Healthy 5.57 (1.43)
Mesomorphv
CAD 5.72 (1.46) 2.079 (1, 73) 0.154
Healthy 5.28 (1.18)
Ectomorphv
CAD 0.91 (0.91) 7.851 (1,73) 0.006
Healthy 1.61 (1.17)
(df) degrees of freedom
Although the mean somatotypes of these groups of men were similar (both 
exhibit high ratings for endomorphy and mesomorphy with the ectomorphic
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component of only minor importance) there are statistically significant differences for 
endomorphy and ectomorphy. The CAD patients were significantly greater in 
endomorphy (P = 0.038) and lesser in ectomorphy (P = 0.006).
The small but significant differences in endomorphy and ectomorphy in the age- 
matched samples are also in agreement with the notion that increased fatness and, 
therefore, weight-for-height are physical characteristics that predispose to CAD.
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5.3 SOMATOTYPE AND METABOLIC FITNESS
The results in section 5.1 show that men reporting consecutively for coronary 
angiography exhibit high ratings, and an almost equal dominance, of endomorphy and 
mesomorphy. In this investigation, canonical correlation analysis was used to 
investigate the relationship between somatotype and the results of the angiographic 
assessment. It was suggested that this multivariate technique allows an important 
aspect of somatotype data analysis to be upheld; i.e. the somatotype is treated as a 
gestalt.
The aim of this subsequent investigation was to examine the association 
between somatotype and fasting concentrations of serum glucose, TC, LDL-C, HDL- 
C, the HDLrLDL ratio and TG in a group of apparently healthy adult males. These 
biochemical parameters have been suggested to be important indicators of metabolic 
fitness (Katzmarzyk et a l, 1998). Metabolic fitness, which includes parameters such 
as blood lipids and lipoproteins, fasting and post-prandial glucose and insulin levels, 
is a term that was first introduced a short time ago and is an important component of 
health-related fitness (Bouchard and Shephard, 1994).
Table I (5.3) shows the age, anthropometric characteristics and metabolic profile 
of the subjects. The mean somatotype rating is defined as an endomorph-mesomorph
i.e. endomorphy and mesomorphy are dominant and equal (or do not differ by more 
than 0.5) and ectomorphy is of minor significance. A breakdown of the somatotypes 
into defined categories (Carter and Heath, 1990) was as follows: endomorphic- 
mesomorphs (n = 24); mesomorphic-endomorphs (n = 24); mesomorph-endomorphs 
(n = 12); central (n = 2); balanced endomorphs (n = 2); mesomorphic-ectomorphs (n = 
1); ectomorphic-mesomorphs (n = 1); balanced ectomorphs (n = 1) ectomorphic- 
endomorphs (n = 1).
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Table I (5.3). Descriptive statistics (means ±  standard deviations) fo r  age, 
anthropometric variables and indicators o f metabolic fitness (n = 68).
Variable Mean SD
Age (years) 43.9 9.1
Body mass (kg) 75.9 9.4
Stature (cm) 174.4 5.6
Endomorphy 5.5 1.4
Mesomorphy 5.3 1.3
Ectomorphy 1.7 1.1
Glucose (mmol.L'^) 5.30 0.36
TC (mmoLU') 4.97 0.93
LDL-C (mmol.L'') 3.09 0.86
HDL-C (mmolL'') 1.21 0.26
HDL:LDL 2.65 0.95
Table II (5.3) shows the results of the canonical correlation analysis. As 
correlations of < 0.30 explain less than 10% of the variance between canonical pairs, 
and statistical significance is largely dependent on sample size, only canonical 
correlations greater than this level are interpreted (Tabachnick and Fidell, 1989). In 
this analysis, as only the first canonical correlation was > 0.30 the second and third 
canonical correlations have been ignored. The first canonical correlation marginally 
failed to reach significance but suggests that somatotype accounts for 24% of the 
variation in metabolic fitness (rc = 0.496, P = 0.06).
280
Table II (5.3). Results o f canonical correlation analysis showing the relationship
between somatotype and metabolic fitness.
First Squared canonical Chi-square Degrees Significance
canonical correlation of
correlation freedom
0.495 0.24 24.328 15 0.06
Figure 1 (5.3) presents the loadings or correlations between the original 
(standardised) variables and their first canonical variate. Again correlations of > 0.30 
were interpreted. For the somatotype variate, endomorphy and mesomorphy both load 
negatively and ectomorphy positively. For the metabolic fitness variate, TC, TG, 
LDL-C and glucose all load negatively and HDL-C loads positively. The size of the 
correlation indicates the relative contribution that each variable makes to its respective 
variate. These loadings suggest that the first somatotype variate is best interpreted as 
one of high endomorphy, moderate mesomorphy and low ectomorphy. The first 
metabolic fitness variate is one of moderately high glucose, TC, TG and LDL-C and 
moderately low HDL-C.
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- 0.5  -
- 0.75 -
GLUCOSENDO MESO ECTO —  TC TG HDL-C LDL-C
■  - 0.968 - 0.524 0.753 - 0.408 - 0.665 - 0.549 0.505 - 0.688
Figure 1 (5.3). Loadings (correlations) between the somatotype components, 
indicators o f metabolic fitness and their respective first canonical variâtes.
Table III (5.3) shows third-order partial correlations between the individual 
somatotype components and the indicators of metabolic fitness. Third-order partial 
correlations were used to adjust for the confounding effect of age and the inter­
relationship between the somatotype components. Endomorphy was positively and 
significantly related to TC (P = 0.09), TG (P = 0.05), LDL-C (P = 0.001) and the
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HDL-C:LDL-C ratio (P = 0.001). Mesomorphy was inversely related to HDL-C (P =
0.05) and ectomorphy was positively related to HDL-C (P = 0.02) and inversely 
related to the HDL-C: LDL-C ratio (P = 0.001).
Table III (5.3). Third-order partial correlations showing the relationship between the 
individual somatotype components and the indicators o f metabolic fitness after 
adjusting the confounding interrelationship between the somatotype components and 
age. Significance values are shown in parentheses.
Somatotvpe component 
ENDO MESO ECTO
Glucose 0.214 (0.09) 0.138 (0.27) -0.140 (0.26)
TC 0.317 (0.01) 0.043 (0.74) -0.187(0.13)
TG 0.238 (0.05) 0.094 (0.46) -0.218 (0.08)
HDL-C -0.222 (0.07) -0.250 (0.05) 0.273 (0.02)
LDL-C 0.331 (0.001) 0.088 (0.48) -0.212 (0.09)
HDL-C:LDL-C 0.430 (0.001) 0.241 (0.05) -0.356 (0.001)
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The association between somatotype and disease of metabolic origin has now 
been examined in several studies. Fredman (1972) studied a relatively small group of 
Tamil Indians who were diabetic, prediabetic or healthy and, although the data were 
not subjected to the rigour of statistical analysis, it was suggested that there was no 
difference in the somatotype of these sub-groups. In a later study, Fredman (1974) 
indicated that diabetic Tamil Indians were significantly more mesomorphic than 
controls and that mesomorphy, but not endomorphy or ectomorphy, was positively 
correlated with fasting glycaemia. Earlier in this thesis, a mean somatotype that was 
characterised by high ratings of endomorphy and mesomorphy, and a low rating for 
ectomorphy was reported for men with CAD. This was in agreement with several 
previous studies that also emphasised the importance of these first two components in 
describing men with CAD (Spain et ah, 1963; Paul et aL, 1963; Smit et al., 1979).
With regard to the dominance of endomorphy and mesomorphy in this 
investigation, the findings are similar to previous quite large studies of Canadian 
(Bailey et aL, 1982) and British men (King, cited in Carter and Heath, 1990). 
However, there does appear to be a difference in the size of the endomorphic 
component that was reported to be 4.1 ± 1.2 for the Canadian men and 3.9 ± 1.1 for 
the British men (means ± SD). Recent data from the Quebec Family Study reported a 
mean somatotype for men of a comparable age that was approximately equal for 
mesomorphy and ectomorphy but 1.5 units lower for endomorphy (Malina et aL, 
1997). As these studies employed the same somatotype method as this study, this 
difference could be due to either systematic bias in skinfold measurements or it may 
reflect the recent increased prevalence of obesity that has been well documented 
(Fehily, 1999). In comparison to the mean somatotype of men with angiographically-
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documented CAD in this study, the mean somatotype of this apparently healthy cohort 
suggests they are a group at high risk of CAD.
The use of canonical correlation analysis in this investigation is because neither 
physique nor metabolic fitness can be adequately described by a single variable 
(Katzmarzyk et aL, 1998). In this study, the first canonical correlation suggested that 
approximately 24% of the variance in metabolic fitness could be explained by 
variation in somatotype. This is similar to a previous investigation of adult males 
(Gordon et aL, 1987) that was conducted using a larger sample. The explained 
variance seems to be smaller in boys aged from 9- to 18-years, but this study was also 
based on a larger sample (Katzmarzyk et aL, 1998). In a study of 233 males of similar 
genetic background, somatotype was found to be weakly associated with CAD risk 
factors that included blood pressure and fasting serum glucose and lipids (Malina et 
aL, 1997). However, at the extremes of the risk factor distributions, there was a clear 
delineation between somatotypes. Those with an adverse risk factor profile tended to 
be more endomorphic and mesomorphic and less ectomorphic than those with a better 
profile who were more ectomorphic.
There are two reasons for exploring the loadings between the variables and their 
respective canonical variâtes. Firstly, the significance of the canonical correlation is 
highly dependent on sample size. Secondly, an examination is necessary to evaluate 
the biological significance of the correlation. The size and directions of the loadings 
are in agreement with those previously reported for younger subjects (Katzmarzyk et 
aL, 1998). An interpretation of the loadings is that a somatotype of high endomorphy, 
moderately high mesomorphy and low ectomorphy is associated with higher fasting 
serum concentrations of glucose, TC, TO and LDL-C and a low HDL-C level.
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Alternatively, a somatotype of high ectomorphy and low endomorphy is associated 
with a greater HDL-C concentration and lower levels of glucose, TC, TG and LDL-C.
Support for this conclusion can be derived from the third-order partial 
correlation analysis that was performed in order to examine the influence of each 
individual component independently of the other two, and age. Analysis of this kind is 
preferred to simple correlations because of the inter-relationship between the 
components. Whilst recognising that this destroys the meaning of the somatotype, i.e. 
it does not treat it as a gestalt, it facilitates the biological interpretation of the data. 
Significant positive correlations between endomorphy and TC, TG, LDL-C and the 
HDL-C : LDL-C ratio can be explained by the metabolic disturbances that are 
associated with obesity (Kissebah and Krakower, 1994). Conversely, relative leanness 
or linearity is associated with a higher HDL-C and an increase in the ratio of HDL to 
LDL cholesterol.
In conclusion, this investigation has shown that somatotype and metabolic 
fitness are not significantly related in a group of men whose mean age was 43.9 ±9.1 
years. However, a somatotype characterised by high endomorphy and low 
ectomorphy is associated with an adverse metabolic profile which includes high TC, 
TG, LDL-C, and glucose and a low HDL-C concentration. A moderately high 
mesomorphy rating also appears to be associated with this adverse metabolic profile, 
although not to the same extent as endomorphy. A high degree of ectomorphy appears 
to be protective against CAD and this is partly mediated by a favourable metabolic 
profile, most noticeably a high HDL-C. These data reaffirm that, as part of a healthy 
living strategy, men should endeavour not to accumulate excess body fat. 
Furthermore, individuals who have high ratings in endomorphy should attempt to lose
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body fat and, as ectomorphy is defined as a lack of weight-for-height, possibly mass 
per se in order to become more ectomorphic.
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CHAPTER 6
SUMMARY, CONCLUSIONS AND DIRECTIONS 
FOR FUTURE RESEARCH
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6.1 SUMMARY, CONCLUSIONS AND DIRECTIONS FOR FUTURE 
RESEARCH
This thesis is a compendium of studies that were performed using data that were 
collected on two separate occasions with a view to studying the association between 
physique, CAD and CAD risk. On the first occasion, men undergoing investigative 
coronary angiography for suspected atherosclerosis were measured with a variety of 
anthropometric procedures. The anthropometric measurements were examined in 
relation to an angiographic scoring system that is designed to account not only for the 
extent of coronary stenosis, but also the anatomical distribution of lesions within the 
coronary arteries. Thus, by considering the portion of the myocardium that is affected 
by the stenosis, it more precisely measures the severity of coronary atherosclerosis in 
comparison to methods that ignore which artery, and which part of the vessel, is 
affected. Furthermore, it treats atherosclerotic severity as a continuous rather than a 
dichotomous variable. For example, two patients could have a single arterial blockage 
of equal size. One blockage may be at a distal site in a small arterial branch the other 
could be at the top of the left main stem. Clearly, the latter of these is of greater 
clinical significance than the former. The system used in these studies, however, is not 
able to account for coronary artery plaque dynamics i.e. the stability of an 
atherosclerotic plaque. As this study and others have now shown that physique is 
associated with CAD, future studies should focus on the relationship between 
physique and plaque morphology.
In agreement with previous investigations reviewed in this thesis, the data 
presented in Chapter 4 suggests that waist and abdominal girths are the simplest 
anthropometric measurements for identifying people at risk of CAD. However, they 
are not sensitive enough to distinguish between those with severe and those with less
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severe CAD. This is probably due to the complex multi-factorial nature of the disease. 
An increased visceral AT is thought to present obese subjects with the greatest risk of 
CVD. Whilst they will be expensive and difficult to perform, a definitive answer to 
the role of fat distribution in CVD risk will only be found when large prospective 
studies that measure visceral fat (or predict it very accurately) are completed.
With regard to which indirect predictor of visceral AT is best from a public 
health perspective, it appears that waist or abdominal girths are equally useful. They 
are easily measured, well understood by the public and cut-off points for CVD risk are 
in existence. Whether these cut-off points are valid across all populations irrespective 
of factors such as age, race and physical level remains to be seen.
One aspect of the relationship between anthropometry and CVD risk that has 
not received much attention is that of proportionality. Put simply, are waist girth 
measurements above a recognised level related to CVD in all individuals or is the 
relationship modified by size? Are the relationships between measures of adiposity 
and CVD risk factors independent of size? Studies outlined in this thesis suggest that 
the absolute size of adiposity indices (girths and skinfolds), and the stature-adjusted 
values are equally related to fasting serum glucose, TG, LDL-C and HDL-C. 
However, adjusting for body mass significantly reduces the strength of this 
relationship. The exact meaning of this finding requires further explanation but it 
appears that adiposity and body mass interact in the relationship with metabolic 
fitness.
Somatotype and CAD severity are apparently unrelated, although men with 
CAD have a somatotype that is high in endomorphy, high in mesomorphy and low in 
ectomorphy. However, the significance of this should not be over-stated as the healthy 
men exhibited a similar somatotype. Because of the small number of subjects used in
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this comparison, further studies are required to clarify the significance of somatotype 
in CAD. One area that should be given specific attention is the role of a large muscle 
mass in CVD risk. The role of fibre type has been outlined in Chapter 2 of this thesis, 
but the significance of muscle mass per se has not been examined. The canonical 
loadings of the somatotype components on the metabolic variables suggests that 
mesomorphy as well endomorphy is associated with higher fasting serum glucose, 
TC, TG and LDL-C and a lower HDL-C.
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